Home Blog Page 157

WHO/PAHO and partners set out Zika strategic response plan for the next 18 months

0

WHO/PAHO and partners have set out their strategic response to Zika which will place a greater focus on preventing and managing medical complications caused by Zika virus infection. To date, US$121.9 million are necessary to effectively implement the Zika Strategic Response Plan, July 2016 to December 2017.
“Much has been learned about Zika virus infection, how it spreads, the consequences of infection and priorities for its control since we developed the initial response framework,” said WHO Director-General Dr Margaret Chan. “The response now requires a unique and integrated strategy that places support for women and girls of child-bearing age at its core.”

The revised Zika Strategic Response Plan includes a greater focus on preventing and managing medical complications caused by Zika virus infection and expanding health systems’ capacities for that purpose. Risk communication targeting pregnant women, their partners, households and communities will be central to prevention efforts to ensure they have the information they need to protect themselves.

Other elements include integrated vector management, sexual and reproductive health counselling as well as health education and care within the social and legal contexts of each country where Zika virus is being transmitted.

The plan highlights several specific characteristics of the Zika outbreak that require a collaborative, global response and support. These include

  • the potential for further international spread of Zika virus given the wide distribution of Aedes mosquitoes that are capable of transmitting Zika virus,
  • the lack of population immunity in areas where Zika virus is circulating for the first time and which allows the disease to spread quickly,
  • the absence of vaccines, specific treatments and rapid diagnostic tests, and
  • inequalities in access to sanitation, information and health services in affected areas.

Funding

More than 60 partners are engaged in the global response to Zika, up from 23 partners in February 2016. To date, WHO, PAHO and 14 partners (out of the more than 60) have expressed funding needs in the combined amount of US$121.9 million to implement the revised plan from now until December 2017.

“Coherent funding mechanisms are essential for successful implementation of this revised Strategic Response Plan,” said Dr Chan. In May 2016, the United Nations Secretary-General established a UN Zika Response Multi-Partner Trust Fund to generate and ensure the effective use of the required funding.


Media contact information

Nyka Alexander: Tel: +4122 791 5029; Mob: +4179 634 0295;
Email: alexandern@who.int

Christian Lindmeier: Tel: +4122 791 1948; Mob: +4179 500 6552;
E-mail: lindmeierch@who.int

Tarik Jasarevic: Tel: +4122 791 5099; Mob: +4179 367 6214;
E-mail: jasarevict@who.int

Pfizer, experts, collaborate on improving healthcare emergency system

2

The need to advance the national health care emergency system of African countries, in order to forestall a continental epidemic, was the focus of the two-day workshop on emergency health system in Africa.

The seminar, which was organised by the Association Of Good Clinical Practice in Nigeria (AGCPN) in conjunction with Pfizer Plc, was well attended by experts on the subject.pfizer_logo_detail

According to the President of AGCPN and Professor of Radiation  Medicine at the University of Nigeria, Enugu Campus, Prof. Ifeoma Okoye, the need for an effective and efficient health emergency system is indispensable,  to the overall healthcare service delivery.

Okoye argued that continuous neglect of health emergency will have negative effect across broad spectrum in the health sector.

She added that “there is the need for capacity development both human and infrastructural, with clinical trial as a fulcrum towards addressing future public health emergencies in Sub-Saharan Africa.

“There is the need for close collaboration between public and private establishments/sectors in Sub-Saharan Africa towards combating and reducing mortality and morbidity.

Also, Prof. Maurice Iwu harped on the need to enhance modulation in tracking diseases as well as the introduction of microbiota system. He noted that there is an urgent need for concerted efforts in improving healthcare emergency in the sector for optimum results.

The participants also emphasized  on how pertinent it is  for  all tiers of Governments, NGO and private partners to support clinical trials and research generally across Sub-Saharan Africa.

 

 

 

Ricoh Makes Information Work for Healthcare

0



Information should be at the heart of patient, staff and business success—not the core of their challenges. We make it easier for healthcare organizations to efficiently capture, transform and manage information to reduce risk, increase efficiency and improve care. Healthcare: www.ricoh-usa.com/healthcare

source

7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit August 29-31, 2016

0

 BABE 2016 welcomes attendees, presenters, and exhibitors from all over the world to Atlanta, USA. We are delighted to invite you all to attend and register for the “7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit” (BABE 2016) which is going to be held during August 29-31, 2016 at Atlanta. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the BABE 2016, where you will be sure to have a meaningful experience with scholars from around the world. All members of the BABE 2016 organizing committee look forward to meeting you in Atlanta, USA.

BABE 2016 Conference which is an International Pharma Marketing Industry Conference is a scientific platform to meet fellow key decision makers all-around the Academic Institutions, Healthcare Institutes, Pharmaceutical, Biotech, CROs supply chain, Logistics practitioners making the congress a perfect platform to share experience, foster collaborations through the research talks & presentations to put forward many thought provoking strategies. It's a perfect stage to brainstorm, discover new ideas, search for new skills and a platform to show your capabilities and discoveries to the world. BABE  2016 will be one of the outstanding Bioavailability and Bioequivalence Conferences.The Bioavailability Bioequivalence Research Center and BA/BE global conferences aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. It plays a key role in the drug development period for both new drug products and their generic equivalents. These studies are also important in the post approval period in the presence of certain manufacturing changes. Information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners can be discussed in bioavailability meeting.

Why to attend???

With all the scientific people over the world focused on learning about Pharmaceutical Current and Novel trends and advanced strategies in Pharma Marketing Industry.This is a best globalised opportunity to reach the largest assemblage of participants from the Pharma community. We anticipate participants, renowned speakers and eminent delegates across the globe attending the conference to share their valuable presentation and galvanize the scientific community. BABE 2016 is a 3-day event offering the Exhibition at venue to showcase the new and emerging technologies and Conduct presentations, distribute information, meet with potential scientists, make a splash with new drug developments, and receive fame and recognition. Our services have always met with great achievement in Business Conferencing. World-renowned speakers, the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.

Target Audience:

  • CRO
  • Professors, Associate Professors, Asst Professors
  • PhD Scholars
  • Graduates and Post Graduates
  • Directors, CEO’s of Organizations
  • Association, Association presidents and professionals
  • Noble laureates in Health Care and Medicine
  • Bio instruments Professionals
  • Research Institutes and members
  • Supply Chain companies
  • Manufacturing Companies

‘Bioavailability and Bioequivalence’ is an international forum to present and discuss current perspectives in drug research. Bioequivalence Conference provides the scope for opportunities to learn progressed by international scientists and academicians. The Bioavailability Bioequivalence Research Center and BA/BE global conferences aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. It plays a key role in the drug development period for both new drug products and their generic equivalents. These studies are also important in the post approval period in the presence of certain manufacturing changes. Information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners can be discussed in bioavailability meeting.

The global generics sector reached $269.8 billion in 2012. This sector is expected to reach $300.9 billion in 2013 and $518.5 billion in 2018, with a compound annual growth rate (CAGR) of 11.5%.

  • An overview of the global market for generic  drug including coverage of therapeutic
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.The North American market is estimated to reach nearly $73 billion in 2011 and is expected to increase at a 7.9% compound annual growth rate to reach nearly $107 billion in 2016.
  • The United States is currently spending almost $250 billion a year for prescription drugs. If drugs were sold in a competitive market, without government-imposed patent monopolies, this might achieve savings up to $200 billion a year.

 

Fig 1

 

Major Associations :

  • Bioanalytical Focus Group and Ligand Binding Assay
  • American Association of Pharmaceutical Scientists (AAPS)
  • Royal Netherlands Chemical Society
  • The European Bioanalysis Forum
  • BEBAC Consultancy Services for Bioequivalence and Bioavailability
  • American Thyroid Association
  • Generic Pharmaceutical Association
  • FDA
  • European Generic medicines Association.
  • Therapeutics Goods Administration (TGA)
  • European Economic Area
  • Canadian Generic Pharmaceutical Association (CGPA)
  • Bioequivalence and Bioavailability forum
  • FDA Office of Surveillance and Epidemiology
  • Drug Watch
  • ORPHANET Parenteral Drug Association
  • PharmGKB
  • US Food and Drug Administration (FDA)
  • American Association for Clinical Chemistry (AACC)
  • American Association of Pharmaceutical Scientists (AAPS)
  • Clinical Trials Information from National Institutes for Health (NIH)
  • National Institute of Standards and Technology (NIST)

For more details please visit- http://bioavailability-bioequivalence.pharmaceuticalconferences.com/

76th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2016

0

d4c1e0e9-48ea-4d41-8ea2-ba62e5af2da5(Buenos Aires, Argentina • 28 August – 1 September 2016)

Rising to the challenge: reducing the global burden of disease.

During the 2016 FIP Congress in Buenos Aires, Argentina pharmacists and pharmaceutical scientists will rise to the challenge to reduce the global disease burden. Are you prepared to take this challenge?

Of the top 10 causes of death around the world, nine are diseases. Heart disease, stroke, HIV/AIDS, chronic obstructive pulmonary disease, lung cancer, diabetes and diarrheal diseases are among this list. But the burden of disease is not just about the years of life lost due to death; it is also about years lost due to living in less than full health. As a result, there has been an effort to change from a sickness care model to a health model. Our role in improving the outcomes of treatments is the essence of the pharmacy profession and of pharmaceutical scientists. Creating, preparing and providing medicines is based on this role. Moving from a sickness model to a health model means that pharmacy is also now about disease prevention and health promotion.

 Pharmaceutical scientists, pharmacists and pharmacy educators are dedicated to integrating evidence-based practice to improve the use of medicines. Innovation that creates new treatment options with medicines, collaborative practices (not only within health professionals, but also individuals and communities themselves), practices that improve the use of medicines, prevention (of both diseases and complications from existing disease) and public health programmes all have the potential to reduce the global burden of disease.

 The International Pharmaceutical Federation (FIP) and the Confederaçion Farmacéutica Argentina (COFA) invite you to Buenos Aires, the dynamic capital of Argentina and home of the tango. Come and be captivated by the lively atmosphere in this elegant city, the gateway to South America, where plains, vineyards, jungles and great rivers await discovery

International Workshop On Health Care Leadership, Financing And Innovation, Dubai

0

Dubai traing 16.-3

In every health care delivery system, there is need for pragmatic leadership to ensure the provision of optimum health care service. All over the world, governments and private institutions are developing and implementing unique models for meeting present and emerging challenges in health care delivery. Pharmanews-WhiteTulip Training is equipped to help deliver the requisite capacity development required to champion sustainable models of service delivery among health care and pharmaceutical industry players.

 

We wish to invite you to participate in our international programme on “Health Care Leadership, Financing and Innovation”, taking place in Dubai, The United Arab Emirates.

 

Date:             Saturday 20 – Thursday 25 August, 2016

Time            9.00a.m – 5.00p.m (daily)

Venue:          Executive Towers at Bay Avenue,

                       Business Bay, Dubai, United Arab Emirates

 Target Participants

Doctors, Pharmacists, Nurses, Medical Laboratory Scientists and other clinical, administrative, management and technical personnel in the public and private health care system.

 Course Content:

  • Essentials of Clinical Leadership
  • Strategic Management and Organisational Communication
  • Quality Management Protocols
  • Health Care Financing Models and Structure
  • Investment Models in Health Care Facility Development
  • Comparative Study of Global Health Care Entrepreneurship Models
  • ICT in Health Care Systems

Learning Objectives:

At the end of the workshop, participants will be able to:

  • Lead effectively, communicate clearly and deliver optimal health care service within the health care delivery system.
  • Understand basic concepts in managing and developing strategies for effective change.
  • Understand globally accepted and sustainable techniques in quality management protocols.
  • Understand global health care financing models, challenges and its opportunities for Innovation in Africa.
  • Comprehend best investment models and current management approaches and strategies for achieving effective facility development.
  • Learn global best-case models for driving health care entrepreneurship ventures.
  • Effectively initiate and supervise ICT integration with operational processes of health care service

 Participants are expected to arrive on Saturday, 20 and depart on Thursday, 25 August.

 Registration Fee

  • $1,850 (or Naira equivalent) per participant on or before 12 August, 20
  • $1,950 (or Naira equivalent) per participant after 12 August, 2016.

 Group discounts: 3 – 5 participants: 5%,    6 – 9 participants: 10%,   10 participants and above: 15%

 

Registration fee covers: Tour, workshop materials, tea/coffee break, lunch, certificates, and visa processing ONLY.

Participants are to take care of their travel expenses, dinner, and accommodation.

 

Hotel Accommodation

Participants can get accommodation close to the workshop venue at an average rate of $100 $120 per night. For more options on hotel accommodation, please visit the online booking site: www.agoda.com

Cancellation

For cancellation of registration fee, 70% of the fee will be refunded, if cancelled at least seven (7) days to the workshop and the information communicated to us by sms or email, using: training@pharmanews-whitetulip.com

There will be no refund if cancelled thereafter.

Method of Payment

Participants should pay registration fee into Pharmanews-WhiteTulip training account in GTBank Plc (A/c No. 0179132705) and send their full names and bank deposit slip number by sms or email to training@pharmanews-whitetulip.com. Payments in dollars should be made to Pharmanews Ltd. Domiciliary Accounts: GTB A/c No. 0005082226

Payment Online

Payments can also be made through our payment portal on GTBank SME market hub facility. To make payment online, visit: https://pharmanews.smemarkethub.com

Please note that payment in naira can only be accepted in Nigeria. In Dubai, the dollar equivalent will be paid.

Financial Transactions in Dubai

Your financial transactions in Dubai will be done in the local currency, UAE Dirham. The current rate is 3.7 Dirham to 1 US$.

Arrival and Departure

Participants are expected to arrive on or before Saturday, 20th and depart Thursday, 25th.

 City Tour

For the tour, temperature will be at an average of 37° Celsius. We advise casual wear with shoes suitable for walking. Cameras will also be useful for pictures.

Travel Information

 Intending participants are advised to make reservation for flight ticket to Dubai through these online booking sites: www.wakanow.com or www.opodo.co.uk. Available airlines on the booking sites are Emirates, Kenyan Air, Etihad, Ethiopian Airways, and Qatar Airways, among others.

Visa

After registration, participants will be contacted on the procedures for visa procurement. The visa fees are covered in the registration fee.

For further information, please contact:

Cyril Mbata                                –   +234 706 812 9728

Adekola Adediran                        –   +234 703 225 2123

Elizabeth Amuneke                    –   +234 805 723 5128

 

Novartis expands partnership with Medicines for Malaria Venture to develop next-generation antimalarial treatment

0
  • Novartis will lead the development of antimalarial compound KAF156 with scientific and financial support from Medicines for Malaria Venture in collaboration with the Bill & Melinda Gates Foundation.
  • KAF156 belongs to a novel class of antimalarials that act against both the blood and liver stages of the parasite’s lifecycle
  • Antimalarials with new mechanisms of action are urgently needed to tackle emerging parasite resistance to current therapies

Novartis announced today that it will further expand its long-standing partnership with Medicines for Malaria Venture (MMV). Novartis will lead the development of antimalarial compound KAF156 with scientific and financial support from MMV in collaboration with the Bill & Melinda Gates Foundation. This agreement sets out the terms and conditions for the development of KAF156 and its future availability to patients.

“With a child dying from malaria every two minutes and the threat of drug resistance growing year-on-year, there is a real urgency to step up global efforts to combat this disease,” said Joseph Jimenez, CEO of Novartis. “Partnerships and collaborations like this one with MMV are essential for the development of next generation antimalarials and accelerating efforts to eradicate this deadly disease.”

KAF156 belongs to a novel class of antimalarial molecules and is one of the first antimalarial drug candidates to enter Phase IIb clinical development in more than 20 years. It acts against the two parasites responsible for the majority of malaria deaths (Plasmodium falciparum and Plasmodium vivax) and against both the blood and liver stages of the parasite’s lifecycle. Further, it has the potential to provide a more convenient dosing regimen and to address the multidrug resistance that has emerged in five countries of the Great Mekong Sub-region (GMS). KAF156 builds on the heritage of Novartis in antimalarial drug development and the launch in 1999 of Coartem®, the first fixed-dose Artemisinin-based Combination Therapy (ACT). ACT is the current standard of care in malaria treatment.

“We are delighted to extend our partnership with Novartis in the development of this exciting candidate antimalarial medicine with the potential to tackle drug resistance and improve patient compliance,” said Dr. David Reddy, CEO of MMV. “As such, this agreement marks an important milestone, as MMV continues its mission to discover, develop and deliver new, effective and affordable antimalarials to the patients who need them most.”

The Novartis Malaria Initiative is committed to drive research, development and access to novel drugs to eliminate malaria. It is one of the pharmaceutical industry’s largest access-to-medicine programs. Since 2001, the initiative has delivered more than 750 million treatments without profit, including 300 million dispersible pediatric treatments, developed by Novartis in collaboration with MMV, mostly to the public sector of malaria-endemic countries. Although preventable and treatable, malaria continues to kill a child every two minutes and threatens the lives of many more.(1) It is caused by parasites transmitted to people through the bite of infected mosquitoes. A comprehensive range of interventions is required to eradicate the disease, from bed nets and spraying for prevention to diagnostics and medicines to treat the disease and block its transmission.

Distributed by APO (African Press Organization) on behalf of Novartis International AG.

Novartis Media Relations
Central media line : +41 61 324 2200

Eric Althoff
Novartis Global Media Relations
+41 61 324 7999 (direct)
+41 79 593 4202 (mobile)
eric.althoff@novartis.com

Patrick Barth
Novartis Global Media Relations
+41 61 696 6273 (direct)
+41 79 732 08701 (mobile)
patrick.barth@novartis.com

e-mail: media.relations@novartis.com

About the Novartis Malaria Initiative

The Novartis Malaria Initiative is focused on conducting research and development for the next generation of antimalarials, improving access to treatment and helping communities deliver better healthcare. Operated by Sandoz, the Novartis generics and biosimilars division, the Novartis Malaria Initiative is one of the pharmaceutical industry’s largest access-to-medicine programs. Since 2001, the initiative has delivered more than 750 million treatments without profit, including 300 million dispersible pediatric treatments, mostly to the public sector of malaria-endemic countries.

Novartis has a long heritage in antimalarial drug development. Coartem®, the first fixed-dose Artemisinin-based Combination Therapy (ACT), was launched in 1999. ACT is the current standard of care in malaria treatment. Currently, there are two potential antimalarial therapies in Phase II clinical trials in the Novartis portfolio, KAE609 (cipargamin)(2) and KAF156. Both are new classes of compounds that treat malaria in different ways from current therapies, and could help combat growing resistance to existing artemisinin-based combination therapies.

About MMV

MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Its mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and delivering new, effective and affordable antimalarial drugs.

Since its foundation in 1999, MMV and partners have built the largest portfolio of antimalarial R&D and access projects ever assembled, and brought forward six new medicines that are already saving lives. MMV’s success is based on its extensive partnership network of over 400 pharmaceutical, academic and endemic-country partners in more than 55 countries.

MMV’s vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease.

www.mmv.org

About KAF156

KAF156 belongs to a new class of dual-acting compounds known as imidazolepiperazines (IZPs) that target the parasite at both the liver and blood stage of its reproductive cycle. If confirmed in clinical trials, the dual antimalarial activity of the IZP compounds would give this class promise as a potential first-line therapy for the prevention and treatment of malaria(3,4). KAF156, currently in Phase IIb clinical trials, is the result of a Wellcome Trust, Medicines for Malaria Venture and Singapore Economic Development Board supported joint research program with the Novartis Institute for Tropical Diseases, the Genomics Institute of the Novartis Research Foundation, and the Swiss Tropical and Public Health Institute. The research program aimed to discover the next generation of antimalarial drugs. Novartis is developing KAF156 with scientific and financial support from MMV.

References

  • World Health Organization, World Malaria Report 2015: http://apps.who.int/iris/bitstream/10665/200018/1/9789241565158_eng.pdf?ua=1. Last accessed January 2016.
  • White NJ, Pukrittayakamee S, Phyo AP, Rueangweerayut R, Nosten F, Jittamala P, Jeeyapant A, Jain JP, Lefèvre G, Li R, Magnusson B, Diagana TT, Leong FJ. Spiroindolone KAE609 for falciparum and vivax malaria. New England Journal of Medicine. 2014 July 31;371(5):403-10.
  • Leong FJ, Zhao R, Zeng S, Magnusson B, Diagana TT, Pertel P. A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers. Antimicrob. Agents Chemother. 2014 Nov; 58(11):6437-43.
  • Kuhen KL, Chatterjee AK, Rottmann M, Gagaring K, Borboa R, Buenviaje J, Chen Z, Francek C, Wu T, Nagle A, Barnes SW, Plouffe D, Lee MC, Fidock DA, Graumans W, van de Vegte-Bolmer M, van Gemert GJ, Wirjanata G, Sebayang B, Marfurt J, Russell B, Suwanarusk R, Price RN, Nosten F, Tungtaeng A, Gettayacamin M, Sattabongkot J, Taylor J, Walker JR, Tully D, Patra KP, Flannery EL, Vinetz JM, Renia L, Sauerwein RW, Winzeler EA, Glynne RJ, Diagana TT. 2014 KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission. Antimicrob. Agents Chemother. 2014 Sep;58(9):5060–7.

SOURCE
Novartis International AG

Voluntary unpaid blood donations must increase rapidly to meet 2020 goal

0

boy-w-logos-630

Voluntary, unpaid blood donations must be increased rapidly in more than half the world’s countries in order to ensure a reliable supply of safe blood for patients whose lives depend on it, WHO said on World Blood Donor Day.

This year, the theme of World Blood Donor Day is “Blood connects us all”, highlighting the common bond that all people share in their blood. The slogan, “Share life, give blood”, draws attention to the role that voluntary donation systems play in encouraging people to care for one another and promoting community cohesion.

“Although we have many external differences, the same vital blood pumps through all our veins,” said Dr Margaret Chan, WHO Director-General. “Voluntary, unpaid blood donation is the act of giving life – the greatest gift any person can give or receive.”

About 108 million blood donations are collected globally every year. Nearly 50% of these blood donations are collected in high-income countries, home to less than 20% of the world’s population. The average blood donation rate is more than 9 times greater in high-income countries than in low-income countries.

However, in many countries, demand exceeds supply, and blood services face the challenge of making sufficient blood available, while also ensuring its quality and safety. An adequate supply can only be assured through regular donations by voluntary, unpaid blood donors.

Regular voluntary unpaid blood donors are the foundation of a safe blood supply because they are associated with low levels of infection that can be transmitted by transfusions, including HIV and hepatitis viruses. Around the world, 25 countries are unable to screen all donated blood for one or more of these infections due to irregular supply of test kits, staff shortages, poor quality test kits, or lack of basic quality in laboratories.

WHO encourages all countries to establish blood services based on full voluntary non-remunerated blood donations. Today, only 62 countries get close to 100% of their national blood supplies from voluntary unpaid blood donations, with 34 countries still dependent on family donors and even paid donors for more than 75% of their blood supply.

Blood can be used whole, or separated into its component parts, such as red blood cells, platelets, plasma, and other “substances” that can be used to treat a wide range of diseases. A single unit of blood can be used to benefit several patients.

Transfusions of blood and blood products helps save millions of lives every year, including during emergencies such as conflicts, natural disasters, and childbirth. It can help patients suffering from life-threatening conditions live longer and with higher quality of life, and supports complex medical and surgical procedures.

“Voluntary blood donors come from all walks of life but they have one thing in common: they put others before themselves — people they don’t even know,” said Dr Ed Kelley, Director of the Department of Service Delivery and Safety at WHO. “Each time they donate blood, they commit an act of selfless heroism.”

World Blood Donor Day has been celebrated annually since 2004, with the aim of improving the safety and adequacy of national blood supplies by promoting a substantial increase in the number of safe, voluntary, unpaid donors who give blood regularly.

This year, the host country for World Blood Donor Day is Netherlands, through Sanquin, the national blood supply organization. The global event will take place on 14 June 2016 in Amsterdam, attended by His Majesty King Willem-Alexander.

Media contact
Simeon Bennett
Mobile: +41-79-472-7429
Office: +41-22-791-4621
Email: simeonb@who.int

BASF increases Prices for Ethanolamines in Europe

0

Ethanolamines are high-class intermediates used in the manufacture of crop protection agents and wood protectants, surfactants for detergents and cleaning products, process chemicals for gas treatment, lubricants and cement additives as well as active pharmaceutical ingredients. BASF produces ethanolamines at its Verbund sites in Ludwigshafen, Germany; Antwerp, Belgium; and Nanjing, China.

With immediate effect, or as existing contracts permit, BASF is increasing its European sales prices for ethanolamines (EOA) as follows:

Monoethanolamine (MEOA)         + 20 EUR/ mt
Diethanolamine      (DEOA)          + 30 EUR/ mt
Triethanolamine      (TEOA)          + 50 EUR/ mt

or by the equivalent amounts in local currency. The price increase will also apply to current supply agreements as soon as and to the extent permitted by their terms and conditions.

logo_twittercard_large

About BASF
At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. The approximately 112,000 employees in the BASF Group work on contributing to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio is organized into five segments: Chemicals, Performance Products, Functional Materials & Solutions, Agricultural Solutions and Oil & Gas. BASF generated sales of more than €70 billion in 2015. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information at  www.basf.com.

Nursing council lists benefits of nursing educational reforms

0

… As Healthy Living Communication holds 6th nurse leaders forum

For nursing to remain relevant in the comity of health care professionals in Nigeria, the cooperation of all stakeholders in the implementation of nursing educational reforms is key, Mrs . Bolaji Shode, head, Lagos office, Nursing & Midwifery Council of Nigeria (NMCN) has said.

Shode, who was speaking in the capacity of the Registrar, NMCN, at the Health care Industry Interactive Forum for nurse leaders, organised by Healthy Living Communications, held at the NIMR Auditorium, Yaba, gave details on nursing education reforms in Nigeria and why it should be embraced by all and sundry.

Explaining the reason for a restructuring  in nursing education,  she  said the change is imperative for the  profession to achieve the best future possible, for  the educational system  to reflect the changing needs, demands and trends in the society, and the more pragmatic the reforms embarked upon, the better the professional growth and development that follows.

 

Nurs cou
L-R: Mr Emmanuel Oriakhi, managing director, Healthy Living Communications; Mrs F.O. Animashaun, head, Nursing Department, Lagos State Health Services Commission; and Mrs Bolaji Soyinde, head,Lagos Office, Nursing and Midwifery Council of Nigeria, at the forum in Lagos

The Lagos NMCN Head further revealed the council’s opinion on the ongoing nursing educational reforms, which they wish to be in line with the National Policy on Education. When this is achieved, she said the advantages will be more than the pains for nurses across the nation.

Some of the benefits of the modification she listed are as follows: authorization of institutions by relevant  organ of the Federal Government to award academic certificates to the graduates;  academic progression of the students along existing educational system will be smooth and straight forward; the difficulty of placement of nurses in the labour market will be eliminated.

Aside the advantages for nurses, she said there are cogent justifications for the reforms, which makes the implementation much more imperative. “Changes in patient and disease profiles; advances in medical and information technology; the  shift to evidence-based practice, the need for life-long professional development;  the challenges of working in health care teams, etc. “, are the justifications she listed.

In her own contribution, the Director of Nursing, Ministry of Health, Alausa-Lagos, Mrs Dorcas Shonibare, charged the nurses on the need to imbibe the soft skill of critical thinking, which aides problem solving.

“In this age and time, nurses should be problem solvers, and that is why the skills of critical thinking, innovation, effective communication, leadership, are indispensable for all of us” she stressed. In order to possess these skills, she said nurses have to be apt to learn and open minded, to achieve excellence in their service delivery.

The Malaria Project Officer, Exxon Mobile Nigeria, Mr Akin Fatunke, who was one of the guests at the forum, tasked the nurses on the need to be abreast of trends in the profession. “Starting with the discipline, you are to ensure that you are up to date with the latest technology and research as it affects you. When I mentioned the fact that nurses need to be professional, I mean as a professional, how do you treat yourself, how do you brand yourself because it is after you are the best friend to yourself that you can give your best to others.

“So the ABC of the profession of nursing is the fact that you care, care, and care for others and of course yourself. I tell you, it will come to a point that after you have taken care of so many other people and people are relegating you to the background, either within the medical profession or not, you begin to see people fighting for you because you have done your job so well”.

On the issue of malaria control in the country, Fatunke said they will not relent in the provision of Insect ides Treated Nets to the people, and will also continue to train nurses, doctors, and pregnant mothers on the ABCD of malaria treatment.

Regarding the frequent complaints on the use of treated nets, he said, the Exxon Mobile health care team have gone back to the drawing board and funded the manufacturers of these nets in Sub Saharan Africa, to ensure that the long lasting insecticide treated nets that are been produced now don’t conduct that kind of heat, and I also discovered that it is an attitude thing.

While appreciating the participants and sponsors of this year’s interactive forum, the convener of the program, MD/CEO, Healthy Living Communications, Mr Emmanuel Oriakhi, disclosed that the wellbeing of patients is ultimate goal of the workshop.

He explained that if nurses have the required knowledge and skills to offer the needed care to patients, and if there is mutual inter-professional relations among health care givers, then the rate of mortality will be drastically reduced.

 

Pfizer unveils its website

0

As part of its activities to satisfy customers' information need, Pfizer in Nigeria and East Africa has recently launched its website whose URL is www.pfizernear.com.

According to the press release announcing the launch of the website, it stated that the company has designed the website to provide the ultimate user-friendly experience with improved navigation and functionality. The new website will allow customers to access detailed product information and videos with the option to share information across all major social networking sites. Created with the user experience firmly in mind, the website has also been built to be compatible with today's browsers and mobile devices.

“We have established this portal as a foundation for credible information. It will be a great platform where stakeholders can explore more into our business, what our business is about and what it can do in the future. We are proud of our website and will continue to improve the site so that it best serves how we communicate to our various stakeholders”,said Ngozi Ushedo, media and public relations manager.

She further asserted that Pfizer is dedicated to making significant contributions on improving global health through innovative initiatives.

 

 pfizer_logo_detail

 

 

About Pfizer Inc.: Working together for a healthier world™

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life.  We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals.  Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world’s best-known consumer products.

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.  Consistent with our responsibility as the world’s leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world.  For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

 

To learn more about our commitments, please visit us at www.pfizer.com

 

 

 

Irrational drug use: When we die not of diseases but from medications

23

Irrational drug use

For some days now, news of a teenage girl, Amina Ibrahim, who died of Stevens-Johnson Syndrome, has become the talk of medical parlance, and of national concern. The poor girl ended up a consumed prey of this rare medical condition after being attended to, for cold and cough, by a quack chemist who, shortly after Amina was terribly down with this condition and was no more, disappeared into thin air. This occurrence, albeit very unfortunate, is very didactic for the Nigerian populace as far as rational and irrational drug use is concerned, and points to the very reason why qualified health care practitioners should, under all circumstances, be our first and last point of call for any of our health issues, and more importantly, why it behoves the medical personnel to improve their modus operandi.

Aforementioned rational drug use, which I believe to the medical world rings a bell, is what the generality of Nigerians should understand, and probably be made aware of in the manner of their peculiar pecuniary awareness; because as it is today, drugs still form a major part of medical therapy. Rational use of drugs demands that ” medicines be taken based on patients' clinical requirements, at doses sufficient for their individual needs, for an appropriate period of time, and at affordable cost for them and community”.
Irrational use of drugs is not a problem peculiar to Nigeria but, in fact, a serious global menace. WHO stipulates that half of all medicines are inappropriately prescribed, wrongly dispensed, insouciantly sold, and half of all patients fail to ensure correct and adequate compliance. Irrational drug use does not leave out overuse, underuse, and misuse of medicines; the use of too many drugs for a patient ( poly-pharmacy ), administration of antimicrobials for non-microbial infections, the use of injection when pharmacotherapy will be achieved with oral, self-medication, the use of medicines for unintended purposes, and general aspect of drug abuse.
In Nigerian context, given the above definition and aspects of rational and irrational drug use, it is quite clear and obvious that irrational use of medicines is commonplace in our society, and which, with little or no attention meted out on it by medical professionals and the government alike , has, pitifully, continued to soar to the detriment of Nigerians.
I, like preponderance of poor Nigerians, have been an indirect victim of irrational use of drugs. I remember about seven years ago, one of my closest relatives received antikoch ( TB drugs) for nothing less than five months before it was later found, using more complex diagnostic measures, that the person in question did not have Tuberculosis. Though before the commencement of the regimen, the sputum test for the condition gave negative result, she was, nonetheless, placed on the said drug. Many people, out of ignorance and inadequate enlightenment, have become addicts, buying and using drugs in a bid to improve their performance at work. Witnessing all this scenario of drug misuse has been one of my experiences during my industrial training as a pharmacy student, and often times, I had to explain to people why depending on drugs to perform maximally at their daily work was not the way to go. Sometimes, we had risible cases of people looking for tramadol to arm themselves before their salacious visit to the brothel.
I would not be amazed if statistical data reveals that Nigeria loses more people yearly to deaths culminated from irrational use of medicines than deaths from traffic accidents, especially if developed nation like U.S., given its technological wizardry and sheer medical advancement , could, according to CDC ( Centers for Disease Control and prevention), record an historical 2.8 – fold increase in total number of deaths from prescription drugs from 2001 to 2014, then probably, it would not be far off to assert that “Pharmageddon” – period when medicine and its use would fetch more ill-health than health- is already, or at best, will soon be upon on us.
Misuse of medicines pervades the nooks and crannies of our society; a common practice among both the illiterate and the gentry. This misuse is exploited for myriad of purposes; boosting sexual performance, for pain relieving, euphoria, improving work strength, for false sense of wellbeing (” to get high”), sedation, for keeping awake, etc, and the vast number of people, from all walks of life, involved, is a pointer to the crystal-clarity of the epidemic nature of this “Plague”. Having said this, some people, however, have partaken in irrational drug use not for the above-listed exploits, but out of ignorance, abject poverty, carefree attitude, etc.
When blaming the goose, gander should not be exempted. The REAL culprits of irrational drug use are not only the quack chemists and patent medicine sellers who parade themselves as medical doctors, but also the qualified health care professionals who, for one reason or the other, perennially fail to conform to their professional ethics. For instance, I know of some health care institutions where patients' relatives are given undue and unethical access to confidential medical files of the in-patients. When these patients need any drugs, but not available in the hospital pharmacy, the patients' relatives would be given the file to search for the drugs outside. This practice, as witnessed in the hospital where one of my friends undergoes his 12-month internship programme, always gives room for any drug addition, subtraction, or alteration on the file by the bearers. Also, the out- patients are generally allowed to go home with their prescription papers and get their drugs wherever they may, even if patients are prescribed controlled drugs like narcotic analgesics. As expected, this has never failed to yield detrimental consequences because, henceforth, patients go about using the same prescriptions for subsequent purchase of drugs.
Patients, who, despite their going to the hospital, have had their medical conditions worsened and probably died due to wrong prescription and dispensing of drugs for wrong or yet to be diagnosed indications, are numerous, and major contributors to this great number have partly been occasional non-performance of necessary tests and examinations, professional negligence on the part of medical personnel involved, wrong diagnosis, large patient to doctor ratio which results in hasty prescription, and unhealthy lack of communication between health care practitioners which frustrates team work and puts patients in the danger zone; where two elephants fight, the grass there suffer.
Sometime recently, there was public outcry about some Nigerians who were about to be executed by Indonesian government for illegal drugs trafficking. Before and after this incidence, we had had cases of many Nigerians partaking in hard drugs trafficking, and for the reason known or vague, the trend can only continue to climb, given the widespreadness of irrational use of medicine in our country. When drugs are being handled like foods that you can easily go to the market and get, then we can only expect the attending consequences. Psychiatric cases, reckless driving by commercial drivers and riders, drug traffickings, rapings, social and political thuggery, disturbance and threat to public peace and security, vandalism,and other anti-social activities, are what that can never be found wanting in a society, like ours, where irrational drug use has become a culture.
Health care personnel should endeavour to always be ethical in their professional dispensation. The drug custodians, pharmacists, should let the mere handling of medicines to the patients be a thing of the time of yore. Drugs are chemicals which have potential to benefit or harm the body system; a common knowledge among these ‘men of honour ‘ which I don't think I need to tell them but feel their patients gravely need to be told. To this end, therefore, comprehensive provision of information on drug side-effects, uses, proper mode and manner of administration, storage, interaction with other co-administered drugs, compliance, etc, will immensely ensure drastic reduction of deaths resulting from medications. Also, performance of necessary tests and examinations, avoidance of hasty prescription, ensuring correct diagnosis, forging healthy rapport through effective communication, inter alia, are matters of utmost saliency which, I'm sure, our doctors know are very crucial in bettering the lot of their patients.
Reduction of patient to health care personnel ratio, provision of world-class medical equipment, availability of funds for the organization of public enlightenment and education on the evil of irrational drug use, proper and implementable policies and legislation against drug abuse and misuse, creation of conducive environment for active and better participation of NGOs and parastatals in the ‘war' against irrational use of medicines and related crimes, all these, if the government is really interested in saving its people from this ‘boko-haramic' menace that threatens the size of our country, then, are worth its urgent attention. Our numerical strength, if greatly harnessed, can breed our greatness. So, nothing should be allowed to tamper with it.
People should learn to live naturally without drugs except for the utmost end of need. Swallowing painkillers and antibiotics for slightest body pain is no brainer, and parading ourselves as self-doctor or pharmacist is suicidal. Paracetamol, to many, is peanut, unbeknown to them that it's hepatotoxic ( has potential to damage liver), while few people know that vitamins from natural sources are way better than vitamins capsules or tablets. Eating balanced diet; staying away from fast and canned foods, regular physical exercise, living in adequately ventilated place, cultivating habit of excellent personal hygiene, reducing stress through sufficient rest and positive thinking, cutting down on alcohol, abstinence from smoking, strict avoidance of refined sugar found in soft drinks (refined sugar contributes to insulin resistance which is highly implicated in diabetes), can keep us away from drugs altogether and save us from their adverse effects.
I will not say creating an El Dorado out of our society is an impractical utopia. Giving this “winged beast” a serious and onerous combative confrontation will in no measure go a long way in fighting this our common “enemy” and creating a perfect or semblance of a perfect society of our own.Not possible? Let's try first and see how far we get. Like one of my friends would say: “not everyone is infected but surely everyone is affected”. Therefore, the war on irrational drug use is a collective battle of the health care professionals, government, and as well as the generality of Nigerians.
BY OMOTOSHO MUIDEEN TITILOPE
muideenomotosho@yahoo.com
07038488933

UI Pharmacy Alumni Association donates N2.5 Million to the faculty

1

Poised to provide an enabling environment for teaching and learning, the Alumni Association of the Faculty of Pharmacy, University of Ibadan, has donated the sum of Two million, Five hundred thousand naira, to support the procurement of  a bus for the faculty.

The event, which took place at the Faculty of Pharmacy, on May 26, 2016, was attended by the executive members of the Alumni Association of the faculty, Dean of the faculty; Pharm (Prof.) Chinedum P. Babalola, FPSN, heads of departments in the faculty , executive members of the Pharmaceutical Association of Nigeria Students, UI Chapter, representatives of the Director of Public Communication of the University of Ibadan and the Executive Officer of the Alumni Association of the University of Ibadan.

UI PIX
L-R: Pharm (Dr). Dapo Adetunji , sub-dean: Undergraduate, Faculty of Pharmacy, UI and financial secretary, UI Pharmacy Alumni Association; Pharm. Adeyinka Adeyemi , asst. general secretary, UI Pharmacy Alumni Association; Miss Bolutife Adedeji , general secretary, PANS, UI; Pharm. Yombo Agboola, chairman, Fund Raising, UI Pharmacy Alumni Association; Pharm. Lanre Tiamiyu president, UI Pharmacy Alumni Association; Pharm (Professor) Chinedum P. Babalola ,dean, Faculty of Pharmacy, UI;, Pharm. Abiodun Adeyemo, vice-president, UI Pharmacy Alumni Association; and Pharm. Olayinka Kotila , general secretary, UI Pharmacy Alumni Association.

President of the Alumni Association; Pharm Olanrewaju Tiamiyu, while handing over the cheque to the Dean of Pharmacy, re-echoed the focus of the Alumni, which was saddled on helping the faculty and by extension, the University. Pharm. Tiamiyu mentioned that the most pressing need of the faculty was the procurement of a bus, which the faculty has been unable to procure in over 30 years of its existence. Though the Alumni executive was re-inaugurated in 2013, Pharm Tiamiyu mentioned that the collaborative efforts put in by all members of the Alumni, including the Board of Trustees, to ensure the success of the donation was just a tip of the ice berg.

Pharm (Prof.) Chinedum P. Babalola, while receiving the cheque applauded the Alumni for their efforts in assisting to provide an enabling environment for teaching and learning in the faculty. She mentioned that the faculty was able to raise some funds for bus procurement during the 30th Anniversary of the faculty, but needed more funds to actualize the dream of having a bus to convey the students on outside postings and visits to community pharmacies.

Miss Bolutife Adedeji, the General Secretary of PANS, thanked the Alumni for the gesture and was hopeful that when the bus is eventually purchased, it will go a long way in alleviating the sufferings that the students go through in boarding public buses to go for external postings, ward-rounds and internships.

Unbreakable Laws of Sales

1

1st law: Conmen and salesmen are the same, except for integrity

People may hear your words, but they feel your attitude. – John C. Maxwell

 

In the sales world, integrity is everything. When we talk about successful relationships, whether in business or in our private lives, we talk about integrity. Integrity is not a common commodity. It is a product that lives inside the mind of a great man. It is a character trait that emanates from inside that overcomes the outside.

Integrity is rare, thus upheld by few; don’t expect it from everyone. Integrity is not riches, yet it is greater than wealth! It is an attribute that doesn’t come easily. Integrity is not a skill; it is a consistent character trait that distinguishes an individual. It is for individuals who want to prove a point even if they are standing alone.

Integrity is one thing everyone wants to see in any deal. Businesspeople want integrity. Spouses go for integrity. Students want integrity in their teachers. Followers want to follow a leader they can trust. Everyone is talking about the importance of integrity. Once integrity is missing, everything is gone!

Integrity covers every gap.  It fixes every other weakness. In the scale of leadership, integrity is rated higher than skill. A lot of people have skills but only few can boast of integrity. A man of integrity could be pardoned in other areas of weakness.

Integrity is the starting point in any appraisal. Deficiency in integrity affects other areas negatively. Integrity is one of the foremost qualities of a successful salesman. A salesman who shows a character of integrity will stand out always; he will command a lot of followership. Integrity has its place in the journey of success. No matter what you do or where you see yourself, once integrity is absent, everything is lost!

In sales, buyers buy from the salesman or company they can trust. This is a given. Sales activities happen everywhere and all the time. We close deals daily and on many occasions. Some deals could turn out as expected while some will furnish us with experiences.

The first unbreakable law of sales talks about two words: Conman and salesman. These two words could be grouped together because of the word ‘‘man’;’ but each one has its peculiarities. The salesman is in the business of selling and providing value to his customers, while the conman is in the business of deceit.

Integrity is the outstanding word that makes the difference in the first law of sales. It is the word that separates the salesman from the conman. The conman and salesman have some things in common. They sell products. They send proposals to their targets. They attend business meetings. But there still exists a difference. While the salesman sells truthfulness, the conman sells dishonesty! This is the distinguishing factor that separates the two.

It is important to note that when a salesman loses the essence of true salesmanship which hinges on integrity, then there will be need to redefine who he really is!  Real selling is Integrity. Anything else is deceit!

Conmen have their selling strategies! They are also innovative. They apply ‘‘reasonable level of ingenuity’’ to ensure they convince their victims. The advancement in technology has also expanded conmen’s trade. They now have the ability to send out thousands of ‘‘fake’’ business proposals. Their proposals come with punchy benefits! All these do not change anything. A conman is a conman; his attributes are consistently negative! He loses because he lacks integrity which is the soul of business. Conmen never keep to their words. Their main stock in trade is falsehood. The answer to sales success still dwells on integrity.

A professional salesman is a man of his words. He goes all-out to keep his words. The salesman who demonstrates an attitude of integrity to buyers wins their hearts. Buyers will buy and continue the buying experience from the salesman when integrity is intact.

In the business of selling, the importance of Integrity cannot be overemphasised. The more buyers believe you, the more you succeed. Be believable!

 

George-Emetuche-150x150

George O. Emetuche is chief executive salesman, The Selling Champion Consulting Limited. He is a Brian Tracy-endorsed bestselling author, sales trainer, motivational speaker, and sales and marketing consultant. www.thesellingchampionconsulting.com

 

PCN should discontinue patent medicine licence in Ekiti towns – ACPN Chairman

1

Olanrewaju Jonathan Ofi

In this exclusive interview with Pharmanews, Pharm. Olanrewaju Jonathan Ofi, chairman, Association of Community Pharmacists of Nigeria (ACPN), Ekiti State Chapter discusses a number of issues relating to community pharmacy practice in Ekiti State. The managing director of Lanre & Lanre Pharmacy and Stores, Ado-Ekiti, also enumerated the multifaceted benefits of the chain pharmacy concept, as well as why he thinks the Pharmacists Council of Nigeria (PCN) should halt issuing of licences to patent medicine dealers in urban areas of the state. Excerpts:

 Tell us about your pharmacy – how was it at the beginning?

After my internship stints at the State Specialist Hospital, Ondo, Central Medical Stores, Ado Ekiti and Ondo State Ministry of Health, Pharmacy Division, Akure, where I spent four months respectively, I was offered employment at the State Specialist Hospital, Ondo. But I was only able to work there briefly because I got a better offer from a particular community pharmacy called Glory Pharmacy and Stores, Ondo State then. So, I was at Glory Pharmacy and Stores as a superintendent pharmacist for four years before I started my own Pharmacy, Lanre & Lanre Pharmacy & Stores in 1993.

At the beginning, it was interesting because, despite the fact that Petroleum Trust Fund (PTF) drugs were available in the hospitals, prescriptions were still coming and people were patronising us because of our location. Patients had confidence  in us. They believed they could always buy genuine and quality drugs from us; so the patronage then was high.

However, in 2008, due to the road dualisation exercise embarked upon by the then state government, part of my pharmacy was demolished; and for good eight months, the pharmaceutical business was paralysed and some of the drugs expired. I was devastated.

Not long after, through the grace of God, I was able to raise some money and I spent so much on renovation with the approval of the state government. Unfortunately, however, another government came in 2011 and demolished the whole complex with the excuse of wanting to plant flowers to beautify Ado Ekiti, the state capital. Sadly, till today the flowers have not been planted.

Really, it is the grace of God that has made us to remain in existence and is still sustaining the pharmacy up till today.

 It’s been a year since you became the chairman of ACPN in Ekiti State, how would you describe the journey so far?

The journey has not been easy, but in the area of achievements, we have been able to bring ACPN into the limelight through our various activities in the state, especially our monthly meetings. We are now visible and we have good working relationship with our parent body, the PSN.

Admittedly, there were some major challenges that I faced when I assumed office, including lack of finance and low turn-out of members at monthly meetings. But I am thankful to God who has been sustaining us and I also appreciate my members for the trust they have in me and their cooperation so far.

It has always been my policy since I assumed this position to ensure that names and contacts of all members are included in the minutes of our monthly meetings, so as to regularly keep in touch with them and constantly furnish them with information about the association from time to time.

In terms of finance, ACPN-Ekiti is presently not owing a dime, as we have cleared all our debts that were outstanding before we came in. Another major issue is that of pharmacists from neighbouring states who wanted to come to Ekiti State to practise dual registration, that is, “register and go”. To prevent this, we now make every pharmacist registering an outlet to sign a printed undertaking that they will attend the monthly meetings and possibly reside in the state. This is to allow them work for the money they earn and to discharge their professional duties as the superintendent pharmacists at their duty posts. To God be the glory we are moving the profession and the association forward in the state.

 What is your assessment of community pharmacy practice in Ekiti?

Community practice in Ekiti is making tremendous progress. We now have pharmacies that are owned and managed by pharmacists in the state and they are doing well – unlike what obtained in the past, when we used to have numerous pharmacies owned by non-pharmacists flourishing at the expense of the professionals. There is a better future for community pharmacy in the state, especially in the rural areas where there are no pharmacy outlets.

 What would you say are the peculiar challenges facing community pharmacy practice in the state?

Access to high quality, efficacious and safe medicines remains a major concern worldwide. In Ekiti State, pharmaceutical premises are concentrated (about 70 per cent) mainly in the capital town, Ado-Ekiti. We are therefore urging and appealing to pharmacists to open pharmacies in the rural areas of the state also, so as to fulfill the global requirements of pharmaceutical care.

More importantly, professional indiscipline and lack of adherence to ethical issues (such as abetting charlatans) remain a big challenge. Also, there is the issue of the Rx sign, which is a symbol for quality products and excellent professional pharmaceutical care and service, but which some outlets are yet to embrace. This is quite worrisome because the symbol is part pf what distinguishes us from charlatans.

I also think community pharmacy outlets should be restricted to pharmacists, so as to prevent the issue of price competition. We have found out that some non-pharmacist-owned retail outlets sell at wholesale prices, thereby attracting more customers to their premises. I would equally advise existing community pharmacies to work on improving the facilities in their premises, so as to make their premises befit a standard pharmacy outlet and not a patent medicine shop.

 How lucrative is community pharmacy business in the state?

Community pharmacy business is very lucrative in Ekiti. As community pharmacists, we have many areas to cover in the sub-urban centres, as the capital city is saturated with patent and proprietary medicine vendors who outnumber community pharmacists.

Let me also quickly say that the PCN must stop issuing patent medicine licences in urban areas and the capital town. Also, the distance between two patent medicine shops should be increased to 800 metres in radius and 1000 metres to a pharmacy.

The chain pharmacy idea is becoming increasingly popular, how do you see the development?

It is a good development in the country because this is a system where a corporate organisation owns more than two stores with pharmacists in charge. It is a good development since pharmacists will always be on duty to attend to patients and to be in personal control of the premises. More pharmacists will be employed and this will reduce unemployment in Nigeria. Also, patients and the general public will be willing to patronise pharmacies where experts are available to provide safe medicine and pharmaceutical care.

In addition, there will be no room for any pharmacist to condone or assist in the manufacture, importation, distribution, sales or dispensing of drugs which are not of good quality. The ‘register and go’ syndrome will also be discouraged.

Furthermore, the concept will stimulate healthy competition among pharmacists. It will motivate existing community pharmacies to improve their facilities and the quality of their services, thereby enhancing community pharmacy practice in Nigeria. Very importantly, though, government should allow only indigenous pharmacists to establish chain pharmacies for now.

 You must have set some objectives for yourself at the beginning of your tenure, how far have you achieved them?

I took over as chairman a year ago and, while some of our objectives are still in the pipeline, others are presently being implemented. Our objectives include a programme called ‘Access to Pharmacists is Access to Health’. It is a programme in which access to medicine in the sub-urban and rural areas will be encouraged. This is to uphold pharmacy best practices by spreading the tenets to the rural areas to influence access to good medicine and pharmaceutical care.

Also, to avoid this profession being hijacked by charlatans, the regulatory authorities will be supported to carry out their functions effectively and efficiently. We are ready to partner effectively with regulatory bodies like NAFDAC, NDLEA, PCN, PIC and others in their anti-counterfeiting efforts.

Community pharmacists will also try all possible areas to invest through partnership. This is to help saturate distribution channels with professionals in the rural areas through personal cash savings, cooperative loans, supplier credits, loans from financial institutions with little interest.

Community pharmacists will equally be encouraged to participate in public health programmes such as the National Programme on immunisation and the Roll Back Malaria initiatives, as well as in policy formulation and implementation in the state.

 What is your assessment of the health care sector in Ekiti?

Health care delivery should be a teamwork because every professional has his or her role to play, and this role should be patient-focused. Unfortunately, the pattern in the state is the same as at the federal level.

A major challenge facing pharmacy profession in Nigeria is the problem of drug counterfeiting, how can this challenge be surmounted?

The National Drug Distribution Guidelines (NDDG) is one programme that if well implemented, will solve the problem of fake and counterfeit drugs in the country. All pharmacists should support it and ensure it is well implemented so that it will benefit the professionals, as well as the general populace.

Also the state government should fund the State Task Force on fake and unwholesome products, while the regulatory authorities should carry out their functions effectively and efficiently.

 

Pharmacy interns should not make money their priority – Pharm. Kareem

3

kareem

In this exclusive interview with Pharmanews, Pharm. Sesan Kareem, prolific author and personal assistant to the PSN President, Pharm. Ahmed Yakasai, speaks on several pertinent issues in pharmacy education and practice – especially as it relates to young pharmacists in Nigeria. He also expresses his delight as PA to the PSN president. Excerpts:

What prompted your decision to study Pharmacy?  

I have a rich background in natural medicine. My great grandma and my mum were vast in using herbs, leaves, vegetables and other natural medicines to help people live healthy. I saw an opportunity in pharmacy profession to leverage my lineage’s rich experience to provide efficacious and safe natural remedies for various ailments. That was why I decided to study Pharmacy.

Pharmacy has always been my dream course and I’m very proud to be a pharmacist, although, my parents – especially my mum – wanted me to study Medicine, because one of my distant uncles, Dr Sunny Kuku is a very successful doctor. He is one of the owners of the EKO Hospital. The truth of the matter is if I were to go back to university again as an undergraduate I would still have studied Pharmacy.

 What has been your experience since you graduated from pharmacy school?

My experience since I graduated from pharmacy school has been diverse and rich. I worked for three years in community practice – JMK pharmaceutical limited, Magodo, as a locum pharmacist. I had my internship at the Lagos State University Teaching Hospital (LASUTH). I served as a youth corps member in Imo State. Presently, I’m in administrative practice, working for the Pharmaceutical Society of Nigeria (PSN) as personal assistant to the President of PSN, Pharm.  Ahmed Yakasai.

I’m also an entrepreneur, author, trainer and youth advocate. I registered my company, Mareek Image Concepts (MIC) with the Corporate Affairs Commission in July, 2013. Our focus includes publishing, training and coaching. I’ve authored some books. I’m a wellness and healthy living facilitator for the Industrial Training Fund (ITF), an expert freelance trainer of the London Professional Training Centre (LPTC), as well being the convener, Motivating the Nigerian Youth, a movement that has trained over 3,000 young Nigerians on leadership and self-development for free.

 What is your motivation for book writing as a pharmacist?

What really motivates me as a person is to help people grow, learn, develop and become better. I’ve authored and published five books – “Maximise Your life”, “Grab Your Destiny”, “Life Is Short, But It’s Really Worth It”, “With Patience You Are A Winner”, and “The Secrets Of A Fulfilled Life.”

I’ve just finished the writing processes of my sixth book – and my first health book – “The Secrets of a Great Health”. My third book, “Life Is Short, But It’s Really Worth It” was published by United PC., United Kingdom, and the book is available across the world. Others were published here in Nigeria. My purpose is to equip and educate people to discover, develop and deploy their inherent greatness in order to achieve their full potentials and make a difference. My values are service, sincerity, simplicity, ingenuity, constant growth, continuing development and team work. I hold on to the philosophy that man should beware of what lies before him, and what lies behind him, but, above all, he should beware of what lies with him.

 You were appointed personal assistant to the PSN President, Pharm. Ahmed Yakasai, last year; how would you describe your experience so far working with him?

Honestly, it is a great honour to be appointed by my mentor, Pharm. Ahmed Yakasai, as his personal assistant. Pharm. Yakasai is an astute leader, a business tycoon, a man of the people with vast experience and incredible achievements; but above all, he is a perfect gentleman.

You know it takes only great leaders to attract emerging leaders (smile). I was informed by another mentor of mine, Pharm. Ifeanyi Atueyi, that I would be the first pharmacist to be appointed as personal assistant to the PSN president in the 89 long years history of the Society. That shows you that Pharm. Yakasai is a trailblazer.

My experience so far working with him has been exciting and challenging. I have learnt a lot and I am learning immensely from him. His managerial and leadership skills, boardroom presence and administrative prowess have helped me to become a better leader, manager, administrator and thinker. I also believe I will continue to contribute my own quota to make sure the vision of Pharm. Yakasai of taking PSN to the next level is sustained.

Furthermore, I believe with every fibre of my being that by the time Pharm. Yakasai will end his administration as President of the PSN, I would have become better in all ramifications..

 What would you say are the challenges facing young pharmacists in Nigeria and how can these challenges be surmounted?

The number one challenge facing many young pharmacists in Nigeria is internship placement. Last year, I wrote a series of articles in Pharmanews on this and I proffered solutions. Let me paraphrase briefly some of my recommendations. One, exponential increase in the number of centres of internship placements; two, geometrical increase in the number of interns employed by tertiary and secondary health institutions; three, careful planning by the Pharmacists Council of Nigeria (PCN) on the population of young pharmacists expected to graduate each year with corresponding internship placements/opportunities, using the Law School as a model; and four, willingness of newly inducted pharmacy graduates to go outside their comfort zone for internship experience, stop putting money first when looking for placement and start as soon as they see any opportunity.  My other recommendations can be read online.

The second challenge is the issue of “register and go” syndrome and the only solution to that is to encourage “register and stay” among pharmacists.

Thirdly, I believe as young pharmacists, we should put our resources, talents and expertise together. It is high time we started thinking of collaboration and partnership in order to achieve something substantial and tangible in the pharmaceutical sector – just as Fola Adeola, Femi Pedro and others did in the banking sector in the late ‘80s with Guaranty Trust Bank (GTB).

As a trained pharmacist, what is your preferred area of practice and why?

I’m currently practising as a pharmacist (smiles). However, going forward, my long-term goal is manufacturing of natural remedies of world class standard for local consumption and export across the globe. The reason is that the world is going green and the best cure to major ailments is in nature.

Natural remedies are safe and efficacious with fewer side-effects. Large scale manufacturing is also a very rewarding business, though it requires a lot of investment. In the medium term, I will look at importation of natural supplements and exportation of natural pharmaceutical active ingredients and excipients. In the short term, a world class community pharmacy.

However, I will still continue to write books, teach, train and inspire people because that connects me to the core of my existence.

 

New vista on hypertension management

0

Hypertension, in Medilexicon’s medical dictionary, means “High blood pressure; transitory or sustained elevation of systemic arterial blood pressure to a level likely to induce cardiovascular damage or other adverse consequences.” According to the Pan African Medical Journal (2012), in addition to the direct costs in form of treatment related costs, there are also indirect costs related to lost man hours and savings among workers due to catastrophic health care expenditures.

In limited resource settings where chronic disease control is yet to be prioritised and access to health care is limited, cost effective and affordable approaches are needed to meet this challenge. Unfortunately, the number of studies that report these costs is quite small, as few economic analyses relating to management of chronic diseases have been conducted in Nigeria.

As noted earlier hypertension or high blood pressure is a condition in which the blood pressure in the arteries is chronically elevated. With every heart beat, the heart pumps blood through the arteries to the rest of the body. Blood pressure is the force of blood that is pushing up against the walls of the blood vessels. If the pressure is too high, the heart has to work harder to pump, and this could lead to organ damage and several illnesses such as heart attack, stroke, heart failure, aneurysm, or renal failure.

Hypertension is said to be the commonest non-communicable in Nigeria. Medical expert, Dr Pamela Ajayi, managing director of Pathcare Nigeria described hypertension as a disease of the African race, as statistics has shown that Africans are more genetically predisposed to developing high blood pressure.

She, however, stated that in spite of its prevalence among Africans, more Nigerians are dying of the disease because of ignorance, poor socio-cultural beliefs and poor health-seeking behaviours. According to her, though there is no cure, high blood pressure can be effectively managed for life when the patient is diagnosed earlier.

Ajayi stated that to quickly address this challenge of undetected cases of hypertension to save lives, every Nigerian must know their high blood pressure status.

Research has shown that the normal level for blood pressure is below 120/80, where 120 represent the systolic measurement (peak pressure in the arteries) and 80 represents the diastolic measurement (minimum pressure in the arteries). Blood pressure between 120/80 and 139/89 is called prehypertension (to denote increased risk of hypertension), and a blood pressure of 140/90 or above is considered hypertension.

Hypertension may be classified as essential or secondary. Essential hypertension is the term for high blood pressure with unknown cause. It accounts for about 95 per cent of cases. Secondary hypertension is the term for high blood pressure with a known direct cause, such as kidney disease, tumours, or birth control pills.

 What causes hypertension?

Though the exact causes of hypertension are usually unknown, there are several factors that have been highly associated with the condition. These include:

  • Smoking
  • Obesity or being overweight
  • Diabetes
  • Sedentary lifestyle
  • Lack of physical activity
  • High levels of salt intake (sodium sensitivity)
  • Insufficient calcium, potassium, and magnesium consumption
  • Vitamin D deficiency
  • High levels of alcohol consumption
  • Stress
  • Ageing
  • Medicines such as birth control pills
  • Genetics and a family history of hypertension
  • Chronic kidney disease
  • Adrenal and thyroid problems or tumours

What are symptoms of hypertension?

There is no guarantee that a person with hypertension will present any symptoms of the condition. About 33 per cent of people actually do not know that they have high blood pressure, and this ignorance can last for years. For this reason, it is advisable to undergo periodic blood pressure screenings even when no symptoms are present.

Extremely high blood pressure may lead to some symptoms, however, and these include:

  • Severe headaches
  • Fatigue or confusion
  • Dizziness
  • Nausea
  • Problems with vision
  • Chest pains
  • Breathing problems
  • Irregular heartbeat
  • Blood in the urine

How is hypertension diagnosed?

Hypertension may be diagnosed by a health professional who measures blood pressure with a device called a sphygmomanometer – the device with the arm cuff, dial, pump, and valve. The systolic and diastolic numbers will be recorded and compared to a chart of values. If the pressure is greater than 140/90, you will be considered to have hypertension.

A high blood pressure measurement, however, may be spurious or the result of stress at the time of the exam. In order to perform a more thorough diagnosis, physicians usually conduct a physical exam and ask for the medical history of you and your family. Doctors will need to know if you have any of the risk factors for hypertension, such as smoking, high cholesterol, or diabetes.

If hypertension seems reasonable, tests such as electrocardiograms (ECG) and echocardiograms will be used in order to measure electrical activity of the heart and to assess the physical structure of the heart. Additional blood tests will also be required to identify possible causes of secondary hypertension and to measure renal function, electrolyte levels, sugar levels, and cholesterol levels.

 How is hypertension treated?

The main goal of treatment for hypertension is to lower blood pressure to less than 140/90 – or even lower in some groups such as people with diabetes, and people with chronic kidney diseases. Treating hypertension is important for reducing the risk of stroke, heart attack, and heart failure.

High blood pressure may be treated medically, by changing lifestyle factors, or a combination of the two. Important lifestyle changes include losing weight, quitting smoking, eating a healthful diet, reducing sodium intake, exercising regularly, and limiting alcohol consumption.

Medical options to treat hypertension include several classes of drugs. ACE inhibitors, ARB drugs, beta-blockers, diuretics, calcium channel blockers, alpha-blockers, and peripheral vasodilators are the primary drugs used in treatment. These medications may be used alone or in combination, and some are only used in combination. In addition, some of these drugs are preferred to others depending on the characteristics of the patient (diabetic, pregnant, etc.).

If blood pressure is successfully lowered, it is wise to have frequent checkups and to take preventive measures to avoid a relapse of hypertension.

How can hypertension be prevented?

Hypertension can best be prevented by adjusting your lifestyle so that proper diet and exercise are key components. It is important to maintain a healthy weight, reduce salt intake, reduce alcohol intake, and reduce stress.

In order to prevent damage to critical organs and conditions such as stroke, heart attack, and kidney failure that may be caused by high blood pressure, it is important to screen, diagnose, treat, and control hypertension in its earliest stages. This can also be accomplished by increasing public awareness and increasing the frequency of screenings for the condition.

 Exams and tests

Your health care provider will check your blood pressure several times before diagnosing you with high blood pressure. It is normal for your blood pressure to be different depending on the time of day.

Blood pressure readings taken at home may be a better measure of your current blood pressure than those taken at your doctor’s office. Make sure you get a good quality, well-fitting home device. It should have the proper sized cuff and a digital readout.

Practice with your health care provider or nurse to make sure you are taking your blood pressure correctly.

Your doctor will perform a physical exam to look for signs of heart disease, damage to the eyes, and other changes in your body.

Tests may be done to look for:

  • High cholesterol levels
  • Heart disease, such as an echocardiogram or electrocardiogram
  • Kidney disease, such as a basic metabolic panel and urinalysis or ultrasound of the kidneys

 Treatment

The goal of treatment is to reduce blood pressure so that you have a lower risk of complications. You and your health care provider should set a blood pressure goal for you.

If you have pre-hypertension, your health care provider will recommend lifestyle changes to bring your blood pressure down to a normal range. Medicines are rarely used for pre-hypertension.

You can do many things to help control your blood pressure, including:

  • Eat a heart-healthy diet, including potassium and fiber, and drink plenty of water. See: High blood pressure and diet
  • Exercise regularly – at least 30 minutes of aerobic exercise a day.
  • If you smoke, quit – find a programme that will help you stop.
  • Limit how much alcohol you drink – one drink a day for women, two a day for men.
  • Limit the amount of sodium (salt) you eat – aim for less than 1,500 mg per day.
  • Reduce stress – try to avoid things that cause you stress. You can also try meditation or yoga.
  • Stay at a healthy body weight – find a weight-loss programme to help you, if you need it.

Your health care provider can help you find programmes for losing weight, stopping smoking, and exercising. You can also get a referral from your doctor to a dietician, who can help you plan a diet that is healthy for you.

There are many different medicines that can be used to treat high blood pressure. See: High blood pressure medicines

Often, a single blood pressure drug may not be enough to control your blood pressure, and you may need to take two or more drugs. It is very important that you take the medications prescribed to you. If you have side effects, your health care provider can substitute a different medication.

 Possible complications

When blood pressure is not well controlled, you are at risk for:

  • Bleeding from the aorta, the large blood vessel that supplies blood to the abdomen, pelvis, and legs
  • Chronic kidney disease
  • Heart attack and heart failure
  • Poor blood supply to the legs
  • Stroke
  • Problems with your vision.

 When to contact a medical professional

If you have high blood pressure, you will have regular appointments with your doctor.

Even if you have not been diagnosed with high blood pressure, it is important to have your blood pressure checked during your yearly check-up, especially if someone in your family has or had high blood pressure.

Call your health care provider right away if home monitoring shows that your blood pressure is still high.

 Prevention

Adults over 18 should have their blood pressure checked regularly.

Lifestyle changes may help control your blood pressure.

Follow your health care provider’s recommendations to modify, treat, or control possible causes of high blood pressure.

 

Compiled by Adebayo Folorunsho-Francis with additional reports from Pan African Medical Journal, Guidelines for the Management of Hypertension In Nigeria, American Heart Association/American Stroke Association and Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine

My battles as UNN’s unwilling vice chancellor – Prof. Udeala

0

Prof Udeala

In this insightful interview with Adebayo Folorusho-Francis, former vice chancellor of University of Nigeria, Nsukka (UNN), Prof. Oleka Kelechi Udeala, speaks on the intrigues surrounding his tenure as an “unwilling” vice chancellor, as well as his other memorable experiences as a veteran pharmacist. Excerpts:

Tell us about your early years

I was the youngest child of my mother’s five children and I received a lot of attention. I think I might have been a precocious child. I was fond of telling a cousin of mine about the possibility that while we had our night, some people somewhere would have their day. I was not yet of school age and never heard of geography. My cousin was intrigued and based on this wanted me to pay him a visit so that I could tell him things he did not know. Each time I did, he gave me a penny.

Art runs in my family and I started drawing and painting with pencil and crayons. By the time I was a freshman in USA I had started painting with oil and got into abstract painting, which was becoming the trend in the 1960s. Maybe it was what I saw at the Solomon Guggenheim Museum in New York City that inspired me. I was also good in drama so much so that in Secondary School, Reverend P.J. Collingwood said that if I were an English boy, he would have recommended that I study Theatre.

I like to create or make things. Whether it was in knitting a cloth or handkerchief – as the females were supposed to in their handwork at primary school – I easily copied and surpassed them, so much so that a boyhood friend of mine dubbed me omuru oka, which means one who surpasses his teacher.

 What was your family like?

There were about 17 children in the family. My father showed no interest in Western education. So, it was an uncle I never knew that sent his first child, my mother’s eldest son, to school (Methodist College, Uzuakoli). I had a stepbrother, Joseph, who was also sent to school but died early in primary school under tragic circumstances.

The other male children were probably sent to Aba as apprentice in a trade or specifically tailoring under a relation or family friend. My eldest brother was the exception. When his guardian died, he could not continue with his secondary school education. He left school and got a job as an account or sales clerk with Paterson & Zochonis in Aba. The female children were married off or sent to serve in a home to learn how to keep a home. With two brothers and two elder sisters, I was soon left alone with my mother.

The fact that there existed names like Joseph and Abraham suggests that although my father was not a Christian, there was missionary influence in my family.

 How did you manage to go to school?

I was made to live with my eldest brother in Aba to reduce the burden on my mother. This must have been around 1945 or 1946 because there were soldiers who had just returned from some war (World War II) regions. With his experience in secondary education and the effect that working for white people had had on him, my brother decided that I should go back to the village to start school in 1947.

Incidentally, at that time, my community was giving scholarship to all children who were qualified to begin school. The initial qualification was the ability to reach over one’s head with one’s right hand and touch the left ear with the middle finger. The final qualification was determined by lot. Wraps of a special leaf that contained gravel and others containing nothing were placed in a basket and passed around. Each child was made to pick a wrap out of the basket. Those whose wraps contained something won the community scholarship. Mine was empty, so my brother had to see me through my primary (1947–1953) and secondary education (1954–1958).

I obtained Grade One from Cambridge University in association with the West African Examination Council. From 1959 to 1960, I worked and studied for Higher School Certificate (Advanced Level). This qualified me for my first job as a science teacher in the Secondary School I attended. The Principal, Rev. E. B. Hall, encouraged me to sit for a competitive public overseas scholarship examination under the auspices of African Scholarship Programme by American Universities (ASPAU). I was successful and by August 1961, I was in USA to begin a baccalaureate degree programme at Brooklyn College of Pharmacy, Long Island University, Brooklyn N.Y. (1961–1965).

The fact that I had a Student J Visa did not permit any further academic activities after my graduation. The philosophy was that one should go back and serve one’s community. I came home some months later in 1966 in the midst of political crisis.

What circumstances led you to study Pharmacy?

What led me to study Pharmacy was an aggregation of circumstances. My Biology teacher, Mrs B. Hay, made us to take interest in professions like Medicine and Pharmacy in her teaching, which also was a sort of career guidance especially in our Advanced Level classes. Also, while my father was neither a traditional healer nor a herbalist, he knew about herbs and used them in treating people. This was apparently imprinted in my memory.

In addition, there was a time I was obliged to leave the village and stay with my eldest brother’s bosom friend, a newly qualified headmaster of a primary school. There was this ex-service man who probably was trained as a dispenser during World War II. He happened to have come from a village next to mine and bore the same surname as mine. Since the dispensary he headed was in the same locality, I was invariably sent to him for every childhood affliction such as intestinal worm infestations, constipation, chicken pox and wounds incurred during play. The large bottles containing “evil smell” and tasting mixtures or solutions such as Epsom Salt, Acriflavine, Iodoform or Tincture of iodine written in strange language intrigued me. The dexterity with which Dispenser Udeala with a shiny steel ‘knife’ burst abscesses, soaked a piece of gauze in a yellow liquid and inserted it in the abscess to get the pus out intrigued me no less.

What choice of study one made for ASPAU scholarship depended on what slot the participating American University had for Africans. I suppose I made the choice of Pharmacy over Medicine in the form I filled. The message came to the principal that a college of pharmacy would like to have me.

In retrospect, would you say studying Pharmacy was a good decision?

Yes! Looking back now, I think my choice of Pharmacy has been a very good one. Many people don’t realise that pharmacy degree curriculum exposes one to several disciplines of the applied sciences. This makes it a composite degree. Depending on which area of Pharmacy one is in, one may be confronted with problem or research akin to engineering (mechanical, design or structure), polymer, particle (nano particle), synthesis, formulation, bio-technology, powder technology and paper science technology.

If you had not studied Pharmacy, what other profession would you have chosen?

I might have chosen Medicine. By the time I graduated in Pharmacy, my American (adoptive) parents encouraged me to go into medicine at Columbia University. They indeed offered to speak on my behalf to someone they knew. I did not accept – ASPAU would not have allowed me because of my visa status. Besides I was already homesick.

However, I doubt if Medicine, in our part of the world, would have been as challenging as Pharmacy has been to me. Maybe Biomedical Engineering might have satisfied me

Tell us some of your memorable experiences in the course of obtaining your degrees.

I was a member of The Rho Chi Society and got Gold Pin for my academic performance. Outside Pharmacy, my memorable experiences encompass people I met, places I visited, how I got to the places, how I waded through racially divided America of the early 60s and how I lived in a society made up of people with strong views on their own side of the divide.

On arriving at the LaGuardia Airport, my first experience was to travel to New York City in a train under the Hudson River. During my summer vacation I had the fun of being at the top floor of Empire State Building, the highest skyscraper in the world then. Due to the fact that a project called Experiment in International Living was fitted into our arrival, I was just like other Nigerians sent to stay with an American family before our different universities re-opened. For me, the chemistry between this family and me was just right. The McKennas became my parents throughout my stay in USA.

Through these Irish-American parents, I met two persons whose names are in the history books. One was Dr Heinrich Bruning, Chancellor of Germany just before Hitler took over.  He fled to America in 1934 having been a strong critic of Hitler who was in ascendency then. He loved seeing me as an opportunity to reminisce about World politics and German colonies in Africa. The other man was Professor Arthur Burns. Little did I know he was a professor of Economics at Colombia University and at the time I knew the family, he was the Chairman of the Federal Reserve Bank.

My American family came all the way from Norwich Vermont where I spent my vacations to take me to theatres in Broadway. Hence, I had the privilege of seeing live, The Sound of Music; West Side Story; My Fair Lady and other great musicals. ASPAU made life worth living by making sure I got free tickets to events in Broadway.

On the dark side was my experience in 1961 when I travelled with my adoptive family from Norwich Vermont to Washington DC and then to West Virginia. We stopped at Silverline Restaurant Route 40 Baltimore Maryland to have some snacks.  As we walked through the door, we heard a roar: “We don’t serve them folks here!” You can trust Americans in making their feelings known. The majority of those seated got up and replied in unison: “If you don’t serve them folks here, we ain’t gonna eat here!” We all walked out. I got instant malaria fever for this was entirely new for a Nigerian.

In my college, made up of almost 95 per cent Jewish immigrants from Europe, I had a great time. Some invited me to their homes. During our class trip to Washington DC, my mates who knew what they wanted took me to a burlesque (performances in a variety show format, which featured bawdy comedy and female striptease). This was too much for my puritan upbringing.

Generally, the north of USA was fine. I made friends with students, African and White Americans. When I still had time, I even painted a picture in oil, Sunset over Brooklyn Bridge for Linda Rush and celebrated Passover in their home. Mr Newman, the Registrar of the College of Pharmacy took me to Reformed Synagogue for worship where I witnessed the reading of the Torah.

 

(To be continued).

Thou shalt not steal

3

Early in 1961, I looked forward to entering a university by September. My options were University College Ibadan, University of Ife or University of Nigeria Nsukka. Eventually, I got admission into the three universities but destiny took me to the University of Ife to study Pharmacy.

As part of my preparations for university life, I decided to relate with those who had already passed through the ivory tower. Fortunately, I came across a young graduate. At that time, only Ibadan had produced graduates. Ife, Nsukka and ABU Zaria were just taking off.  I admired this handsome graduate of History, teaching in a secondary school, and decided to come close to him in order to obtain information about life in the university.

Luckily, the day I visited him, he was just about to have his dinner. He invited me to the table and insisted that I enjoy the rice and fried plantain with him. Although I was not hungry, I had to join him out of courtesy. He dashed into the kitchen and brought a serving plate, tumbler and a set of cutlery for me and then blessed the meal. As I picked up the fork and knife, I noticed that ‘UCI’ was engraved on them.  They were most likely   stolen from the UCI refectory. Instantly, I lost my appetite for the food and my respect for him. From my family upbringing and the Christian school, Dennis Memorial Grammar School, Onitsha, which I attended, stealing in any form was an anathema. I didn’t visit him again because I did not want to associate with a thief.

Like this teacher, some of us do certain things without realising the spiritual implications. But the Word of God is clear on this issue. “Thou shalt not steal” (Exodus 20:13). Stealing simply means taking something that does not belong to you in a way that is wrong or illegal. It could be a tangible substance like money, pen, drugs; or intangible ones like an idea or an intellectual property.

In the workplace, various types of stealing are commonly practised by employees. Some steal their employers’ money, time, property, customers, goods and so on. Where these practices go on, the business does not prosper. The business owners suffer losses of their investments. As a matter of fact, any business that is free from any form of stealing by the staff will keep on thriving, even in hard times. And even in the best of times, businesses can collapse as a result of stealing by the employees.

On the other hand, employers also steal from their employees. An employer that keeps staff working beyond the official closing time without overtime allowance is stealing from the employee. You are stealing his time, his money, his peace of mind, his joy and his life. And do you consider the opportunity costs of doing so? For example, the time this staff should be using to take care of his family, undertake some private development courses, enjoy hobbies or rest, is usurped by the employer without proper compensation.

Some employers are guilty of defrauding their employees by paying starvation wages. Deuteronomy 24:14 says, “Thou shalt not oppress an hired servant that is poor and needy, whether he be of thy brethren, or of thy strangers that are in thy land within thy gates:” As an employer, you must be honest with your employees and pay them when due. Do not say there is no money and deliberately withhold or divert what is due to them. Their cries may reach the ears of God. “Behold, the hire of the labourers who have reaped down your fields, which is of you kept back by fraud, crieth: and the cries of them which have reaped are entered into the ears of the Lord of sabbath” (James 5:4).

Many businesses also steal from their customers in their ambition to make money. This is why there are fake and counterfeit products everywhere. From 1993, when the National Agency for Food and Drug Administration and Control (NAFDAC), was established with Prof. Gabriel Osuide, as the Director General, it has been engaging in war with drug fakers and counterfeiters. This war came to a climax during the tenure of the Late Prof. Dora Akunyili (2001- 2009).

When Dr Joseph Ikem Odumodu  was appointed the Director General of the Standards Organisation of Nigeria in 2011, we became more aware  that a lot imported goods – electrical and electronic items, tyres etc. – were fake. The main motive for the faking and adulteration of these products is to cheat the consumers and take their money. For drugs, in particular, it is not only their money that is stolen. The producers and sellers of fake and counterfeit medicines also steal people’s health and sometimes their lives, resulting in death.

Are you guilty of adulterating what you sell? Are you using a false balance?  Do you substitute high quality goods with inferior ones? Are your advertisements deceptive in order to catch gullible buyers? Are your cheap prices made possible by defrauding your customers, either in quantity or quality? Does your paracetamol tablet contain 100  instead of 250 grammes of paracetamol powder?

If your business is dishonest, your religion is a sham.

 

 

Onyechi, Lawal task community pharmacists on business sustainability

1

As part of its commitment to improving the ethical and entrepreneurial acumen of its members, the Association of Community Pharmacists of Nigeria (ACPN), Ipaja-Dopemu-Egbeda-Akowonjo (IDEA) Zone, recently held its 8th Annual Pharmaceutical Business Growth Seminar.

ACPN 8th National Conference
L-R, Pharm. (Mrs) Folashade Lawal; Pharm. (Mrs) Abiola Paul-Ozieh; Pharm. Olateju Olakiigbe; Pharm. Deji Osinoiki; Pharm. Oyekunle Babayemi and Pharm. (Sir) Ike Onyechi at the 8th annual business seminar of ACPN, IDEA Zone

The seminar, themed “Growing Trans-Generational Pharmacy”, was held at Jjag Hall, Shasha, Lagos  and had in attendance eminent personalities and stakeholders in the pharmacy profession.

Dignitaries at the event included Pharm. Deji Oshinoiki, father of the day; Pharm. Olateju Olakiigbe, managing director, Egbeda Pharmacy and chairman of the occasion; Pharm. (Mrs) Folashade Lawal, MD/CEO, Victory Drugs Limited; Pharm. Ike Onyechi, (FPSN), chairman, Alpha Pharmacy and Stores Limited; Pharm. Gbenga Olubowale, Lagos PSN chairman, represented by Pharm. Oyekunle Babayemi; Pharm. Abiola Paul-Ozieh, chairman, ACPN, Lagos State; and Pharm. Madehin Olanrewaju Gafar, among others.

In his lecture which had the same title as the theme of the event, Pharm. Ike Onyechi, who described trans-generational pharmacy as a process of running a pharmacy business that outlives the owner noted that certain factors are essential to making a pharmacy business trans-generational.

“The pharmacy business should be structured in a way that when the owner dies, the business continues thriving, while the family keeps the business going in such a way that the vision and aspirations of the owner is well sustained,” he said, adding that it’s quite unfortunate that only 30 per cent of businesses in Nigeria survive the second generation, with 10 per cent surviving the third generation, and only three per cent surviving the fourth generation.

Using the example of Alpha Pharmacy Limited, the former chairman, West African Postgraduate College of Pharmacists (WAPCP), Nigeria Chapter, said a business must be built on the right foundation and according to God’s dictate.

He added that pharmacists must have sound knowledge of management, planning and marketing in order to run a successful trans-generational business.

“Community pharmacists must be readily available to give sound, professional advice and to help their clients deal with everyday health concerns and problems facing them,” he advised.

The doyen of retail pharmacy further told participants how Alpha Pharmacy Limited was doing all within its power not to become old-fashioned, saying that he had to rebuild the company’s Enugu Branch, furnished it to taste and moved it to a permanent site.

“Alpha Pharmacy and Stores Limited was founded in 1985 as a small outlet on Allen Avenue, Ikeja, Lagos, but today, the retail outfit has grown into a large community pharmacy store and a respected wholesaler and distributor of rare ethical products, and presently, it has eight branches strategically located in the north (Abuja), east (Enugu), west (three branches in Lagos) and south (two branches in Port Harcourt) of Nigeria for ease of distribution to numerous customers,” he stated.

Citing companies like Novartis, Samsung, Dangote Group, Deyo Pharmacy and Pharmanews Limited as some of the companies that have positioned themselves to become trans-generational, Onyechi advised community pharmacists to sharpen their skills and knowledge by attending short-time certificate courses as approved by international bodies and government, adding that the role of the pharmacist has evolved from provision of drugs and information to patient care and that pharmacy as a profession has come a long way and must continue to advance.

In his remarks, Pharm. Deji Oshinoiki urged all community pharmacists in the zone to collectively tackle the challenges facing quality health care delivery in the country and ensure they gain back the trust which the public once reposed in them.

Speaking in the same vein, chairman of the occasion, Pharm. Olateju Olakiigbe, said he was delighted that pharmacists in the zone are benefiting what others were not benefiting, adding that the annual business is apt as it affords pharmacists in the zone opportunity to learn from the experiences shared by the personalities who come to the seminar every year.

“The theme of this year business seminar focuses on growth and succession and for me, it is germane because it answers two questions on how we grow our businesses and what happen to our businesses after our death. Many of us are already planning towards this, but we need to be tutored by the experts on how best to go about it, so I am happy that we are now wiser and better informed,” he said.

In her own address at the seminar, Pharm. (Mrs) Mfon Nsese Ufot, zonal coordinator, ACPN, IDEA Zone, explained that the theme for the seminar was very important to pharmacists who always wish that their businesses continue to thrive after their death, considering the rate at which so many businesses crumble after the demise of their owner.

“The annual seminar has become a platform where experienced and seasoned pharmacists are brought to impact members of the zone and the public with knowledge on current startegies and skills required for profitable operations in today’s environment that is becoming rougher by the day. We need not over-emphasize the fact that pharmacists in the zone, as well as the public have always been positively impacted by these semianrs, and this in turn culminates in a better health care delivery system for the general public,” she said.

Also speaking at the event, Pharm. Folashade Lawal who presented the address, “Satellite Pharmacy: Opportunities and Challenges”, disclosed that satellites pharmacy are not common in Nigeria, despite their significance in meeting the needs of certain sets of people.

Speaking further, the Victory Drugs boss reiterated that the roles of pharmacists in the modern world has evolved into full-time patient care, as they now perform roles which medical doctors often neglect.

“We now have a suitable place for discussing confidential information with our customers and patients; we maintain and improve professional performance; we manage patients’ medication therapy; and we comply with national professional obligations, guidelines and legislation, among others,” she said.

She also emphasised that more community pharmacists show interest in establishing outlets in rural areas, noting that provision of drugs and health care in underserved areas is crucial.

“The reason why we should we endeavour to be in the rural areas is that we are needed more there as all Nigerians, irrespective of where they are located have the right to be served by us and these people in the underserved areas are dying unjustly.”

Speaking further, she explained that unlike the urban areas, rural areas are full of opportunities for community pharmacists.

“The opportunities in the underserved areas for we community pharmacists are numerous, as we are going to have access to enough space to locate our pharmacy, easy access to goodwill from people of the community, minimal running cost, less competition, highly profitable and possibly easy access to loan interest,” she noted.

Maydon sales managers undergo specialised training

2

–        As expert enumerates reasons salespersons underachieve

On 11 April 2016, staff of Maydon Pharmaceuticals Limited gathered at the conference centre of D’Palms Hotel, Airport Road, Ikeja for a two-day workshop, tagged ‘Leading and Managing Maydon Pharmaceuticals Sales Team for Result.’

In attendance at the workshop, conducted by Pharmanews-White Tulip Consulting, were sales managers, regional managers and the national sales manager.

Speaking on ‘Sales Management,’ Pharm. Tunde Oyeniran, chief operating officer of Pharmanews-White Tulip Consulting, disclosed that quite a number of sales representatives don’t like admitting that they find the job challenging.

“It is something we all know. Even Google, the almighty search engine,  confirms that sales management is not fun. Otherwise how come we have zero matches any time we search for words like ‘I love being a sales manager ‘, ‘I like being a sales manager’, ‘I love sales management’ or ‘I want to be a sales manager?

“By contrast, search for the following topics and you’ll be surprised at the number of results: ‘I love Paris Hilton (25,400 matches), ‘I want to be rich’ (102,000 matches) and ‘I hate my boss’ (59,200 matches),” he observed.

Maydon Pharma specialised sales training
Group photograph of participants and facilitators at the training programme for Maydon Pharmaceuticals Ltd. themed ‘Leading and Managing Maydon Pharma Sales Team for Result’, held from 11 – 12 April, 2016, at D’Palms Hotels, Ajao Estate, Lagos. (Front row, L-R); Mr Gbenga Adeniyi, HR/admin manager, Maydon Pharma; Mr Adekola Adediran, business development manager, Pharmanews-WhiteTulip training; Pharm. Tunde Oyeniran, chief operating officer and facilitator, Pharmanews-WhiteTulip training; Barr. (Pharm.) Layi Abidoye, a facilitator; Mrs Sochi Vivian Dunu, managing director, Maydon Pharma; Mr Uche Udozorh, director, business, Maydon Pharma, and; Pharm. Adebayo Gbadamosi, chief sales officer, Maydon Pharma.

The training expert praised the sales managers of Maydon Pharmaceuticals for setting a good example through their open-door policy towards their sales representatives.

“Being a sales manager is not about you anymore. The day you become a manager, it becomes about them. Your job is to walk around with a can of water in one hand and some fertilizer in the other. When the reps are not making the numbers, the responsibility for ensuring that every member of the sales team is successful and performing at optimum levels lies entirely with management,” he stressed.

Oyeniran further explained that when a salesperson is underachieving, sales managers certainly have reasons to be worried.

“Cases like this tend to throw up questions like: Are they visiting and talking to enough prospects? Are they talking to the right people within the organisations? Are they able to penetrate the formal DMU (Decision Making Unit) and get to the MAN?” he noted

The pharmacist-cum-trainer enumerated eight reasons why sales people fail. According to him, the first mistake sales managers make is picking the wrong person for the position though a wrong or no selection process.

“Two, it is possible the sales people had little or no training at all. Three, the representatives were probably expected to do all of their own planning. Again, there is this mistake of leaving them without competent supervision.”

Continuing, Oyeniran said, “Let us look away from the usual administrative error. We need to also find out if sales people are properly motivated to meet objectives. It is possible too that they are inadequately supported by a competent manager, not stimulated by appropriate incentives and not regularly appraised against a set of agreed objectives.”

As a lasting solution to ensuring pro-active attention from sales people in various regions, Oyeniran counselled that managers must continue to meet with each person on the sales team to gather some “emotional intelligence (EI).”

The trainer further suggested that sales managers should also go on sales calls with members of their team and with a view to constructively critiquing their sales pitch later.

Oyeniran also stressed the importance of being sensitive to the personal and professional needs of salespersons as this is the most effective way to motivate and get the best out of them.

“Treat the people below you like kings and queens because they are doing the hard work. Be the person they want to come to with questions and problems. Realize that a salesperson’s problem is your problem.

“Train your team constantly and review team goals regularly. Always maintain your personal integrity. As a manager, teach self-sufficiency, resourcefulness and be ready to take bullets for the team,” he urged.

Quoting the popular maxim of Socrates, the pharmacist said, “A group of donkeys led by a lion can certainly defeat a group of lions led by a donkey.”

Maydon is a forefront pharmaceutical company in Nigeria. Incorporated in 1994, its main operations started in June 2006 shortly after registering with the Pharmacists Council of Nigeria (PCN). Since then, the company has continued to meet the health care needs of the people through its several NAFDAC-registered, commerce-and-industry-mediated and WHO-certified pharmaceutical products.

Currently, Maydon Pharma has over 74 registered products as well as over 40 staff across Nigeria.

 

Capacity to contract: Transactions of infants

27

Tamara is a 16-year-old student of Government Secondary School, Port Harcourt.  Quite frequently, he patronises D-Line Pharmacy & Stores on the same street as his family home.  All the members of his family are well known to Pharmacist Donald and the staff of the pharmacy.

To get some relief from a recurring headache, Tamara goes to the pharmacy to buy some painkillers.  Unfortunately, he does not have money on him at the time; so he takes the medication on credit with a promise to pay later.  He also collects a bottle of perfume and adds to his bill.

The following day, on his way back from school, Tamara stops at D-Line Pharmacy & Stores to pick up five more bottles of perfume.  He explains that they are required as Christmas gifts for his friends at school.  He is given the additional bottles of perfume on the condition that his entire bill will be settled by the end of the week.

Two weeks after, Tamara is yet to return to the pharmacy to pay his bill.  Incidentally, his mother comes to purchase anti-malaria drugs and is informed of her son’s outstanding debt.  Pharmacist Donald demands that Mama Tamara settle the bill for the unpaid painkillers and perfumes.  Mama Tamara refuses to pay, claiming that the sale of goods to her son is unenforceable because Tamara is still a minor.  In view of this, what is the legal consequence of the transaction?

As previously stated, a contract is an agreement which is binding at law.  However, even when all the ingredients of a valid contract are present, it may not be enforceable against certain categories of people like infants, lunatics, drunkards and the illiterate.  The general rule at common law was that contracts made by an infant were voidable at his option, i.e. not binding on the infant but binding on the other party.

The issues to be considered in this case are:

  1. The meaning of infant.
  2. The legal position of contracts made by infants.
  3. The meaning of necessaries.

The position of contracts made by infants has been modified at common law by the Infants Relief Act of 1874 as follows:

(a) The Act specifically declares that three particular types of contracts with infants are absolutely void:

(1) contracts of loan, i.e., lending money to an infant;

(2) contracts for goods (other than necessary goods); and

(3) accounts stated.

(b)            Secondly, the Act stipulated that it would no longer be possible for an infant to ratify at majority, those contracts which were formerly not binding on an infant unless ratified by him after the attainment of majority.  In other words, if he now ratifies such contracts, such “ratification” has no legal effect.

The first issue to be determined is who is an infant?  The age of twenty-one has been fixed at common law as that at which absolute and unlimited legal capacity to contract shall commence.  Persons below that age are, therefore, infants for the purpose of contractual transactions.

In the case of Labinjoh v. Abake, a Nigerian adult sued to recover from the defendant, a Nigerian girl, the balance due to the plaintiff for the goods sold and delivered to the defendant.  On appeal to the Full Court, the court confirmed that the Infants Relief Act was a statute of general application in force in Lagos.  It therefore follows that, for matters governed by English law, the correct age of majority is twenty-one.

The second issue to be addressed is the legal consequence of contracts made by infants.  The summary of the Infants Relief Act of 1874 is as follows:

(a) All contracts of loan for non-necessary goods and accounts are absolutely void.

(b)            Contracts for necessary goods and beneficial contracts of service remain absolutely binding on the infant.

(c) Contracts which are binding on the infant, unless repudiated by him either during infancy or within a reasonable period after the attainment of majority, remain unchanged and unaffected by the Act.  These are contracts in which the infant acquires an interest in property, with continuing obligations, such as the purchase of land, leases, renting of an apartment, purchase of shares in a company, partnership agreements, etc.

(d)            Contracts which were not binding on an infant, unless ratified by him after the attainment of majority, were no longer ratifiable by him after majority.  In other words, such contracts become void.

In the matter of Tamara and D-Line Pharmacy, there was a purchase of painkillers and perfumes.  These two sets of items would be treated differently.  As it can be proven that the painkillers were necessary for use by the buyer (who was a minor); the perfumes, on the other hand, would be seen to be luxury goods.

Section 2 of the Sale of Goods Act provides that, “where necessaries are sold and delivered to an infant, or minor or to a person, who by reason of mental incapability or drunkenness is incompetent to contract, he must pay a reasonable price, thereof.” By this provision, Tamara would be liable to pay for the medication he bought, since those items were necessary.

The Sale of Goods Act defines necessary goods as “goods suitable to the condition in life of such an infant or minor or other person, and to his actual requirements at the time of sale and delivery.”  In the case of Chapple v. Cooper, Judge Alderson stated that “things necessary are those without which an individual cannot reasonably exist… thus, articles of mere luxury are always excluded, though luxurious articles of utility are in some cases allowed.”

In conclusion, the sale of painkillers to Tamara was a valid transaction for which he is liable.  However, the perfumes are luxury items, the sale of which would not be binding on Tamara, being that he is a minor (below the contractual age of twenty-one).

 

Principles and cases are from Sagay: Nigerian Law of Contract

We need more people like him

0

You would like Ola a lot. Most people do. He was the kind of guy who listened when you talked, who smiled often, and who said things that made the people around him smile. He was intelligent, but in a way that made others feel comfortable. It’s the way he expressed himself in simple terms that you can understand – almost like he’s articulating the thoughts you already had in your head, but hadn’t yet found the right words to say aloud.

It doesn’t matter who you are either. Ola always had a way of relating to you. Because, in a way, he’d been there with you all along. He could think like you, so he understood you.

So many of us have limitations in our perceptions. We understand the soldiers but not the politics governing the war. We understand the people who go to the movies but not the ones who attend auto-races. But somehow Ola understood all of us. It’s his gift.  If he hadn’t actually been to the auto-race you’re talking about, he’d be honest about it – but he’d make you feel as if he was right there with you. And once you returned home after spending a good time with Ola, you’d catch yourself smiling and thinking that there needed to be more people like him in the world. Because if there were, there would be far less to worry about.

Ola passed away today. I don’t really want to discuss the details, because honestly they aren’t relevant. It could have been a car accident. It could have been old age. We are often far too concerned with how people died, rather than how they lived. And I want you to know how he lived. He told stories – lots of stories that contained subtle insights and wisdom about our lives and the world around us. And today, I want to share with you the last story he told me before he died:

 His last story

One Sunday morning when I was a little boy my father surprised me and took me to the fishing docks. But instead of fishing, as all the other little boys and girls were doing with their fathers, we sat down on the end of one of the docks and watched all the other children fishing. For hours, we sat there and watched until we left without ever casting a single fishing line into the water.

I was simultaneously sad and angry. On the drive home I told my father that I’d never forgive him for being so cruel to me. He looked at me, smiled and said, “I love you, Ola.” When I didn’t respond, he asked, “Did you notice how happy all the other little boys and girls were? Did you see their smiles? Could you feel the happiness in their hearts?” After a moment of silence I quickly snapped, “I don’t really care! I just want to go fishing like everyone else!” My father sighed and kept driving.

We went back to the fishing docks dozens of Sunday mornings throughout my childhood. And each time we saw hundreds of other little boys and girls jumping and laughing and celebrating as they reeled in fishing. But we still never cast a single fishing line into the water. We just sat there on the end of that same dock and watched. And my father never explained why. But he didn’t need to. Because years later, as I entered adulthood, I suddenly realised that it was those mornings we spent sitting on that dock that taught me how to be patient and to love. 3

Character is not the only component of leadership. There are also: approaches to thinking (Shakespeare’s Hamlet tells us that “Nothing is good or bad as thinking makes it so.”), learned skills in concentration, fundamental beliefs, personal values and specific actions that detract from or add to contentment and well-being. But character is still the essential component.

 Why character matters

Who we are makes a difference. The way we treat others matters. The decency or indecency that fills our hearts and minds matters. Our values as expressions of what we believe and how we live our lives really does make a difference to our leadership. The traits we’ve developed over time are of no little consequence to how we feel about who we are. Happiness increases our ability to demonstrate extra ordinary leadership.

When we look in the mirror, it’s often our character (or lack thereof) that speaks the loudest. But not all character traits are created equal, at least, not insofar as leadership is concerned. The following, then, are those traits I’m convinced will have the greatest impact on your leadership and indeed your happiness:

1. Courage

Courage is resistance to fear, mastery of fear, not absence of fear.– Mark Twain

Fear is the great thief of leadership and happiness according to the works of Marc and Angel. It is parent to surrender. It sneaks in closed doors and robs us of resolve and the commitment and ability to endure to the end.

Courage, on the other hand, is fear’s great nemesis. It challenges fear, pushes it back, and keeps it in check by taking steps toward its objection. Courage thereby shatters the shackles of fear, sending it into the insignificant margins of obscurity.

Courage allows us to challenge our comfort zones, approach people and situations, embrace life and accept the pain that’s inevitable in all of life’s changes and challenges. Without courage, leadership is a little more than an illusion, a temporary mirage, a puff of smoke that dissipates into thin air at its first challenge.

2. Patience

Patience is waiting. Not passively waiting. That is laziness. But to keep going when the going is hard and slow – that is patience.

How happy are impatient people? This is a rhetorical question, of course. The answer is obviously “not very.” At least not for very long. Impatience is another major bully to happiness and indeed to extraordinary leadership. It pushes happiness out of the neighbourhood almost as soon as it shows up. Let life happen, at least a little. You’ll find it that much more beautiful and happy when you do.

But learning to accept and allow, to go with the flow and relax a bit is critical to living a happy life and demonstrating extra ordinary leadership. Impatience is often the irritation we feel at the loss of control. But life bubbles and gurgles in ever-changing streams and flows of unpredictable activity. It simply is not 100 per cent controllable. And the more we try to control and manipulate the outcome of life and the events that boil up around us with any kind of precision, the more frustrated we’ll be at the effort.

So breathe. Relax. Take it in. Be patient. Learn to accept the uncertainties of life.

3. Gratitude

Gratitude changes the pangs of memory into a tranquil joy. – D. Bonhoeffer

To be grateful is to notice the good amidst the bad, the colour against the backdrop of grey, the lovely even if it’s surrounded by the ugly. It’s to count your blessings and recognise how beautiful life is even when life isn’t quite going as planned.

Learning to be grateful requires the desire to see what’s sometimes hard to locate for those who are not accustomed to seeing it. It requires retraining your mind to think about the silver linings in life. But for gratitude to affect your leadership and happiness in the deepest way, it must permeate your soul, encompassing attitude and thought, and becoming the general way you perceive life.

Gratitude doesn’t ignore the difficulty of challenges. But it focuses on benefits and opportunities of challenges. The Chinese characters for the word “crisis” literally mean “danger” and “opportunity”. All challenges and crises bring along with them greater opportunities.

When we’re grateful, our problems don’t disappear, they simply occupy less space in our hearts, minds and lives. The reason is that grateful people are focused on that for which they are grateful. By definition, that means the difficult, disappointing and painful commands less of our attention.

As a matter of fact, I don’t believe there is a single more important character trait to your extra ordinary leadership and happiness than developing the persistent, even automatic grateful response to life.

4. Love

Darkness cannot drive out darkness; only light can do that.( Hate cannot drive out hate; only love can do that.-Martin Luther King Jr

Love conquers all, as they say. And while perhaps not always technically true (I don’t think any person’s love of murder would make this act of violence any less evil, for instance), love certainly goes a long way to being nearly true.

To recognise the centrality of love to living a happy life and showing extraordinary leadership, just imagine a life lived without it. Imagine a hateful, loveless life of happiness and extraordinary leadership (I know. That’s the point. It’s not possible).

The more love that beats in your heart, the happier and more buoyant your heart will be and the more you can demonstrate extraordinary leadership. The more you love life, the more life will love you back. The more your followers will be inspired by your extraordinary leadership.

Love overlooks weakness and closes its eyes to idiosyncrasies. It accepts, seeks, and empowers what’s best in others. This is the road to travel.

 5. Forgiveness

To forgive is the highest, most beautiful form of love. In return, you will receive untold peace and happiness. – Robert Muller

There’s nothing much more conducive to happiness and indeed extraordinary leadership than the ability to forgive quickly, spontaneously and freely. People who hold on to pain, who nurse their wounds, who call out the troops to seek vengeance for the wrongs done to them, may win battles here and there. But the war against unhappiness will largely be lost before it’s even started. An unhappy person cannot provide extraordinary leadership.

Refusal to forgive with exaggerated and lingering resentments lead to a self-imposed imprisonment that inhibits leadership. It’s the very bars that keep others imprisoned in our hearts that keeps happiness far away, at a distance, peering in at best. It’s time we free ourselves by letting old pain dissipate into the darkness, so new opportunities can take us to greater heights of joy.

So, have you forgiven your parents for their weaknesses as parents? Have you forgiven the playground bully or abusive ex-spouse, or your neglectful children( or inconsiderate neighbour or insensitive leader?

If you haven’t, you’re picking at the open wounds that can only irritate, infect and fester. Such open wounds often turn cancerous, metastasising, entering the bloodstream of other relationships, infecting them with its mortal disease as well. Instead, open your heart to forgiveness. Then your heart will finally be open enough to catch its share of happiness as well and your journey to extra ordinary leadership will be smooth.

Lagos ALPs takes health awareness, screening to Ikeja community

2

– Conducts free HIV, blood sugar, BP, cholesterol tests

Keeping to the popular saying that prevention is better than cure, the Association of Lady Pharmacists (ALPs), Lagos State Chapter, recently held a health awareness campaign and free screening programme for residents of Ikeja and its environs.

Proudly supported by LiveWell Initiative (LWI), a self-sustaining health-promotion and empowerment organisation and the Ikeja Local Government  Council, the two-day programme was organised to mark the commencement of the 12th Biennial National Conference of ALPs.

L-R: Pharm. (Mrs) Abiola Paul-Ozieh, Pharm. (Mrs) Modupe Ologunagba and Dr (Mrs) Moyosore Adejumo at the event.
L-R: Pharm. (Mrs) Abiola Paul-Ozieh, Pharm. (Mrs) Modupe Ologunagba and Dr (Mrs) Moyosore Adejumo at the event.

The event, which featured a health awareness walk beginning at the main gate of the Lagos State University Teaching Hospital (LASUTH), and ending at the main hall of the Ikeja Local Government Secretariat, offered opportunity for  many people to access free health counselling and screening on HIV, blood sugar, blood pressure, body mass index (BMI), cholesterol, among others

According to Pharm. Modupe Ologunagba, chairperson, ALPs-Lagos, the programme was organised as a part of the association’s contribution to improvement in public health.

“Health screening is important because Nigeria is undergoing epidemiological disease transition and we found out that a lot of people are coming down with chronic disease conditions and health issues like high blood pressure, diabetes and other silent killer diseases…this awareness is very important and we are happy we have done it,” Ologunagba said.

Explaining further, the ALPs boss noted that regular health exams and tests can help detect health problems before they become complicated and sometimes untreatable.

“By getting the right health services, screenings, and treatments, you are taking steps that help your chances for living a longer, healthier life. Your age, health and family history, lifestyle choices, what you eat, how active you are, whether you smoke, and other important factors impact what and how often you need health care,” she advised

While addressing the people of Ikeja community in the course of the screening exercise, Dr (Mrs) Moyosore Adejumo, director of pharmaceutical services (DPS), Lagos State Ministry of Health, urged the people to consider their health first in everything they do, adding that looking healthy is not always an indication that one is free from diseases.

Speaking further, the Lagos DPS who declared the screening session open, commended the Lagos State Governor, Akinwumi Ambode for his laudable role in prioritising security of lives and properties, as well as ensuring that there is conducive business environment for people of the state to operate in.

In his goodwill message, chairman of the Pharmaceutical Society of Nigeria (PSN), Lagos State, Pharm. Gbenga Olubowale, who was represented by Pharm. (Mrs) Abiola Paul-Ozieh, chairman, Association of Community Pharmacists of Nigeria (ACPN), Lagos State, expressed the delight of Lagos PSN at the activities of ALPs in the state, noting that regular health screening is essential to good health and health care.

“Health screening incorporates several tests, including preventative screenings and physical examinations to check patients’ current health and risks, and if any problems are found, the health care provider will provide information on treatment plans and ways that you can prevent health issues in the future,” she said.

While thanking ALPs for the beneficial initiave, one of the participants, Mr Gbenga Akemoloju, a staff of Ikeja Local Government Council, said he was delighted that an association like ALPs could come to their community with such a laudable programme.

He also expressed his relief at finally knowing his health status, while promising that he was going to inform as many people as possible to come for their health screening as well.

Another participant, Mr Awolesi Muyiwa, from Onigbongbo LCDA, thanked the organisers of the programme for giving him the opportunity to know his health status and the need for him to remain healthy.

Other dignitaries at the event were Pharm. (Mrs) Margret Obono; Pharm. (Mrs) Yetunde Morohundiya, former national chairperson, ALPs; Pharm. (Mrs) Bisi Bright, vice-president, LWI; Pharm. Hafsat Adeshina, CPC chairman, Eko 2016; Assistant Corp Commander Olawale Odekunle, FRSC, Ikeja Area Command; and Executive Secretary, Ikeja Local Government Council, Hon. Dally Adeokun, among others.

Internet of Things: Opportunities for the pharma and health care industries

1

“More objects are becoming embedded with sensors and gaining the ability to communicate. The resulting information networks promise to create new business models, improve business processes, and reduce costs and risks” Mckinsey – Internet of Things (2010)

IOT Shrivastava (Wipro Ltd 2015)
Source: Shrivastava A. (Wipro Ltd 2015)

The Internet of Things (IoT) refers to the networking of physical objects through the use of embedded sensors, actuators, and other devices that can collect or transmit information about the objects. Advances in wireless networking technology have made it possible to collect data from these sensors almost anywhere at any time. The information collected from these smart devices can then be analysed to optimise products, services, and operations.

In recent years, we see an increasing use of IoT in the pharmaceutical and health care industries. Pill-shaped microcameras – “chip in a pill”, a special ingestible pill – have been developed to traverse  the human digestive tract, capturing the health status, as well as drug effects on key organs, and transmit the data to a wearable device. This data is then sent as a report over cloud to health care personnel (HCP) for diagnosis. The information obtained can enable HCPs to prescribe personalised medicines that will improve drug efficacy considerably and reduce treatment period.

The Internet of Things is also applied in helping people keep track of their medications at home through smart devices used as personal medication assistant. An example is Amiko which aims to inform, alert and remind people with asthma (patient) to take the right dosage of medication and alerts them should the medication run low.

Shrivastava A (Wipro Ltd 2015)

IoT is transforming the Healthcare industry. Use of smart devices in clinical development and supply chain has helped in many aspects such as manufacturing and supply chain management, higher R & D productivity, improved pharmacovigilance and regulatory compliance adherence.

Scope of application

  •  Research and development

IoT applications such as “’Organ in a Chip” can drastically improve R&D productivity through rapid trials running multi-stage diagnostics as noted by Akash Shrivastava, a lead consultant with life sciences. During drug development and clinical trials, smart reporting and advance analytical tools will help generate vital diagnostics, enabling real-time reporting as there will be no need for continual feedback by subjects. This will reduce data reporting cost.

  • Reduce time-to-market for new drugs

IoT application can enable pharma companies to plan better with faster decision making using real-time information obtained from smart systems integrated across the pharmaceutical value chain components. The insights acquired during drug research, efficacy, adoption, patient outcomes will be valuable to leadership and marketing teams especially during drug launch, drug pricing, and drug marketing and related strategy development.

  • Regulatory compliance adherence

IoT application will enable real-time data reporting to central systems through the use of  smart devices. This will help improve pharmacovigilance and adverse effect rate can be minimised using the vital diagnostics collected from patients, thereby improving drug quality in terms of safety.

IOT Shrivastava A (Wipro Ltd 2015)
Source: Shrivastava A. (Wipro Ltd 2015)

References:

  • Shrivastava A. (2015) “NextGen Pharma takes smart strides with Internet of Things” Wipro Ltd, Doddakannelli, Sarjapur Road, Bangalore – 560 035, India. http://www.wipro.com/documents/nextgen-pharma-takes-smart-strides-with-internet-of-things.pdf
  • Chui M., Löffler M., and Roberts R. (2010) “The Internet of Things”. McKinsey Quarterly.
  • Christopher Colucci (2015) “Internet of Things in Pharma & Healthcare” https://www.linkedin.com/pulse/internet-things-pharma-healthcare-industry-christopher-colucci.

Increasing the life expectancy of Nigerians

0

The recently published 2016 World Health Statistics report by the World Health Organisation (WHO) lumping Nigeria among countries with the lowest life expectancy figures calls for serious concern. According to the report, despite worldwide increase in life expectancy, Nigeria, with an average score of 54.5 years for both men and women, is still among the seven countries with the lowest scores. The other six countries in descending order are Lesotho (53.7 years), Cote D’Ivoire (53.3), Chad (53.1), Central Africa Republic (52.5) years, Angola (52.5) years and Sierra Leone (50.1 years).

The World Health Statistics 2016 contains data from 194 countries on mortality, disease and health system indicators, including life expectancy, illness and death from key diseases, health services and treatments, financial investment in health, as well as risk factors and behaviours that affect health.

While the report shows that there is an improvement of five years in the life expectancy for Nigeria and across Africa – the biggest ever leap since WHO started publishing the health statistics in 2005 – the fact that Nigeria is still ranked with indigent and war-ravaged African countries is a serious indictment on Nigeria as a nation.

Life expectancy at birth, it must be understood, is the average number of years a newborn infant would be expected to live if health and living conditions at the time of its birth remained the same throughout its life. It reflects the health of a country’s people and the quality of care they receive when they are sick.

Actually, the WHO’s dismal verdict on Nigeria could not have come as a surprise to any careful observer. The statistics showing that life expectancy is low in Nigeria is simply a confirmation of the obvious. In recent times, the number of obituaries in the dailies announcing the untimely demise of young people has been on the increase – a proof that many Nigerians are dying in their prime.

The reasons life expectancy is abysmally low in Nigeria are multifarious and thus require a multifaceted approach to tackle. The first and perhaps  most glaring reason Nigerians are dying young is the appalling standard of living in the country. Majority of the citizens are groaning under the weight of hardship, even as the economy continues to nosedive and inflation rates continue to skyrocket, making it hard for many to meet the basic requirements for healthy living. This endless struggle for survival invariably increases the stress level for many individuals which in turn leads to diverse health issues that are often ignored until  it is too late.

Another major reason is inadequacy of quality health care delivery in the country. This is not unconnected to the nearly apathetic attitude of the government to the country’s health sector. For instance, despite the WHO recommendation and repeated calls from concerned stakeholders, budgetary allocation to the health care sector in the country remains hugely disproportionate. Correspondingly, most hospitals in the country are clearly lacking in required infrastructure to provide quality care. Many sick Nigerians who could have been nursed back to health have suffered avoidable complications and in some cases died due to poor care in our hospitals.

It must also be added that this poor health care delivery, especially at the grassroots level, contributes significantly to the high incidence of maternal and neo-natal mortality in the country. While records show that the situation has improved in recent years and helped contribute to the five-year increase in life expectancy, it must be stated that Nigeria is still on the unenviable list of nations where maternal and neo-natal mortality is still high.

But, perhaps, the worrisome state of the nation’s health care sector and the attendant fallouts might have been significantly mitigated, had the sector itself not been so prone to the canker of corruption that continues to ravage every aspect of our national life. There have been allegations that the bulk of the financial aid given by donor countries and agencies is often siphoned to individual accounts, rather than being spent on building hospitals, upgrading hospital equipment and facilities, and investing in life-saving research and development.

Only recently, The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) said it was suspending disbursement of funds to Nigeria following discovery of large scale fraud to the tune of millions of dollars. The organisation, which is the highest donor to Nigeria in terms of HIV and malaria, said it had disbursed more than $1.4 billion to the country since 2003. Mark Dybul, an executive director at Global Fund, said an audit report exposed “challenges of grants not achieving impact targets, poor quality of health services, treatment disruptions and fraud, corruption and misuse of funds”. This, indeed, constitutes part of the cogent issues to be addressed by stakeholders in any attempt to improve life expectancy in the country.

However, beyond the economic and health care delivery challenges, we must emphasise that Nigerians must be enlightened to begin to individually take measures to ensure they do not die needlessly and prematurely.  Nigerians must adopt lifestyle that enhances long life and refrain from behaviours that shorten life. Such lifestyle modification includes eating the right food in the right quantity and at the right time, shunning sedentary lifestyle, getting adequate sleep and above all cultivating the habit of regular medical examinations to ensure early detection of health conditions.

We believe that with pragmatic and proactive measures by the Nigerian government, backed by the commitment of the citizenry to staying healthy by embracing healthy lifestyle habits, the life expectancy rate of Nigerians will soon experience substantial and consistent improvement.

 

 

How I became first pharmacy student to emerge OOU-SUG president – Shofoyeke

0

Adedapo Shofoyeke

Adedapo Adeniyi Shofoyeke, a 400-level pharmacy student of Olabisi Onabanjo University, Ogun State recently emerged the 31st Students’ Union president of the institution. He is the first pharmacy student  to ever hold such a position in the history of the institution. In this interview with Adebayo Folorunsho-Francis, Shofoyeke who is the first of five children, bares his mind on how he grew up loving Pharmacy and the battle he fought to become the first pharmacy student to attain his current status. Excerpts:

What was growing up like?

Growing up was fun and quite eventful. I attended Mayflower Junior School (1999-2005) and Mayflower Senior School (2005-2011), Ikenne-Remo for both Primary and Secondary education. My father, the late Pharm. (Prince) Kehinde Shofoyeke, managing director of Prince Eagles Pharmacy, was a pharmacist of repute in Ogun State and beyond, even in death; while my mother is a teacher. I actually had a usual childhood – played, read, was scolded and every other thing a Nigerian child from an average family went through, and would have ever gone through. Good old days! I still have fond memories of them.

 Why choose Pharmacy ahead of other science courses?

Well, after my first JAMB in 2011 where I scored 184…I wished to study Medicine and Surgery at University of Lagos (UNILAG). Unfortunately I didn’t meet up with the target and was instead admitted to study Mathematics and Statistics in Oduduwa University, Ipetumodu, Ile-Ife (2011-2012).  However, a number of events came up and I had a re-think. It was there and then that the idea of Pharmacy surfaced and my late father played a crucial role in enlightening me on the prospects of the profession.  I resisted initially but then the flare sprung and that was the beginning of my odyssey in Pharmacy. I eventually gained admission into Olabisi Onabanjo University in 2012

So, do you think you took the right decision in choosing   Pharmacy?

Sure! I know that I took the best option for me and I am proud to be an undergraduate in the Faculty of Pharmacy.

What makes you think you took the right decision?

Pharmacy remains a very good profession because of the high level of integrity attached to it. Besides, it blends with my spirit and perspective of helping humanity.

 Assuming there was no profession like Pharmacy, what other profession would you have chosen?

I would have invented Pharmacy.

 Tell us some of the memorable experiences you’ve had so far

Well, I wouldn’t say I’ve had much experience. One thing is sure, though. I have been bent and moulded to become a corporate person, with high confidence in myself and my abilities.  Thanks to the dean of my faculty, Prof. Mbang Femi-Oyewo. She is such a mother who would take time to ensure that, aside academics, we learn and imbibe the culture of self-esteem and good communication skills.  This has been the foundation.

 What circumstances led to your election as SUG president. What was the  contest like?

It was a thing of chance, calculation and opportunity. They say opportunity comes but once; however, one must be ever prepared to take up challenges and handle such opportunity when it presents itself.  The terrain of OOU is quite amusing.  We run a multi-campus system – you have the main campus in Ago-Iwoye, the College of Engineering in Ibogun, the College of Agriculture in Ayetoro and the College of Health Sciences/Faculty of Pharmacy in Sagamu.  According to the records, OOU-SUG has had 30 presidents. I am the 31st.  Interestingly, the 30 ex-presidents were all from the Ago-Iwoye Campus. However, in 2014, a student from Ibogun Campus (Ayannuga Olugbenga) contested for presidency but lost due to the fact that he was not from the main campus. The following year, he re-contested but the election didn’t hold due to issues with the university calendar.  It was from there that I took the inspiration and baton.  We launched a concerted campaign and, today, God has crowned our little effort with victory, an unprecedented one. The election took place on 27 January, 2016 and we were sworn-in on 5 February, 2016.

Where do you see yourself after school?

I see myself in the corporate world as a business tycoon and, later, in the business of governance.

How did the students take the news of having a pharmacy student being their new leader?

Of course, there will always be politics. While some were happy, some were infuriated. But now we are all united

Since OOU runs a multi-campus system, how do you hope to extend your administration to all?

Well, the Union allows for a vice-president and an assistant general secretary in each campus. These take correspondence in each campus.  Just yesterday, we started distribution and installation in all campuses. The good work has commenced.  Today, we presented a projector, a projector-screen and the accompanying gadgets to Prof. Kayode Oyesiku, Provost of OOU College of Engineering, Ibogun. This is part of the Students’ Union efforts in upgrading the standard of education in OOU – and also, in preparation for a series of accreditations coming up across our various colleges and faculties.

You dropped a hint earlier about moving into business and politics after school. Are you shunning the idea of practising pharmacy?

We have thousands of pharmacists all around the country searching for internship placements – which means that something is amiss. This wasn’t the case in the last two decades. And it sends a signal that entrepreneurship and innovation are key to survival in our evolving and somehow volatile economy. Perhaps within the next few years, Pharmacy might have overcome its present employment gridlock. But as a well-tutored person,  my goals are clearly set.  I will rather start a venture and promote it, alongside my late father’s production venture. However, I have not absolutely ruled out the idea of practising.

Funding is essential to the survival of any organisation. How does your administration source for fund?

We often explore our personal connections. However, the Vice-Chancellor, Prof. Adejimi Adesanya, has been very supportive.

How do you balance academic work with the stress of running the Students’ Union office?

It has been God thus far.  It is very challenging.

What is your advice to pharmacy students seeking to follow your footsteps by vying for SUG presidency?

They need to start believing that anything and everything is possible. I will be glad to see such new development.

 

ACPN canvasses pharmacist DG for NAFDAC

25

The Association of Community Pharmacists of Nigeria (ACPN) has lent its voice to the call on the federal government to appoint a pharmacist as the next director general of the National Agency for Food and Drug Administration and Control (NAFDAC) for greater efficiency.

ACPN national chairman, Dr Albert Kelong Alkali made this position known at a press briefing in preparation for the annual conference of the association, tagged: “Coal City 2016” which holds in Enugu, Enugu State from 29 May to 3 June 2016.

The ACPN boss expressed concern that recent happenings in the Nigerian pharmaceutical indicates that an important agency like NAFDAC needs to be more efficient.

According to him, challenges confronting the sector include the numerous illegal pharmaceutical premises and patient medicine stores scattered all over the country, as well as the increasing proliferation of fake and substandard pharmaceutical products, which is fuelled by the activities of open drug markets that are left to operate freely.

L-R: Pharm Adeoye Afuye, national secretary; Pharm (Dr) Albert Kelong Alkali, national chairman; and Pharm (Mrs) Bridget Okocha, chairman, conference planning committee (CPC), Enugu ACPN national conference at the press briefing.
L-R: Pharm Adeoye Afuye, national secretary; Pharm (Dr) Albert Kelong Alkali, national chairman; and Pharm (Mrs) Bridget Okocha, chairman, conference planning committee (CPC), Enugu ACPN national conference at the press briefing.

Alkali argued that even though he had nothing personal against the immediate past DG of NAFDAC, Dr Paul Orhii, his appointment had been in error, as someone like him could never provide the required leadership insight for the various teams of inspectors at NAFDAC since he was not trained in the area of drug and food administration.

Alkali said only a registered pharmacist and practitioner can demonstrate adequate knowledge of the various dimensions of pharmaceutical practice, noting that Dr Orhii, for example, was an expert in pharmacology which is only one of the eight specialty areas in the pharmacy profession.

“This logically cannot make anybody have a good knowledge of Pharmacy,” Alkali said. “And let me also point out that expertise in drug and food matters is also exclusive to a registered pharmacist by virtue of his training. This is why pharmacists, in tandem with global best practice, are described as experts in drugs.”

The ACPN helmsman said it is therefore apt to emphasise that in terms of the regulatory processes in a core regulatory agency like NAFDAC, only a pharmacist has a jurisdiction as a regulatory officer in all the core mandate areas of pharmacy, food and drugs.

Alkali also revealed ACPN’s stance on the operation and implementation of the National Health Insurance Scheme (NHIS), describing it as faulty and fraudulent.

“The National Health Insurance Scheme was established by the federal government to make health more affordable and accessible by the majority of Nigerians, but unfortunately the Nigeria factor has crept into the implementation of the laudable programme and made it difficult for the government to realise its laudable goals and objectives,” Alkali stated.

Bemoaning the mode of payment on the NHIS in particular, the ACPN boss lamented that the global capitation mode of payment (instead of the fee-for-service for secondary providers) has compromised the standard, efficiency and quality of services rendered by primary providers of the scheme.

Alkali also observed that pharmacists, physiotherapists, laboratory technicians and other relevant health care personnel have been sidelined in the operation of the NHIS.

“A situation where consultations, prescription, laboratory investigations, physiotherapy and dispensing of drugs are carried out by the same person is not in the best interest of the patient. It is unethical and exploitative; therefore, Nigerians who are enrollees of the NHIS should rise and ask questions on the functionality of the NHIS as we pharmacists, say no to global capitation,” Alkali said.

On the way forward for the scheme, Alkali urged the government to ensure that the enabling act of parliament setting up the NHIS is strictly followed so that Nigerians can benefit immensely from the scheme.

 

 

Baale explains why Pharmacy is tougher than other courses

1

Leadership expert, Lere Baale, has revealed the reason Pharmacy is tougher than any other course in the world, noting that while it is impossible to score less than zero (0) in all other courses, a student of pharmacy can score less than zero.

Addressing academic staff and past pharmacy students of Olabisi Onabanjo Univeristy’s (OOU) at the launch of the institution’s Pharmacy Alumni which took place at Westown Hotel, Ikeja, Lagos on 1 May, 2016, Baale who was the keynote speaker reiterated that Pharmacy is the greatest of all professions.

“Even if your aggregate falls in the range of First Class, you will still repeat that course. That is why we tend to have some course mates with whom we started together still in one or two sets below us. It is one interesting feature of pharmacy practice,” he said.

 

L-R: Pharm Adetutu Afolabi, chairman, OOU Faculty of Pharmacy Alumni planning committee and Prof. Saburi Adesanya, vice chancellor of Olabisi Onabanjo University presenting an award to Pharm (Pastor) Kayode Yusuf, managing director of L’Pacemaker Pharmaceuticals Limited
L-R: Pharm Adetutu Afolabi, chairman, OOU Faculty of Pharmacy Alumni planning committee and Prof. Saburi Adesanya, vice chancellor of Olabisi Onabanjo University presenting an award to Pharm (Pastor) Kayode Yusuf, managing director of L’Pacemaker Pharmaceuticals Limited
L-R: Prof.  Mbang Femi-Oyewo, dean, OOU Faculty of Pharmacy; Pharm Segun Taiwo, newly inducted pharmacy alumni president and Prof Saburi Adesanya, vice chancellor of Olabisi Onabanjo University, during the official launch of the institution’s Pharmacy Alumni, held at Westown Hotel, Ikeja, Lagos recently.
L-R: Prof. Mbang Femi-Oyewo, dean, OOU Faculty of Pharmacy; Pharm Segun Taiwo, newly inducted pharmacy alumni president and Prof Saburi Adesanya, vice chancellor of Olabisi Onabanjo University, during the official launch of the institution’s Pharmacy Alumni, held at Westown Hotel, Ikeja, Lagos recently.

The director of BusinessSchool Netherlands Nigeria who is also a regional partner of Howes Consulting Group further emphasised on the theme of the gathering, “Role of Professional Alumni in Nation Building,” saying it should not be underestimated.

“Although I know you held this launch here (Lagos) because of the dignitaries you invited, I suggest that you host subsequent ones in your faculty back in OOU. If you find the heat too much there, let some of you donate air conditioners to create comfort.

“If the buildings are not conducive, build new ones for the school. That is how it starts. Just as my alma mater alumni, you need to start donating toward the development of your faculty. I know it is an expensive project but you can do it and God will help you,” he enthused. .

While eulogising Prof. Saburi Adesanya, Baale said he had deep respect for the vice chancellor being a veteran pharmacognosist.

He added that while pharmacognosy is indeed a very difficult course, it is not as boring as many people claim.

The pharmacist also applauded the effort of Prof Mbang Femi-Oyewo, dean, OOU Faculty of Pharmacy, adding that without her support, his last years at Pfizer where he worked would have turned out to be a nightmare.

Thanking the keynote speaker for his gesture, Prof. Femi-Oyewo remarked that the launch of OOU Pharmacy Alumni was a dream come true.

“Since inception, we have a total of about 122,000 pharmacists. Anywhere you go, pharmacists from OOU are the best in their chosen fields. However, a school cannot do without alumni, which is why we need to have a formidable one on ground.

“The first and sixth pharmacy sets had come to donate things to the school. I was also amazed to receive a delegation of past students who trooped out to honour me on my birthday. This is the first time any former student is coming to honour a dean in the school. We expect other past students of the faculty to see how they can contribute to the development of the institution,” she urged.

Buttressing her view, Prof. Saburi Adesanya, vice chancellor of Olabisi Onabanjo University said he was elated that something as big as alumni commissioning was happening in the Faculty of Pharmacy.

“Many of you must have been wondering why Prof. Femi-Oyewo and I are so close. She was actually my coursemate at the University of Ife. But I am happy today that since its creation, OOU Faculty of Pharmacy has grown in leaps and bounds.

“For those who have recently visited, you will agree with me that the buildings were not the same as the ones you used during your time. Your new pharmacy facility is one of the best in any Nigerian school today. We are not there yet, but we believe that we can be the best in the world,” he said.

Charging the new members of the alumni, Afolabi Sorunke, national president of OOU Alumni Association, stressed that there were numerous benefits attached to being members.

According to him, joining prestigious clubs like Ikoyi or Ikeja club costs about N2 million per year.

“But let me reassure you that both don’t even have huge lists of members that match those of OOU. We have members in United Kingdom, The Netherlands, United States, and some other African countries. OOU is reaching far greater heights, let us be part of that success story,” he charged.

The mission of the pharmacy alumni, according to Pharm Adetutu Afolabi, chairman of the inaugural committee, is to bring together successful pharmacists, network and also see to the betterment of present pharmacy students of the institution.

The event featured activities such as constitution of inaugural executive members for the alumni, as well as presentation of awards to the trio of Pastor Kayode Yusuf, managing director of L’Pacemaker Pharmaceuticals Limited; Prof. Saburi Adesanya; and Prof. Mbang Femi-Oyewo, in recognition of their support for the inauguration of the alumni.

In attendance were Dr Timothy Fajemirokun, senior lecturer, Faculty of Pharmacy; Dr Lateef Kassim, OOU senior lecturer; Dr Olushola Aremu, head of department, Pharmaceutics; Mr Niyi Oduwole, deputy registrar, Corporate Affairs Commission; Pharm. Tosin Ishola, executive director of Bentos Pharmacy; and Pharm. Sesan Kareem, personal assistant to president of Pharmaceutical Society of Nigeria (PSN).

Others were Pharm Segun Taiwo, newly inducted pharmacy alumni president; Pharm Olaide Soetan, managing director of NHC Pharmaceuticals Limited; Pharm Abolaji Noibi, manager, Globacom Limited; Pharm. Ayodimeji Badejoko, managing director of Agenda Pharmacare Limited; Pharm Akinyele Aje, sales manager, Seagreen Pharmaceuticals Limited and Pharm Abimbola Olanrewaju, brand manager, Novartis Nigeria Limited.

 

 

Pfizer Academy trains community pharmacists on patients’ management

1

Towards the need for continuous capacity building and empowerment in the pharmacy profession, Pfizer Plc has organised a one-day Pfizer Pharmacy Academy, the objective of which was to deploy an impactful, world class integrated medical education/soft skills training to a minimum of 500 class A & B retail pharmacists in Lagos.

The training was aimed at empowering pharmacists with the principles of patient management with medications and to enhance their knowledge, as well as to equip them with tools, in order to have a reorientation towards new medicines.

Pfzer
L-R: Consultant Urologist, Dr. Funmilade Omisanjo; Managing Director, Victory Drugs, Pharm. Folasade Lawal; Chairman of the occasion, Lere Baale; Consultant Family Physician, Lagos University Teaching Hospital (LUTH), Dr. Nebe Nwamaka; Consultant Orthopaedic Surgeon, Dr. Alimi Mustapha; Marketing Director, Pfizer Nigeria and East Africa Region, Winston Ailemoh; Consultant Cardiologist, Dr. Adanijo Monisola; at the Pfizer Pharmacy Academy held at the Four points by Sheraton Hotel, Victoria Island, Lagos

Speaking at the event, Chairman of the occassion, Lere baale emphasized the importance of new medication in patient management, saying that every time you come up with a new medication, for every dollar you spend on new innovation, you will save as much as eight dollars on hospitalization. Typically this is costing the US economy 300 billion on both hospitalization and associated costs of manning for those people.

He further stated that the training will enhance their knowledge base on medication on the group of medication for that therapy area, while disabusing their minds from the practice of recommending cheaper brands in place of expensive brands, stating that this has led to complication of cases.

“That you think a medicine is cheap does not mean the pharmacological profile and the biopharmaceutical profile are the same with another, in fact, its creates more problem when the patient would need to go back to the hospital, because the patient is going to be hospitalized, and when the patient is taking a bed space that he shouldn’t have taken in the first instance, in a country like ours where we do not have enough bed space, then the compounding effects will be more than imagined.

“If somebody needs to be given a particular brand, you cannot use pricing alone to determine which brand is the best to be picked. A number of people that will use pricing alone without a means of protecting quality, such practice will lead them to become victims of substandard drugs, because many have been blinded on medications that they should have been able to use to manage Glaucoma”, he explained.

A Consultant Urologist, Dr. Funmilade Omisanjo, during an exclusive interview with Pharmanews at the Academy, spoke on the prevalence of erectile dysfunction among Nigerian men, saying that at least 30% to 40%  of men, who are above the age of 40 will have some degree of erectile dysfunction,  be it the mild form of dysfunction or severe form.

Omisanjo, who is also a senior lecturer with the Lagos State College, identified the causes of erectile dysfunction to include: age, lifestyle, obesity, smoking, alcohol, secondary factors- diabetes, hypodermia, and high blood pressure.

“Age is a very important factor; also lifestyle is a very important. Obesity is necessitated with that, lack of exercise people who do sedentary work or people who don’t do my physical activity. That kind of lifestyle will also predisposed people to erectile dysfunction. Things like smoking, taking a lot of alcohol. Most of these recreational drugs that people take actually have side effects of affecting erection negatively. Then of course you have various co-morbidity other diseases thing like diabetes mellitus, hypodermia, people who have problems with high level of cholesterol in their system, high blood pressure, people who have problems with their nerves, then of course there are medications people take various medical conditions that have various erectile dysfunction as a side effects. These are some of the function that predisposed men to erectile dysfunction”, he asserted.

On whether herbal drugs are effective in treating the condition or not, he acknowledged that the local things that patients take actually do work sometimes, though they work at the expense of some other things. “I will give you an example; most of the local things that people take are invariably things that have been soaked in alcohol. Alcohol in itself can be a risk factor for erectile dysfunction besides, the chronic intake of alcohol can have other side effects on the liver and all that. You can never tell what the concentrations of these things are. So in as much some of these do work, there are not the things we prescribe routinely”.

The urologist, who discouraged the intake of herbal remedies for the treatment of erectile dysfunction, advised men to always endeavour to seek expert opinion and treatment because they have well proven medications that do work.

He however, urged pharmacists to be discerning in dealing with patients, saying that they sometimes come under the pretence of the need for an energy booster or some herbal supplements. “I think health care givers should be sensitive to patients need. When people come with all these kind of loose complaints as it were, I think the pharmacists should take out time and have a discussion with the patients and when you see there is some degree of erectile dysfunction,  I think you need to encourage the patient to see an expert.

 

Professor Frank Stangenberg-Haverkamp receives the “African Alliances HE for SHE” Award for Women Empowerment

0

A very important initiative to empower an unprivileged segment of women in Africa

During the 11th African Congress for Women Entrepreneurs, Professor Frank Stangenberg-Haverkamp, Chairman of Executive Board and Family Board of E. Merck KGaA received the “African Alliances He for She Award” for Women Empowerment. This was in recognition of Merck’s efforts to empower women in the field of research and healthcare through the Merck Capacity Advancement Program and UNESCO – Merck Africa Research Summit.

The award also recognizes Merck’s significant contribution to empower infertile women in Africa through the ‘Merck More than a Mother’ campaign.

Prof. Stangenberg-Haverkamp receives his HE for SHE award
Professor Frank Stangenberg-Haverkamp receives the “African Alliances HE for SHE” Award for Women Empowerment
Prof. Frank Stangenberh addresses the audience at the Merck More than a mother pan african launch
Prof. Frank Stangenberh addresses the audience at the Merck More than a mother pan african launch

 

 
“I am very happy to receive this important award. The “Merck More than a Mother” campaign is a very important initiative to empower an unprivileged segment of women in Africa,” Prof. Dr. Frank Stangenberg –Haverkamp said upon receiving his award. “Women who suffer infertility have been neglected, mistreated and discriminated because they cannot bear children, while we must also consider that 50% of infertility is caused by male factor and yet women are solely blamed for it.”

Dr. Amany Asfur, President of African Alliances of Women Empowerment explained, “We are very proud to acknowledge Merck’s efforts to empower infertile women in Africa by improving their access to information, awareness, health and change of mindset through their historic ‘Merck More than a Mother’ campaign.”

“Through the ‘Merck more than a Mother’ campaign we started an important project called ‘Empowering Berna.’ The project seeks to help infertile women, who cannot have children anymore, start their own businesses and build their independent and happier lives. I am very passionate about this project and I will follow it up by myself with women organizations across Africa.” mentioned Dr. Rasha Kelej, Chief Social Officer of Merck Healthcare.

The “African Alliances He for She Award” award also recognizes the UNESCO- Merck Africa Research Summit- MARS’s new initiative to empower African women researchers. The initiative is very critical for Africa’s future, and its social and economic development, which cannot be achieved except with the economic empowerment of women and youth.

During the same conference, the African Women Empowerment Award was granted to H.E. Samba-Panza, Former President of Central African Republic and H.E. Prof. Ellen Johnson-Sirleaf, President of Liberia, who was represented by H.E. Julia Duncan-Cassell Liberian Minister of Gender.

During the African conference for women entrepreneurs, a high level panel of Merck More Than a Mother was conducted during which, Hon. Sarah Opendi the Ugandan Minister of Health, Hon. Jean Kalilani the Malawian Minister of Gender, Children, Disability and Social Welfare, Hon. Julia Duncan-Cassell the Liberian Minister of Gender and social affairs, Hon. Dr. Lanre Tejuoso the Nigerian Chairman Senate Committee on Health, Hon. Qedani Dorothy Mahlangu MEC Health Gauteng Government, South Africa, and parliamentarian members and academics from Uganda, Kenya, Angola, Mozambique, Tanzania, Nigeria and Ivory Coast, discussed Merck More Than a Mother objectives and intervention across Africa and a commitment was made to kick off the campaign in each country during 2016 and 2017.

Distributed by APO (African Press Organization) on behalf of Merck KGaA.

View multimedia content

About Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 40,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2014, Merck generated sales of € 11.3 billion in 66 countries. Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, EMD Millipore and EMD Performance Materials.

About African Alliance for Women Empowerment

African Alliance for Women Empowerment was established in 2006 with focal points across Africa with the main objective of Empowering Women of Africa to Meet the Millennium Development Goals (MDGs). This is through economic, political and social empowerment of Women.

SOURCE
Merck KGaA

Pfizer participates, partners UNIBEN at international symposium

0

In line with Pfizer contribution to the advancement of medical knowledge and its demonstrated commitment to world class medical education, capacity building and excellence in the pharmaceutical industry, Pfizer has just participated at the International Symposium/Doctoral Colloquium, held at the University of Benin.

In his opening remarks, the Vice- Chancellor, Prof. Orumwense ably represented by Prof. Abiodun Falodun, expressed the determination of the institution to be a very strong research-based  institution in all academic fields, adding that it was a  privilege to have a guest lecturer, a professor of Pharmacology from the University College of London.

UNIBN
L-R: Registrar, University of Benin, Mrs.O.A Oshodin; Guest Speaker, Prof. Humphrey Rang; Deputy Vice Chancellor (Academic), University of Benin, Prof. Abiodun Falodun, Mr. Luke Obasuyi; at the International Symposium/Doctoral Colloquium held in University of Benin, Edo State.

Appreciating the University authority for bringing such a distinguished academic like Prof. Humphrey Rang, on behalf of the College of Medical Sciences, Prof. V.I Iyawe, expressed the desire of the students and staff of the college to have more of such programmes organised in the institution.

Speaking at the conference, titled “Drug discovery in a changing world”, Rang disclosed that over the past 50 years, new therapeutic drugs have been exclusively discovered and developed by the Pharmaceutical industry which has transformed modern medicine. The rate at which new medicines are introduced remain high. Despite its antecedents, herbal medicine practices of Pre-history, and the origins of apothecaries trade in the middle ages, science-based drug discovery was impossible (with a few exceptions) until the scientific coming –of –age of the key disciplines.

A professor of Pharmacology from the University College of London, Rang called on governments to invest in research into drugs and cure to advance medical practice in the country.

He reiterated that the increasing emphasis on identifying and exploiting new drug targets, a strategy exemplified by the development of the first beta-adrenoceptor blocking drugs, ACE inhibitors and strains proved highly successful towards the end of the 20th century and the industry produced many profitable block buster drugs.

He posited that in the last 30 years, most notably, the growing importance of molecular cell biology and genomics,  have provided many new techniques and therapeutic opportunities, but also thrown up new challenges for the industry.

Rang enumerated the benefits of modern medicine, saying the rate at which new medicines are introduced remained as high as ever.
He said drug discovery depended largely on the support of the government because of huge financial involvement just as he called for international donors supports.For instance, he said it cost him $1 billion to get into the discovery of drugs for certain ailments.
A professor of pharmacology at the University of Benin, Professor Hope Obianwu also noted that over 4 million Nigerians are sickle cell anaemia patients.
He said the only cure for sickle cell “though funny” is marijuana which is identified as a narcotic. My research on sickle cell anemia which we have used and proved the efficacy is Indian hemp for the proper treatment of sickle cell anemia “that is the good, the bad and the ugly side of marijuana.
 Representative of Pfizer Pharmaceutical Company at the event, Luke Agbo said Pfizer Company in partnership with the University of Benin believes in making the world a healthier place. “Partnering with the university in programmes like this will help expand the broad of knowledge.” He said.
He added that, the lecture exposes students and stakeholders in the medical sector the opportunity to appreciate science noting that,” Pfizer is doing a lot of work to enable our local scientists to develop strengthen that capacity and also trying to create an enabling environment for young intellectuals, particularly the medical and pharmaceutical students.”  

Pfizer trains community pharmacists in Lagos

0

Towards the need for continuous capacity building in the pharmacy profession, Pfizer Plc has organised a one-day Pfizer Pharmacy Academy, to intimate community pharmacists in Lagos with global trends in the practice, to equip them for world class health care delivery,  comparable to what obtains in developed countries of the world.

Pfzer
L-R: Consultant Urologist, Dr. Funmilade Omisanjo; Managing Director, Victory Drugs, Pharm. Folasade Lawal; Chairman of the occasion, Lere Baale; Consultant Family Physician, Lagos University Teaching Hospital (LUTH), Dr. Nebe Nwamaka; Consultant Orthopaedic Surgeon, Dr. Alimi Mustapha; Marketing Director, Pfizer Nigeria and East Africa Region, Winston Ailemoh; Consultant Cardiologist, Dr. Adanijo Monisola; at the Pfizer Pharmacy Academy held at the Four points by Sheraton Hotel, Victoria Island, Lagos

Details later…

 

 

Nigeria Receives Record Praziquantel Donation

1

Merck supplies around 34 million tablets this year to fight schistosomiasis in the west African country.

Merck, a leading science and technology company, announced today that the largest single delivery of praziquantel tablets in the history of the Merck Praziquantel Donation Program recently arrived in Abuja, the capital of Nigeria. The west African country has received around 34 million tablets for mass distribution to school children. With this, Merck has donated more tablets to a single country than it did to the entire continent in 2012 (27 million). Today in Geneva, Nigeria's Minister of Health, Prof. Isaac Folorunso Adewole, expressed his country's thanks to Merck and the World Health Organization (WHO) for their joint efforts in the fight against the neglected tropical disease schistosomiasis. Stefan Oschmann, Chairman of the Executive Board and CEO of Merck, met the minister on the occasion of the 69th World Health Assembly (WHA), the decision-making body of WHO, in Geneva. The participants included Dr. Kesetebirhan Admasu, Minister of Health of Ethiopia, as well as WHO Assistant Director-General Dr. Ren Minghui.

“We want to eliminate the insidious worm disease and give children the opportunity to participate in the economic development of their home countries. Our donation of 34 million tablets to WHO for Nigeria – enough to treat 13.6 million school children – shows that we are on the right track. However, millions of children still suffer from schistosomiasis. And we know that we alone cannot solve the problem with our tablets,” said Oschmann. In Africa, Merck is supporting educational and awareness programs, researching schistosomiasis therapies for very young children and cooperating with partners in the Global Schistosomiasis Alliance, among other things. “Furthermore, in the future we will collaborate even more closely with our partners to finally eliminate schistosomiasis,” Oschmann continued.

“With more than 235 million people requiring treatment, schistosomiasis is one of the most prevalent tropical diseases in Africa. The worm disease is widespread in all regions of Nigeria, above all among children. We are therefore grateful for every sustained initiative that supports us in fighting schistosomiasis,” said Adewole. Admasu added, “Merck’s commitment not only helps children who are ill – it also relieves the public healthcare systems of the affected countries.”

Minghui continued, “Medicine donations such as this are essential to the fight against neglected tropical diseases. If we are to meet the ambitious sustainable development goals, we need the strong engagement of the private sector, sectors outside health and all development partners.”

As part of its responsibility for society and within Health, one of its corporate responsibility strategic spheres of activity, Merck is supporting WHO in the fight against the worm disease schistosomiasis in Africa. Praziquantel is well tolerated and the most effective treatment to date for schistosomiasis. Since 2007, more than 74 million patients, primarily school children, have been treated. To this end, Merck has donated over 340 million tablets to WHO.

According to WHO, Nigeria is the world’s most endemic country for schistosomiasis. It is estimated that around 37% of the overall population (64.1 million people) requires treatment. Nigeria has been participating in the Merck Praziquantel Donation Program since 2008. To date, through WHO Merck has donated nearly 105 million tablets to Nigeria, making it the main beneficiary country of the donation program. In total, nearly 20 million Nigerian patients have been treated to date, primarily school children.

 

Distributed by APO (African Press Organization) on behalf of Merck KGaA.

 

Schistosomiasis
Schistosomiasis is a chronic condition and is one of the most common and most devastating parasitic diseases in tropical countries. It is estimated that 260 million people are infected worldwide and that around 200,000 die from it each year. Flatworms transmit the chronic disease. It is widespread in tropical and subtropical regions where large sections of the populations have no access to clean water and sanitary installations. People become infected with the disease by worm larvae mainly in freshwater, for example while working, swimming, fishing or washing their clothes. The miniscule larvae penetrate human skin, enter the blood vessels and attack internal organs. The infection rate is particularly high among school-aged children. Praziquantel is the only active ingredient with which all forms of schistosomiasis can be treated. WHO has therefore deemed praziquantel, the most cost-efficient solution for the health of patients in need, as the drug of choice.

The Merck Praziquantel Donation Program 
Merck initiated the Praziquantel Donation Program in cooperation with WHO back in 2007. Since then, more than 340 million tablets have been donated and over 74 million patients treated, mainly school children. Merck has committed itself to maintaining its efforts in the fight against the tropical disease until schistosomiasis has been eliminated. To this end, Merck is donating up to 250 million tablets per year to WHO. The planned annual donation has a value of around US$ 23 million. In addition, Merck is supporting an awareness program at schools in Africa in order to educate children about the causes of schistosomiasis and ways to prevent it. Furthermore, as part of a public-private partnership, the company is researching a new formulation of praziquantel that can also be administered to very young children. To date, the tablets are only suitable for children older than six. At the end of 2014, Merck founded the Global Schistosomiasis Alliance together with partners such as the Bill & Melinda Gates Foundation and World Vision International.

Further information on the fight against schistosomiasis is available on the Internet: http://www.apo.af/FAS9kr.

All Merck news releases are distributed by e-mail at the same time they become available on the Merck website. Please go to www.MerckGroup.com/subscribe to register online, change your selection or discontinue this service.

About Merck
Merck (www.MerckGroup.com) is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.8 billion in 66 countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

SOURCE
Merck KGaA

Antidiabetics Market Research & Industry Analysis (2016-2020)

0

(By James K Griffin)

Diabetes mellitus, commonly known as diabetes, is a group of metabolic diseases in which blood sugar levels goes extremely high over a prolonged period. Antidiabetics are the medicines developed to stabilize and control blood glucose (sugar) levels amongst diabetes patient. Antidiabetic drugs are generally used to control diabetes. Insulin pramlintide (Amylin), GLP-1 receptor agonists such as byetta and victoza are the different types of antidiabetics drugs. The global antidiabetics market is driven by increasing prevalence of diabetes mellitus.

Increasing disposable income has been resulted into significant changes in lifestyle. This in turn has been resulted into increasing incidences of disorders such as obesity which may cause the diabetes. This is primarily triggered the demand for antidiabetics. Additionally, advancement in pharmaceutical sector helps to drive the antidiabetics market. However, high cost of insulin is expected to be a major restraint of antidiabetics market. The market size and forecasts in terms of revenue (USD million) for the period 2015 to 2020, considering 2014 as the base year, have been provided for this segment of the report. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2015 to 2020.

Access sample report visit at http://www.syndicatemarketresearch.com/request-for-sample.html?flag=S&repid=51861

The report provides a comprehensive view on the antidiabetics; we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the antidiabetics market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate and general attractiveness.

The global antidiabetics market is segmented on the basis of product and region. The productsegments of the global antidiabetics market include insulin, rapid acting, long acting, premixed, premixed analog, short acting, intermediate acting, antidiabetics, alpha-glucosidase inhibitors, biguanides, sulphonylureas, glp-1 agonist, meglitinides, dpp-4 inhibitors, sglt – 2 and thiazolodinediones. Insulin dominated the overall market in terms of revenue.

Major regional segments analyzed in this study include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, further bifurcation of region on the country level, which include U.S., Germany, UK, France, China, Japan and India. North America dominated antidiabetics market.

Some of the key players for global antidiabetics market include Boehringer Ingelheim GmbH, Astra Zeneca plc, Eli Lilly & Co., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, SanofiS.A., Johnson & Johnson, Mankind Pharma Ltd., and Teva Pharmaceutical Industries Ltd.

Inquiry for buying report visit at http://www.syndicatemarketresearch.com/market-analysis/antidiabetics-market.html

Optum Healthcare Success Story

0



You can’t get any more personal than your health. That’s why Optum Healthcare uses Salesforce to develop personalized health journeys for its millions of customers. With a holistic view of each customer, information is real-time, relevant, and actionable across each channel.

source

Benue State School Of Nursing To Be Re-accredited Soonest

0

Good news to all nursing students in Benue State, as the state Governor, Mr Samuel Ortom, has directed the Ministry of Health to apply for the re-accreditation of the School of Nursing and Midwifery Makurdi.

The institution’s operational license was withdrawn in 2014 and the ministry is expected to apply to the Council of Nursing and Midwifery for accreditation.

Governor Ortom, in a Channels TV reports,  gave the directive while on the state wide inspection of ongoing projects ahead of preparations to mark his administration’s One Year Anniversary.

The Governor in company of his commissioners and contractors handling the reconstruction and furnishing of the School of Nursing, said the institution was ready for human capital development.

Governor Ortom arrived at the School of Nursing and Midwifery in company of political appointees and the contractors handling the reconstruction and furnishing of the institution.

Over 80 per cent of the structural work has been completed, while details like furnishing, landscaping and fittings were being installed ahead of the re-accreditation of the institution.He warned against further delays in seeking for approval to reopen the school.

In a reaction to the development, the President, National Association of Nigerian Nurses and Midwives (NANNM) Comrade Abdurafiu Adeniji, said there is standard for  everything, adding that any institution that falls short of the laid down standard by the Nursing and Midwifery Council of Nigeria will suspended from operating.However, I am optimistic that Benue School of Nursing will be re-accredited if they  meet the required standard.

 

PCN Shuts 138 Shops In Delta State

0

Poised to rid the nation of illegal circulation of substandard drugs, the Pharmacists Council of Nigeria (PCN) has sealed 27 pharmacies and 111 patent medicine shops in Delta State, on Monday 16, 2016.

Speaking during the exercise, according the Channels TV reports,  the Director and Head of Inspection and Monitoring, Mrs Anthonia Aruya, who led the team of inspectors, said the shops were sealed for offences ranging from dispensing poisonous drugs, poor storage conditions and non-registration with PCN.

The operators, around  Asaba and Okpanam axis who were taken unawares by the visit of the monitoring team, had nothing to say, as they were aware of the consequences of their unlawful operations.

Also in Warri and its environs, the monitoring team which was led by the Head of Enforcement, Stephen Esumobi, sealed several pharmacies and patent medicine shops which were operating illegally.

Pharmacies and medicine shops that were duly registered with the PCN were not affected.

At the end of the exercise, which lasted for one week, Mrs Aruya advised members of the public to patronise only licensed pharmacies and patent medicine shops, as drugs purchased elsewhere could not be guaranteed to be safe for their use.

 

 

Pharm. Oluwatosin Caleb ADEYEMI

0

Tosin Adeyemi

Pharmanews personality of the month, Pharm. Oluwatosin Caleb ADEYEMI is a lecturer in the Department of Clinical Pharmacy and Biopharmacy, University of Lagos (UNILAG) and current chairman of Nigerian Association of Pharmacists in Academia (NAPA), Lagos branch.

Born in the ancient city of Omu-Aran in Irepodun Local Government Area of Kwara State, the pharmacist gained admission into the Faculty of Pharmacy, Ahmadu Bello University (ABU) and bagged a Bachelor of Pharmacy degree in 2008.

In 2011, he applied to the Department of Clinical Pharmacy and Biopharmacy, Postgraduate School, University of Lagos for his master’s degree programme. Three years after he got his master’s degree in 2012, he enrolled again at the institution for his PhD.

Adeyemi started his career as GHAIN focal pharmacist, General Hospital, Bama, Borno State (March 2010-February 2011). In 2012, he joined Mebik Pharmacy, Gbagada, Lagos as superintendent pharmacist. Shortly after, he moved to HealthPlus Pharmacy in the capacity of superintendent pharmacist.

In a bid to fulfill his childhood dream, the NAPA chairman soon called it quits with community pharmacy practice and moved into the field of academia. With his unmistakable flair for imparting knowledge, it didn’t take him long before the dream materialised. In 2014, his alma mater (UNILAG Faculty of Pharmacy) appointed him as Lecturer II in the Department of Clinical Pharmacy and Biopharmacy.

Aside being the current NAPA chairman (Lagos branch), Adeyemi is the project coordinator of the Young Pharmacists’ Group of International Pharmaceutical Federation (FIP), The Hague, Netherlands (Project Coordinator).

He is also a member of several professional bodies, such as the Pharmaceutical Society of Nigeria (PSN); the West African Postgraduate College of Pharmacists (WAPCPharm 2013); the Institute of Public Managers and Administrators of Nigeria (2010); the Nigerian Institute of Management (2011); Cochrane Drugs and Alcohol Review Group, St Albans House, London; Pharmanews Training Faculty; Pharmalliance Group and the Faith Tabernacle Medical Team (Head of Pharmacy), Ota, Ogun State.

Some of his academic works include: “Identifying Risk Factors For Cardiovascular Disease During A Medical Mission Outreach”, Nigerian Journal of Pharmacy; Self-Reported Adherence to Antihypertensive Drugs in a Nigerian Population using the Morisky Medication Adherence Scale, Nigerian Quarterly Journal of Hospital Medicine; A Survey of Antibiotic Use in Respiratory Tract Infections in a Community in Zaria, Kaduna State, West African Journal of Pharmacy and A Review of Phenobarbital in the Management of Hyperbilirubinemia in Newborn Infants, Nigerian Journal of Pharmacy.

In recognition of his selfless service, he has received the following laurels: HealthPlus Pharmacy’s Outstanding Manager of the Year (2013) and Best Academic Poster, Pharmaceutical Society of Nigeria Annual Conference 2014 (jointly received with Pharm (Mrs) Folashade Lawal of Victory Drugs limited).

His hobbies include reading, travelling and counselling.

Pharmacy students are too preoccupied with academics – PANS editor

0

Jibril Chado is a 500 -level pharmacy student of the Usmanu Danfodiyo University, Sokoto (UDUS). He is the current national editor-in-chief, Zone C of the Pharmaceutical Association of Nigeria Students (PANS), as well as being auditor-general of PANS-UDUS. In this exclusive interview with Pharmanews, the soft-spoken Jibril reveals some of the plans of PANS-UDUS editorial department for pharmacy students within the next one year, as well as the challenges facing the department. He also discusses the contribution of Sir (Pharm.) Ifeanyi Atueyi, publisher of Pharmanews to the development of pharmacy practice in the country. Excerpts:

Whose decision was it for you to study Pharmacy?

It was purely my decision. It’s no more a hidden fact that Pharmacy is one of the most lucrative courses in the world today, and for this and some other reasons I fell in love with it. Also, I am an inquisitive person and I have always wondered about drugs – how they are made, how components are put together to make a formulation and how they cure various diseases. This curiosity was also one of the important reasons I found myself in the school of pharmacy and I am glad today because I took a very good decision then.

 

What motivated your decision to contest for the post of PANS editor-in-chief?

The love of writing, the need to be heard and the opportunity to motivate other students through creative writing constituted my major drive. There is a saying that ‘the pen is mightier than the sword’. So, disseminating information to people through writing or other means is very important and can g o a long way in benefiting people.

I have discovered that, being pharmacy students, we have a very tight schedule and we hardly have time to access information about what is happening around us; in fact, we care less about what is happening around the world. So I thought it wise that I should bridge that gap by positioning myself in such a way that my colleagues would benefit greatly and this has yielded many positive results. My colleagues now have access to the editorial board and know what is going on around them.

 

What goals have you set to achieve before the end of your tenure as the editor-in-chief?

Some of the objectives I hope to have achieved at the end of my tenure, especially within my zone include: a) Enlightenment of pharmacy students on the various opportunities that abound in the profession; b) to increase awareness and keep all pharmacy students, especially those under my zone, up-to-date about happenings in the pharmacy profession and beyond; c) to give opportunity to some pharmacy students who are talented writers to utilise their gifts; d) to increase the representation of Zone C in the annual PANS magazine so we won’t be left out; and e) to create and promote awareness about the activities of our zone to other schools of pharmacy in the country and beyond.

 

How have you been coping, combining editorial responsibilities of PANS with your studies?

I have to categorically state that it has not been an easy task; but with zeal and commitment, many things are achievable. We all know how demanding and tasking pharmacy school is but, with God, I have been able to cope.

 

In terms of membership participation, have you been getting the needed cooperation among your fellow pharmacy students?

 

It’s actually disheartening to say this – but the fact remains that the level of cooperation among my fellow students has been quite discouraging. Majority of them usually feel preoccupied with academic activities to the extent that they hardly have time for anything else. It has always been difficult getting articles and write-ups from colleagues and whenever I call for editorial meeting, where we can brainstorm on how to get editorial contents, I hardly see anybody. We are hopeful, though, that this challenge will be surmounted soon, as we have made it our duty in the editorial team to constantly post articles about current happenings on the editorial board and creating awareness about the board among the students.

 

How would you assess the contribution of Pharmanews publisher, Pharm. Ifeanyi Atueyi, to the development of the profession?

Gratitude of unimaginable level has to be given to Pharm. Ifeanyi Atueyi for his enormous contribution to pharmacy journalism. I have received the Pharmanews journal and gone through the contents and I am bold to say that it has contributed to the development of pharmacy profession nationwide and globally. I also want to say that we the younger ones appreciate his efforts. We are praying that God keeps strengthening him while we hope to achieve his feats and possibly surpass him one day.

 

I shall pass this way but once

3

 

I shall pass this way but once; any good that I can do or any kindness I can show to any human being; let me do it now. Let me not defer nor neglect it, for I shall not pass this way again.” -Etienne de Grellet, Quaker Missionary

 About four decades ago, when I was a junior high school student, a senior, whose name I cannot fully recall now, pasted this note in bold letters by his bedside: ‘I SHALL PASS THROUGH THIS WAY BUT ONCE’. My ‘senior’ was preparing for the West African School Certificate Examinations and the signpost represented his absolute determination to pass all the subjects at one sitting.

Surely, he passed as purposed and he must have moved on to higher projects since then but his signpost made an everlasting impression on my young mind. I could not stop thinking about these words and, over the years, I have found out that they have meanings that are much deeper and wider than the space constructed by my ‘senior’.

Inferences

As human beings, some of our actions seem to suggest that we lack a basic understanding of our vulnerability and that no one is omnipresent, immutable and immortal as God. At creation, God charged man to multiply and replenish the earth. It was a charge to do good and all the resources needed to carry out this assignment were provided by God himself. He gave man dominion over everything that moves upon the earth. This charge was repeated many times in the Holy book and reinforced by the teachings and actions of the patriarchs.

However, as the world increased in population and complexity, the heart of man became corrupted and completely shifted from doing good. We no longer see the opportunity of holding positions of authority and privileges as a call to service. Rather, we act as slave masters, looking down on people below, removing the ‘connecting bridges’, offering no help to the weak, and behaving as if tomorrow will never come. We condemn and brutally malign those who are not ‘doing well’ or not as privileged as we are. We forget so easily that the race doesn’t always go to the swift, nor the battle to the mighty, nor food to the wise, nor wealth to the intelligent, nor favour to the knowledgeable, ‘but time and chance happen to them all’.

Instances

It is there in our history as a nation: From Sir Abubakar Tafawa Balewa as Prime Minister to Dr Goodluck Jonathan as President, the route to the top was dotted by happenstance and not individual wisdom or any exceptional abilities. Whatever position you are holding now or whatever situation you find yourself now, the best approach is to use the opportunity to make things better for the people around you and the environment that you live in. You may never have a repeat chance to do so.

At independence, this country was blessed with men (and women) of vision who knew what to do with the resources and privileges at their proposal. One of them was Chief Obafemi Awolowo who introduced the Free Education Programme in his region among many other things. This singular act changed the lives and fortunes of so many people, their families even unto generations. Little wonder that that era remains golden in our thoughts and records till date.

Awolowo and his contemporaries have passed through this way and they will never pass here again but their good works remain indelible in our memories. The missionaries of old brought evangelism, schools and hospitals to cater for the spiritual, educational and health needs of the people. They have come and gone but their good deeds bear eloquent testimony to their presence in our midst.

Influences

We have just one chance in life and whatever we need to do to make the world a better place to live; we must do it now before we stop breathing. You are not using your opportunity well if you are a thief, a kidnapper, a murderer, a rapist, etc or you are engaged in schemes that make others miserable. You are not doing good if you refuse, neglect, or fail to render assistance where it is most needed. If you hoard essential commodities and make people suffer just to make money, you are not doing good. If you steal the money allocated to projects in your ministry, department, agency or company, you are not doing good.

Nigeria will be much better if we all imbibe and act on the eternal words of Etienne de Grellet. You shall pass this way but once and you are advised to do good now because when death comes, you will become a thing, an ordinary corpse that will ooze out foul smell, if not quickly or properly disposed.

We are where we are today because majority of people, particularly our leaders, are not doing good. Let us resolve today to change our ways and follow the path of righteousness to build a just and prosperous nation.

10 nominees announced for AIF’s Innovation Prize for Africa 2016

0

IPA.JPG

–       African ingenuity this year showcases breakthroughs in malaria and other public health burdens, smart solutions for farmers and dynamic power initiatives …

–       Urine Test for Malaria (UMT) is a rapid non-blood diagnostic medical device that can diagnose malaria in less than 25 minutes

–       Api-Palu is an anti-malaria drug treatment developed out of natural plant extract

–       Exatype is a software solution that enables healthcare workers to determine HIV positive patients’ responsiveness to ARV drug treatment

–       Aceso is an imaging technology, capable of performing full-field digital mammography and automated breast ultrasound at the same time

The African Innovation Foundation (AIF) (www.AfricanInnovation.org) today announced the top 10 nominees for its landmark programme, the Innovation Prize for Africa (IPA). Now celebrating its 5th year under the theme “Made in Africa”, IPA is the premier innovation initiative in the African continent, offering a grand share prize of US$150 000 and incentives to spur growth and prosperity in Africa through home-grown solutions.

“In the past five years, I’ve seen innovation grow from a mere buzzword to a sturdy path for African growth in multi-disciplinary industries across the continent. As Africans, we have the talent, potential and clout to solve our own problems with ingenuity too, and IPA is testimony of this,” said Pauline Mujawamariya Koelbl, IPA Director at the helm of this initiative since its launch in 2011.

The IPA has seen tremendous growth in applications and increasing interest from both innovators and innovation enablers over the years. To date, IPA has attracted more than 6 000 innovators from 50 African countries, making it a truly Pan African initiative. IPA 2016 attracted a record 3 600 plus innovators and received 985 successful submissions from 46 African countries. African ingenuity this year showcases new breakthroughs in malaria and other public health burdens, smart solutions for farmers and dynamic energy initiatives.

AIF will host the IPA 2016: Made in Africa awards ceremony and its first ever Innovation Ecosystems Connector on 22 and 23 June 2016 in Gaborone, Botswana. This premier innovation event has been endorsed by H.E. Lieutenant General Seretse Khama Ian Khama, the President of Botswana, who will preside at the Awards Ceremony. Collaborating partners include the Ministry of Infrastructure, Science and Technology (MIST), and the Botswana Innovation Hub (BIH). Visit our event website to learn more about planned activities and partnership opportunities http://event.innovationprizeforafrica.org/

Listed below are the top 10 IPA 2016 nominees. Prior to the final announcement at a special gala ceremony on 23 June 2016 at the Gaborone International Conference Centre (GICC), the expert panel of IPA judges (see http://innovationprizeforafrica.org/ipa-jurors/) will once again deliberate through live pitching sessions and one-on-ones with each nominee to select the top three winners. For fuller details of the 10 nominees, their innovations and related images, please see: http://innovationprizeforafrica.org/2016-finalists/

 

Tackling malaria and other public health burdens

Dr. Eddy Agbo, Nigeria: Urine Test for Malaria (UMT)

Urine Test for Malaria (UMT) is a rapid non-blood diagnostic medical device that can diagnose malaria in less than 25 minutes. Africa has the highest number of malaria cases worldwide; more often than not, when fever is detected, anti-malaria medication is administered. However, the inability to quickly diagnose and commence malaria treatment can lead to various complications including kidney failure, build-up of lung fluid, aplastic anaemia and even death. UMT uses a dip-stick with accurate results in just 25 minutes. The technology detects malaria parasite proteins in the patient’s urine with fever due to malaria. The UMT is simple and affordable, and a potential game changer in managing malaria across Africa.

 

Valentin Agon, Benin: Api-Palu

Api-Palu is an anti-malaria drug treatment developed out of natural plant extract. It is significantly cheaper than available anti-malarial drugs, and has great inhibitory effects on 3D7 strains of plasmodium falciparum the causative agent of malaria. Sub-Saharan Africa is home to 88% of malaria cases and 90% of malaria deaths reported globally (WHO: 2015) with some African governments spending up to 40% of their public health budgets on malaria treatment. Api-Palu manifests as a fast rate of malaria parasite clearance from the blood following short term treatment, with relatively lower doses. It is available in tablets, capsules or syrup. The drug has been approved in Benin, Burkina Faso, Tchad, and Central Africa Republic because of its therapeutic and non-toxic effects.

 

Dr. Imogen Wright, South Africa: Exatype

Exatype is a software solution that enables healthcare workers to determine HIV positive patients’ responsiveness to ARV drug treatment. According to WHO, 71% of people living with HIV/AIDS reside in Africa. Until now, governments’ response has been to ensure access to treatment for all. However, a growing number of people on ARVs are resistant to drug regimens, leading to failure of the therapy, exacerbating the continent’s HIV/AIDS burden. Exatype processes the highly complex data produced by advanced “next-generation” DNA sequencing of the HIV DNA in a patient’s blood. Through a simple report, it detects drugs that are resistant to the patient, then highlights the need to avoid these to ensure successful treatment. Exatype has the potential to contribute towards effectively managing HIV/AIDS in Africa, and also holds promise in helping detect drug resistance for other disease burdens such as Tuberculosis (TB) and malaria.

Dr. Kit Vaughan, South Africa: Aceso

Aceso is an imaging technology, capable of performing full-field digital mammography and automated breast ultrasound at the same time, dramatically improving breast cancer detection. Annually, there are more than half a million cancer deaths in Africa and these numbers are expected to double in the next three decades. If diagnosed early enough, the cancer can be treated successfully. However, because 40% of women have dense tissue, their cancers cannot be seen on X-ray. Furthermore, a false negative finding can have devastating consequences. Aceso is a single device that can acquire dual-modality images – full-field digital mammography and automated breast ultrasound – at the same time. This world first system is protected by international patents and has been successfully tested in two separate clinical trials with 120 women.

 

Design architecture and learning platforms

Dr. Youssef Rashed, Egypt: The Plate Package (PLPAK)

The Plate Package (PLPAK) is a robust software solution that assesses the architecture of building plans or technical drawings, determining structural integrity of the end design. PLPAK applies the boundary element based method to analyse and view practical design on building foundations and slabs. This enables engineers to represent building slabs over sophisticated foundation models easily, building information modelling techniques and eliminating human error.  With the rapid growth of African cities, there is increased demand for infrastructural developments to support the growing population. The infrastructure system in Africa, especially building architecture, tends to go untested due to huge associated costs in verifying structure integrity, and can lead to the collapse of buildings with many deaths. PLPAK addresses this through its low-cost, easy to use but world class tool.

 

Godwin Benson, Nigeria: Tuteria

Tuteria is an innovative peer-to-peer learning online platform that allows people who want to learn any skill, whether formal or informal, to connect with anyone else in proximity who is offering that skill. For instance, a student needing math skills can connect online with someone in their vicinity offering remedial classes in mathematics. The tutors and the learners form an online community that connects them, and once a fit is established, they meet offline for practical exchange. Both tutors and learners are thoroughly vetted to ensure safety, accountability and a quality learning experience. Globally, conventional methods of education and learning are transitioning from centralized to distributed, and from standardized to personalized. Such trends have resulted in better learning outcomes. Tuteria fits in well with this model, and has been highly recommended by the IPA judges for the African continent.

 

Smart farming solutions

Olufemi Odeleye, Nigeria: The Tryctor

The Tryctor is a mini tractor modelled on the motorcycle. By attaching various farming implements, it can carry out similar operations as a conventional tractor to a smaller scale. Farming for most small scale farmers in the continent is tough, laborious and characterized by low productivity. Small scale farmers are constrained by the costs involved in switching to mechanized agriculture and use of heavy equipment. However, through inspired alterations to a motorcycle’s engine, gearing system and chassis, this innovation has made it possible to mechanize agriculture in Africa for small scale farmers in a way that was previously inaccessible. Additionally, the Tryctor is easy to use and cheaper to maintain as 60% of its parts and components are locally sourced.  The IPA judges were captivated by the clever adaptation of a motorized solution that is ubiquitous in Africa, largely for transportation to a solution for mechanized farming for small scale farmers.

 

Samuel Rigu, Kenya: Safi Sarvi Organics

Safi Sarvi Organics is a low-cost fertilizer made from purely organic products and waste from farm harvests, designed to improve yields for farmers by up to 30%. Rural farmers in sub-Saharan Africa pay huge costs for fertilizer, which is often produced abroad and imported. Owing to such high costs farmers can only afford the cheap, synthetic, and acidulated fertilizer varieties. In many areas where the soil is inherently acidic, use of acidulated fertilizers can lead to long-term soil degradation and yield loss, at about four percent per year. Safi Sarvi costs the same as traditional fertilizers, can reverse farmers’ soil degradation and lead to improved yield and income. The product uses biochar-based fertilizer which can counteract soil acidity, retaining nutrients and moisture in the soil. Additionally, the carbon-rich fertilizer removes carbon from the atmosphere by at least 2.2 tons of carbon dioxide equivalent per acre of farm per year.

Dynamic energy initiatives

Andre Nel, South Africa: Green Tower

Green Tower is an off-grid water heating and air conditioning solution based on solar power that uses advanced thermos-dynamics to create up to 90% savings in electricity consumption.  Water heating and air conditioning systems can account up to 60% of energy consumption in a home or building. There are a number of heating and cooling systems in the market, but few that have demonstrated consistency in efficiencies regardless of weather conditions. The Green Tower improves efficiency of a solar heat pump with solar thermal collectors, low pressure storage tanks and heat exchangers. With Africa’s middle class rapidly growing and demand for energy outstripping supply, this initiative has the potential for large scale roll out. Green Tower can conserve limited energy resources, diverting them from heating and cooling systems to more productive industries.

Johan Theron, South Africa:  PowerGuard

PowerGuard enables consumers to determine the maximum amount of power supply required for daily operations. Consumers can thus reduce their power demand, especially during peak times, leading to a more efficient power supply, and helping to reduce power cuts. PowerGuard addresses electricity fluctuations, and power delivery and supply challenges by reducing the peaks, relieving pressure on the electricity network. Consumers can set their own maximum peak power usage needs. This technology substantially reduces load shedding and power rationing, diverting power to more productive industries. Africa faces a high demand for grid power, but with limited resources and an aging infrastructure, the existence of a smart grid can help reduce the pressure on existing infrastructure while moving the continent slowly towards renewable energy.

Walter Fust, Chairman of the AIF Board was impressed by the level of submissions for IPA 2016: “As we celebrate the five year IPA journey, our mission to engage, inspire and transform is evident in the IPA process – from the growing registrations, to the level of talent and ingenuity we see in the nominees, as well as the enthusiasm from our expert judges in seeing these innovations at work to solve some of Africa’s intractable challenges. Now while we await announcement of the winner, we call on all innovation enablers to join hands with us to unlock the potential of these nominees.”

Next stop: Which of these top 10 nominees will impress our judges most, and win IPA 2016?  Stay tuned to learn more about who is scripting Africa’s growth story through innovation!

 

Distributed by APO (African Press Organization) on behalf of African Innovation Foundation (AIF).

 

For more information, contact:

Aulora Suerga Stally

AIF Communications Manager

Phone: +41 (44) 515 54 68

Mobile: +41 (79) 834 9163

E-mail: a.stally@africaninnovation.org

 

Tshepo Tsheko

BIH Director, ICT & Marketing

Phone: + 267 391 3328

Mobile: + 267 71 341 972

E-mail: tshepo.tsheko@bih.co.bw

About the African Innovation Foundation (AIF)

AIF (www.africaninnovation.org) works to increase the prosperity of Africans by catalysing the innovation spirit in Africa.

About the Innovation Prize for Africa (IPA)

IPA (www.innovationprizeforafrica.org) is a landmark initiative of the AIF with the purpose of strengthening African innovation ecosystems and spurring growth of market-driven African solutions to African challenges.

 

SOURCE

African Innovation Foundation (AIF)

Management of asthma

0

Asthma 2Asthma is described as a respiratory condition marked by attacks of spasm in the bronchi of the lungs, causing difficulty in breathing. It is usually connected to allergic reaction or other forms of hypersensitivity.

Asthma (from the Greek άσθμα, ásthma, “panting”) by definition is a disorder that causes the airways of the lungs to swell and narrow, leading to wheezing, shortness of breath, chest tightness, and coughing.

It is caused by inflammation in the airways. When an asthma attack occurs, the muscles surrounding the airways become tight and the lining of the air passages swells. This reduces the amount of air that can pass by.

In sensitive people, asthma symptoms can be triggered by breathing in allergy-causing substances (called allergens or triggers). In a research titled, “Unmet needs in asthma treatment in a resource-limited setting: Findings from the survey of adult asthma patients and their physician in Nigeria,” Olufemi Olumuyiwa Desalu,  a professor in the Department of Medicine, University of Ilorin Teaching Hospital, gave some insights into the challenge of managing asthma in the country.

Desalu argued that about 50 years ago, asthma was uncommon in Nigeria. However recent reports from different parts of Nigeria have shown a prevalence of adolescent and adult asthma in excess of 10 per cent, as well as a rising trend in the prevalence of asthma. The increase in the burden of asthma has been attributed to environmental factors such as urbanisation, industrialisation and adoption western life style

In view of this rising prevalence of asthma in our society, there is need for better understanding of the asthma patients’ perception and the treatment practice of physicians.

The Pan African Medical Journal recently published a scientific paper on “Challenges in the Management of Bronchial Asthma among Adults in Nigeria: A Systematic Review.” In the paper, it asserted that asthma management goes beyond treating patients in acute attack because the skill and competence of long term care is lacking in most doctors and this fact needs to be emphasised and addressed to improve the care.

Another reason is lack of consultation time for asthma educators or nurses with an interest in asthma, especially when the physicians are running very busy clinics. Lack of support group may also have contributed to low level of asthma education as they are known to offer additional patient support.

Further challenges encountered in asthma management in places like Nigeria include: lack of standard diagnostic equipment such as peak flow meters, and spirometers; skin allergy tests test/allergen specific IgE estimation; and equipment for exhaled nitric oxide. Histamine/methacholine challenge tests are also lacking.

In a review of 68 tertiary hospitals in Nigeria, 26 (38.2 per cent) had peak expiratory flow rate meter in the emergency rooms, 20 hospitals (29.4 per cent had spirometer; only 10 of the 68 hospitals reviewed (14.7 per cent) had skin allergy test facilities.

asthma-promoting-cells-could-help-treat-asthma

 What is asthma attack?

An asthma “attack” or episode is a time of increased asthma symptoms. The symptoms can be mild or severe. Anyone can have a severe attack, even a person with mild asthma. The attack can start suddenly or slowly. Sometimes a mild attack will seem to go away, but will come back a few hours later, and the second attack will be much worse than the first. Severe asthma symptoms need medical care right away.

During an asthma attack, the lining of the airways in the lungs swells. The muscles around the airways tighten and make the airways narrower. All of these changes in the lungs block the flow of air, making it hard to breathe. Knowing what is happening in the lungs during an asthma attack will help you to know why it often takes more than one medicine to treat the disease.

What triggers asthma attacks?

The more industrialised a place is, the higher the prevalence of asthma, because areas with industrial/air pollution trigger asthma. Also, the more developed a place is, the more likely they would have a higher rate of asthma cases.  For example, Lagos would be expected to have a higher rate of asthma cases than, say, a village. Also, it is believed that in cleaner environments, people are less likely to be exposed to some germs and particles that will stimulate it.

Effluents from cars and industries have also been associated with asthma. Other factors, including heredity and the person’s predisposition to allergies and certain conditions, can equally trigger an attack. For example, a person could be sensitive to infections, virus, bacteria, cigarette smoke, or certain types of food, drugs, a change in weather from cold to hot and vice versa. Some can also react to psychological factors.

What are the symptoms of asthma?

The most common symptom is wheezing. This is a scratchy or whistling sound when you breathe. Other symptoms include:

  • Shortness of breath
  • Chest tightness or pain
  • Chronic coughing
  • Trouble sleeping due to coughing or wheezing

Asthma symptoms, also called asthma flare-ups or asthma attacks, are often caused by allergies and exposure to allergens such as pet dander, dust mites, pollen or mould. Non-allergic triggers include smoke, pollution or cold air or changes in weather. Asthma symptoms may be worse during exercise, when you have a cold or during times of high stress.

Children with asthma may show the same symptoms as adults with asthma: coughing, wheezing and shortness of breath. In some children, chronic cough may be the only symptom.

If your child has one or more of these common symptoms, make an appointment with an allergist / immunologist:

  • Coughing that is constant or that is made worse by viral infections, happens while your child is asleep, or is triggered by exercise and cold air
  • Wheezing or whistling sound when your child exhales
  • Shortness of breath or rapid breathing, which may be associated with exercise
  • Chest tightness (a young child may say that his chest “hurts” or “feels funny”)
  • Fatigue (your child may slow down or stop playing)
  • Problems feeding or grunting during feeding (infants)
  • Avoiding sports or social activities
  • Problems sleeping due to coughing or difficulty breathing

Patterns in asthma symptoms are important and can help your doctor make a diagnosis. Pay attention to when symptoms occur:

  • At night or early morning
  • During or after exercise
  • During certain seasons
  • After laughing or crying
  • When exposed to common asthma triggers

How is asthma diagnosed?

An allergist diagnoses asthma by taking a thorough medical history and performing breathing tests to measure how well your lungs work. One of these tests is called spirometry. You will take a deep breath and blow into a sensor to measure the amount of air your lungs can hold and the speed of the air you inhale or exhale. This test diagnoses asthma severity and measures how well treatment is working.

Many people with asthma also have allergies, so your doctor may perform allergy testing. Treating the underlying allergic triggers for your asthma will help you avoid asthma symptoms.

 

How important is early detection and treatment?

It is very important because if not treated early, asthma could damage the lungs. Inflammation means there is redness and swelling in the lungs. If the inflammation is not controlled, it could lead to what is called the remodelling of the airway. The airway could be damaged permanently if the problem is not addressed properly.

 How can one prevent or control triggers?

Here are some common triggers and the actions you can take to control them. Controlling your triggers will help you have fewer asthma symptoms and make your asthma treatment work better.

 Foods

Sulphites and sulphating agents in foods (found in dried fruits, prepared potatoes, wine, bottled lemon or lime juice, and shrimp), and diagnosed food allergens (such as milk, eggs, peanuts, tree nuts, soy, wheat, fish and shellfish) have been found to trigger asthma.

 How to control it

  • Wear a medic-alert bracelet that identifies your food allergies
  • Carry injectable epinephrine to provide first aid during an emergency allergic reaction, see your doctor for more information about this. Did you know children can carry their asthma and allergy medications while at school?
  • Read food labels closely to avoid eating hidden triggers

Pollen

Pollen are tiny particles produced by trees, grasses, weeds, and flowers. They are carried on the wind or by insects, and can cause asthma attacks. Air pollution can also cause asthma attacks.

  • Use air conditioning, if possible, during seasons when pollen is highest.
  • Keep windows closed during seasons when pollen is highest.
  • Consider staying indoors during the middle of the day and afternoon when the pollen count is highest.
  • If you are outside when the pollen count is high, it might help if you wash your hair before you go to bed.
  • Check the air indexes, and avoid going outdoors when the pollution or pollen counts are high.

Avoid the following indoor/outdoor pollutants and irritants:

  • Wood-burning stoves or fireplaces
  • Unvented gas stoves or heaters
  • Other irritants (e.g., perfumes, cleaning agents, sprays)
  • Volatile organic compounds (VOCs) such as new carpeting, particle board, painting
  • Newly manufactured materials found in floor, wall, and ceiling coverings and furniture have strong odours. Odours from glues, paints, or treatment processes give off chemical irritants, including volatile organic compounds (VOCs). This is called off-gassing.
  • Air out new materials in areas with plenty of ventilation
  • Maintain floor, wall and ceiling coverings properly

Asthma and pregnancy

During pregnancy, asthma symptoms will worsen for about one-third of all women. Symptoms may be most severe between weeks 29 and 36 (about the seventh to the ninth month) of pregnancy.  Asthma symptoms such as coughing, chest tightness, wheezing, and shortness of breath can keep your baby from getting enough oxygen to grow well. A good rule of thumb to remember is, if you are feeling short of breath, your baby will be feeling it much more. If your asthma isn’t under control, your baby could be less healthy and smaller when born, or could even be born too early. But these things don’t need to happen because of asthma.

Asthma can be controlled so that it doesn’t hurt your baby or you. Here are the steps you can take to control your asthma and protect your baby:

Work with your doctor and other health care providers.

Go over your Asthma Action Plan to make sure it is right for you as your baby grows.

  1. Keep your appointments.
  • Write down all the questions you have before each visit. It helps you remember to ask them all.
  • Tell your doctor about any wheezing, coughing, or shortness of breath that you have.
  • Tell your doctor if you notice any changes in your asthma or breathing patterns
  • Tell your doctor any concerns you have about your medicines or the other parts of your Asthma Action Plan.
  • Make sure you know what your doctor or asthma educator wants you to do before you leave the office.
  1. Take your medicines.
  • Follow the directions exactly in your Asthma Action Plan about when to take your asthma medicines and how much of each medicine to take.
  • Don’t stop taking your asthma medicines unless your doctor tells you to.
  • Talk to your doctor before you take ANY new medicines, herbal treatments or over-the-counter drugs (those that you choose yourself at the store, such as headache, cough, or cold medicine).

Remember: Using asthma medicine during pregnancy is much safer than letting your asthma get out of control. Such asthma medicines as inhaled beta-agonists (quick relief medicines like Maxair or Proventil), cromolyn (medicines that prevent triggers from causing reactions in your lungs, like Intal), and inhaled steroids (long-term controller medicines like Flovent) are safe for pregnant women when you take them as directed by your doctor.

  1. Watch your asthma and treat symptoms fast.

Pregnancy is a time of change. Your asthma can get worse, better, or stay the same. If this is your first pregnancy, there is no way to predict what will happen with your asthma. If you have been pregnant before, your asthma is most likely to change—or not change—the same way it did with your last pregnancy. It is very important for you to watch your asthma closely.

  • Use a peak flow meter each day, if told to by your doctor, so you can see changes in your asthma and act early.
  • Know how to tell if your asthma is getting worse. Make a list with your doctor or asthma educator of the ways you can tell if your asthma is getting worse.
  • Make an Asthma Action Plan with your doctor for dealing with any sign or symptom that your asthma is getting worse. Make sure you know how to use it, and get a new one if there are changes in your asthma treatment.
  1. Stay away from your asthma triggers.

Your asthma triggers are those things that make your asthma worse. House dust mites or damp places, animals, tobacco smoke, and very cold air are some examples of asthma triggers. You can stay away from some triggers. For other triggers, you can take action to keep them from starting your asthma. See our complete list of triggers and learn about how to avoid or reduce contact with them.

 

  1. Do not smoke or stay around people who smoke.
  • Cigarette smoke makes it more likely that you will have asthma episodes.
  • Smoking during your pregnancy makes it more likely that your baby will be born too early and too small. Your baby is more likely to be sick more often, too.
  • If babies breathe in other people’s smoke, the babies’ lungs will not grow and work as well as they should. The baby is likely to have more colds and earaches.
  • When babies live with people who smoke, they have a greater chance of developing asthma.
  • If you smoke, now is the time to stop! Your health care provider will help you. Ask about it now, and find more on second-hand smoke and quitting.

 Asthma and exercise

Anyone exercising hard enough may have shortness of breath. But when this happens sooner than expected, or happens along with other symptoms such as chest tightness, wheezing, or cough, then it may be asthma.

Exercise is a common trigger of asthma. The terms “exercise asthma” or “exercise induced asthma” are often used, but these are some common ways that exercise makes asthma worse:

  • Exercise sometimes makes asthma symptoms worse in someone who does not usually need asthma medications (Intermittent Asthma)..
  • No matter which way it happens, breathing may be even harder when the air is colder and drier. At rest, breathing through the nose warms and humidifies (moistens) the air taken in. During exercise, breathing faster through the mouth lets air that is colder and drier than usual into the lungs. The colder and drier air can trigger symptoms like coughing and wheezing.
  • Once the airways are triggered the airway lining may begin to swell (inflammation), smooth muscle bands around the airway can tighten (bronchospasm), and extra mucus can be made. The swelling, tightened muscle bands, and extra mucus can partially block the airways. This makes it harder to get air in and out of the lungs. The exact way this happens may be different in traditional asthma compared to Exercise Induced Airway Narrowing.
  • Activities like long-distance running, hockey, and cross-country skiing are more likely to trigger symptoms because they are held in cold temperatures or have the player working hard for longer amounts of time. Activities like walking and swimming are less likely to trigger symptoms because players use short bursts of action mixed with breaks, or are done in warmer and more humid places.

 How to prevent symptoms during exercise

There are things that can be done to help prevent symptoms with exercise. Start with a warm up period of light activity before any harder exercise. Avoid exercising in cold and dry air. Avoid exercise when other triggers, such as respiratory infections or smoke, can cause more trouble breathing.

The goal is to be able to exercise without symptoms. Most people with asthma can take part fully in sports or be as active as they would like to be. They need to work with their health care provider and follow their Asthma Action Plan to be able to do this.

 What are the treatment options for asthma?

There is no cure for asthma, but symptoms can be controlled with effective asthma treatment and management. This involves taking your medications as directed and learning to avoid triggers that cause your asthma symptoms. Your allergist will prescribe the best medications for your condition and provide you with specific instructions for using them.

  • Controller medications are taken daily and include inhaled corticosteroids (fluticasone (Flovent Diskus, Flovent HFA), budesonide (Pulmicort Flexhaler), mometasone (Asmanex), ciclesonide (Alvesco), flunisolide (Aerobid), beclomethasone (Qvar) and others).
  • Combination inhalers contain an inhaled corticosteroid plus a long-acting beta-agonist (LABA). LABAs are symptom-controllers that are helpful in opening your airways. However, in certain people they may carry some risks. LABAs should never be prescribed as the sole therapy for asthma. Current recommendations are for them to be used only along with inhaled corticosteroids. Combination medications include fluticasone and salmeterol (Advair Diskus, Advair HFA), budesonide and formoterol (Symbicort), and mometasone and formoterol (Dulera).
  • Leukotriene modifiers are oral medications that include montelukast (Singulair), zafirlukast (Accolate) and zileuton (Zyflo, Zyflo CR).
  • Quick-relief or rescue medications are used to quickly relax and open the airways and relieve symptoms during an asthma flare-up, or are taken before exercising if prescribed. These include: short-acting beta-agonists. These inhaled bronchodilator (brong-koh-DIE-lay-tur) medications include albuterol (ProAir HFA, Ventolin HFA, others), levalbuterol (Xopenex HFA) and pirbuterol (Maxair Autohaler). Quick-relief medications do not take the place of controller medications. If you rely on rescue relief more than twice a week, it is time to see your allergist.
  • Oral and intravenous corticosteroids may be required for acute asthma flare-ups or for severe symptoms. Examples include prednisone and methylprednisolone. They can cause serious side effects if used on a long term basis.

People with asthma are at risk of developing complications from respiratory infections such as influenza and pneumonia. That is why it is important for asthma sufferers, especially adults, to get vaccinated annually.

With proper treatment and an asthma management plan, you can minimize your symptoms and enjoy a better quality of life.

 What are the types of management available for asthma patients?

There are several types. A clean environment is important and asthma occurs because the child is reacting to something. So, the first method is what is called environment manipulation, where those things the child reacts to are removed from the environment. For example, a child with asthma shouldn’t be exposed to a room with rugs because of the particles and house dust in the rug. A carpet is more advisable or something that is cleaned regularly to be free of dust.

Parents who smoke should also stop smoking in the house because it could trigger asthma attacks. So, it is important to modify the child’s environment, especially if it is not a severe case.

Also, generators should not be kept near the windows because of the smoke and heat from it. Also, an affected child can be treated with drugs. The drugs are two types; the relievers and preventers. The relievers are those that work immediately. They are given to the child to relieve them to help their airways dilate. That’s why it is called relievers to relieve that acute situation. A common drug used is Ventolin, which is in tablet, injection and inhaler forms. Its generic name is Salbutamol. There are other types of drugs for treatment and there is an international treatment guideline that every doctor is supposed to know and follow its guideline. If it is an emergency, doctors use oxygen.

The preventers are usually those that work much later. What they do, as their name suggests, is to prevent asthma attacks. Many of the preventers are long active steroids. These steroids, as well as other anti-inflammatory drugs, can decrease the symptoms of asthma. Steroids have some side effects when it is taken periodically. Both types – relievers and preventers – cannot be substituted for one.  The former relieves the immediate situation so the patient does not die, while the preventers are supposed to be given so that the asthma attack does not happen later. If it is an emergency case, the doctor would have to admit the patient and give oxygen and some injections.

 Are there particular ways to manage asthma?

Yes, it depends on the situation. Early detection and proper treatment helps. There is what is called partnership in asthma management. In medicine, we say self-treatment is not good, but this is encouraged in asthma because it helps a lot. So, members of the family must be carried along so that whenever there are any symptoms, they would know how to prescribe the drugs to the child or check the function of their lung and all that. For example, a three-year-old might not be able to use an inhaler, so there is a special device like a pipe, which the inhaler is pressed into and as the child breathes in from the pipe, he inhales the content. Some children are too young to use inhaler because there is a coordinated action of inhalation that the child may not be able to do alone.

Should children with asthma be involved in any form of exercise?

Yes, a child with asthma can be involved in doing exercises and outdoor activities, including football and swimming. That child can even play professional football. What should be prevented are those exercises that are intensive and rigorous and take several minutes longer than necessary without a rest period.

 Advice to parents of asthmatics

Parents shouldn’t panic when they are told their child has asthma. Most children, by the age of six, are likely to outgrow asthma or later in life during their teenage years from the age of 13. Up to 90 per cent or nine out of 10 children will outgrow it by the time they become teenagers.

Asthma is a chronic disease, but it usually doesn’t kill people. Deaths resulting from asthma are less than one per cent. But the major problem is that people don’t follow up on treatment, they just go and buy the inhaler and that’s it. The child should be taken to the hospital for regular checkups, say every three to six months. That would help to ensure that the child does not suffer many of the problems resulting from asthma.

Asthma could affect the psychology and even growth of the child if not properly managed. But if managed and treated properly, the child can outgrow it. Again, the parents should comply with the drugs prescribed by the doctors. They should not wait until the child has the symptoms before they give the medications. They should also keep relievers drugs at home.

Report compiled by Adebayo Folorunsho-Francis and Temitope Obayendo with additional information from: The Pan African Medical Journal and United State National Library of Medicine; American Academy of Allergy Asthma & Immunology; and Asthma Initiative of Michigan (AIM).

 

Address by the president of the Pharmaceutical Society of Nigeria (PSN)

0

Pharm.  Ahmed I. Yakasai, FPSN, on the occasion of a courtesy visit to his excellency President Muhammadu Buhari, GCFR, on Thursday, 7 April, 2016

INTRODUCTION

It is my privilege and honour to lead this delegation of the Pharmaceutical Society of Nigeria to your office on this auspicious occasion. On behalf of my colleagues, I wish to thank you immensely for granting us this audience.

The Pharmaceutical Society of Nigeria was founded in 1927 and registered under Section 21 of the 1922 Companies Act. It is the umbrella body of all the registered pharmacists in Nigeria with a vision to be recognised as a society whose members are accessible health care professionals responsible for the provision and rational use of safe, effective and affordable medicines, pharmaceutical care and the promotion of public health and quality of life.

This visit affords us an opportunity to interact with you and share our humble perspectives on the role that the pharmaceutical sector can play in national development, when carefully harnessed.

We shall also bring to your notice our thoughts on some contemporary issues, especially as it relates to healthcare delivery. These include:

  1. The continued instability in the health sector and the National Health Act 2014.
  2. Critical issues affecting Nigerian pharmaceutical manufacturers.
  3. Implementation of Pharm.D (Doctor of Pharmacy) programme.
  4. Implementation of NHIS.
  5. Reconstitution of the Pharmacists Council of Nigeria and Boards of Teaching/Specialist Hospital.
  6. Welfare of health workers in Nigeria.
  1. The Continued Instability in the Health Sector and the National Health Act 2014.

For a comprehensive, coordinated, safe health system that is responsive to the needs of the population, efficient use of resources, increased job satisfaction, with reduced stress and burnout of health professionals, we need collaborative practice, based on trust and mutual respect amongst the health care team.

Internationally, the World Health Professions Alliance (WHPA) brought together the International Pharmaceutical Federation, the World Medical Association, the International Council of Nurses, the World Dental Federation and the World Confederation for Physical Therapy for collaborative practice. It is possible to achieve the same goal in Nigeria when the federal government plays its much expected stabilisation role by insisting each player restricts his latitude to his area of due competence. Government must insist on allowing the rule of law to take roots by showing the way on how the law rules at all times.

Again, the full implementation of the National Health Act (NHA) 2014 will go a long way in stabilising the health sector. It is important to put on record that the NHA 2014 is probably the only statute that attracted the attention of a wide spectrum of stakeholders in health and the larger society.

Some pressing challenges in the health sector which have lingered for so long compel a dire need to appeal to Your Excellency to urgently look into the problems.

  1. Non employment of graduates of Pharmacy into federal tertiary hospitals as intern pharmacists or as registered pharmacists. Even federal health institutions in the catchment areas where pharmacy graduates are trained often times refuse to employ them.
  2. The attitude of the management in some of the federal health institutions is a major let down. Often times the Drug Revolving Funds which is a creation of the Essential Drug Act are decapitated because the funds are diverted to other endeavours, which is a violation of the Drug Revolving Funds manuals and guidelines in the enabling statute.

The Pharmaceutical Society of Nigeria finds it necessary to inform you on the viability of well-managed Drug Revolving Funds in public health institutions, as witnessed in public health facilities like the Pharmacy Department at the National Orthopaedic Hospital, Igbobi, Lagos.

  1. The federal government should make conscious effort to adhere to enabling statutes of various regulatory agencies in the health sector to avoid stress junctions and other disruptions in equilibrium.

At this point, the Pharmaceutical Society of Nigeria must seize the discourse to specially congratulate Your Excellency for your disposition to shun privatisation/commercialisation of public health facilities which would have derailed good and impactful health care in Nigeria.

 

  1. Critical Issues affecting Nigerian pharmaceutical manufacturers

The critical areas where Nigerian pharmaceutical manufacturers need robust engagement with the government aggregate in three main areas. These include:

 

  1. Priority status

The PSN wishes to commend the efforts of the Federal Ministry of Health in initiating a Drug Distribution Guideline for the country which offers a major opportunity in sanitising the chaotic drug distribution channels and by extension curtail the problem of fake and counterfeit pharmaceutical products in our system. The PSN, PCN, NAFDAC and FMOH have worked maximally on this project and we strongly urge the government to sustain the spirit in the current dispensation.

 

  1. Patronage
  2. We urge government to issue a policy directive for all government health care establishments to patronize pharmaceutical products manufactured in Nigeria for all Essential Medicines’ tenders and purchases. The Nigeria Drug Policy provides that 70 per cent of government purchase should be sourced from local manufacturers.
  3. We also humbly request the payments of longstanding debts owed to the industry, to reverse the current negative impact on the industry.
  1. Ecowas Common External Tariff (CET)

The implementation of ECOWAS CET which allows finished pharmaceutical products to be imported at zero percentage duty is a good gesture and same should be extended to raw and packaging materials which now attract a duty percentage ranging from five per cent to 20 per cent. This means that locally manufactured pharmaceutical products have become uncompetitive. The fall out is an imminent closure of all Nigerian pharmaceutical plants.  We urge government to intervene on this critical issue.

  1. Implementation of Pharm.D (Doctor of Pharmacy) Programme.

Your Excellency, the draft Benchmark Minimum Academic Standards (BMAS) document for the Pharm. D degree which is clinical pharmacy as patient-oriented degree, is currently receiving final inputs at the National Universities Commission for eventual consideration of the Federal Executive Council through the Honourable Minister of Education. The FEC’s blessing of the document will bring the pharmacy training to same standards with what generally obtains all over the world, which is patient-centric.

  1. Implementation of NATIONAL HEALTH INSURANCE SCHEME (NHIS)

In the spirit of the broad spectrum of reforms, there is no reason why for six years now the NHIS encourages unlawful payment mechanisms, dubbed global capitation, while HMOs also capitate secondary and tertiary facilities which utterly disrupts the equilibrium of the health system.

We demand that the Federal Government direct the board and management of the NHIS to immediately adopt lawful payment mechanism to wit, capitation for primary providers and fee for service for secondary and tertiary providers.

Government must also redress the capitation modes by embracing international global best practices on what constitutes a primary facility for capitation in Nigeria.

  1. Reconstitution of the Pharmacists Council of Nigeria and Boards of Teaching/Specialist Hospital

Your Excellency, we do not wish to bore you with all the tragedies associated with the constitution and operations of the Pharmacists Council of Nigeria in a particular dispensation, specifically between 2009 and 2011.

In the short time we have had to run without a governing council, we have tried very hard to sustain the ideals of pharmacy practice in Nigeria. Fundamentally, disciplinary matters and accreditation of pharmacy facilities for training suffer in the absence of Council.

We urge Your Excellency to approve the immediate reconstitution of the Pharmacists Council of Nigeria. The Pharmacists Council of Nigeria is the regulatory agency of the federal government that regulates and controls pharmacy practice in all its aspects and ramifications in Nigeria. This gives it a specific approbation in law to register all cadres of premises where drug endeavours take place. Our concern remains that anything that disrupts full implementation of the Pharmacists Council of Nigeria mandate makes consumers of health vulnerable to the fake drug syndrome.

In the same vein, it is pertinent that we inform Your Excellency about the lopsidedness of appointments on the boards of teaching and specialist hospitals, as well as federal medical centres. In the last dispensation, pharmacists were represented on only five of the well over 55 boards of these federal health institutions. Our experience confirms that this lopsided appointment format affects health care plans and ultimately overall output. We therefore reiterate our previous appeal that at least one pharmacist be appointed on each of the boards of our federal health institutions.

  1. Welfare of Health Workers in Nigeria

It is pertinent to mention that we have valid court judgments, collectively bargained agreements, Memoranda of Understanding (MOUs) and even circulars signed with government which have remained implemented on a haphazard or discretionary basis by the federal health institutions, such as the following:

  1. Implementation of the spirit of the existing  circular on promotion of our members from CONHESS 14 to 15 as directors which places premium on the need to sanction defaulting hospital managements.
  2. Specific steps must be taken by the Head of Service of the Federation to ensure the expedited issuance of an enabling circular authorising consultancy cadre for health professionals that have adhered to due process, to be vested with consultancy status, as a prelude to inculcating this cadre into the schemes of service of these health professionals. This must be worked out with the Federal Ministry of Health in line with the spirit of the circular on consultancy and specialist allowances Ref. SMH.491/S.2/VOL II.221 of 29 March, 1976, which authorises consultancy status for all health professionals, and the condition precedent of the National Industrial Court of Nigeria (NICN) that provides for a nod of the Federal Ministry of Health for the appointment of consultants.

iii.     Payment of arrears of specialist allowances to qualified hospital-based health professionals, with effect from January 1, 2010, should be ensured.

  1. Full payment of arrears of the skipping of CONHESS 10 which remains outstanding since the year 2010.
  2. Release of the circular on adjustment of salary since January 2014 and immediate payment of at least two months arrears, while the balance is accommodated with proven evidence in the 2016 budget. This particular subject matter has lingered for some time, with threats of strike by health workers which was averted by the skills of Late Barrister Ocholi, the former Minister of State for Labour. Your Excellency, I appeal that in tandem with your progressive change mantra, that you facilitate immediate approval of this request.
  3. Sponsoring an amendment bill to correct the anomalies in Decree10 of 1985 (CAP U15 463) LFN 2004, especially in the following areas:

(a)      LOPSIDED COMPOSITION OF THE BOARD OF MANAGEMENT

(b)       APPOINTMENT OF CHIEF EXECUTIVE OFFERS (CEOs) OF FEDERAL HEALTH INSTITUTIONS

(c)        APPOINTMENT OF CHAIRMAN MEDICAL ADVISORY COMMITTEE (C-MAC)

(d)       APPOINTMENT OF DEPUTY CHAIRMAN MEDICAL ADVISORY COMMITTEE (C-MAC)

(e)       TRAINING OF HEALTH PROFESSIONALS

(f)        REMOVAL OF THE BORDERS OF RESTRICTION ON PERMANENT STAFF OF FEDERAL HEALTH INSTITUTIONS

 

Lastly, we find it imperative here to appeal to Your Excellency to redress the defects in the appointment of the Director General of NAFDAC in the immediate past dispensation. For the records, Your Excellency, the condition precedent to be appointed as Director General of NAFDAC is that eligible candidates must have a good knowledge of Pharmacy, food and drugs. Pharmacy is globally rated as a frontline profession. It is therefore logical to conclude, like the Office of the Attorney General and Minister of Justice did in 2001, prior to the appointment of Late Prof. Dora Akunyili, that only a registered pharmacist can meet the provision in Section 9 of the NAFDAC Act which unambiguously spells out the eligibility criterion for a prospective Director General of NAFDAC.

 CONCLUSION

Your Excellency, we wish to convey our appreciation for your approval of this courtesy call. We have followed your progressive stride which is a flow of your rich antecedents and have no doubt that the ship of the state is headed for the right direction. We assure Your Excellency that we shall strive to evolve an invincible bilateral consortium with this administration in its march to reposition Nigeria in the comity of decent nations.

 

Thank you and may God bless Federal Republic of Nigeria.

 

Faithfulness in employment

1

I returned to Lagos to rehabilitate myself soon after the devastating Nigeria-Biafra civil war ended in January 1970. The first employment I got was with Toki Nigeria Ltd, which had several pharmacies in the Lagos area. The owner, Chief A. O. Akoni, studied in the UK and worked with The Boots Pure Drugs which had a chain of pharmacies. Application of his Boots’ experience locally made him to be the first pharmacist to establish a chain of pharmacies in Nigeria.

I managed his headquarters pharmacy at Ajele, in the heart of Lagos Island, and later a branch at the Federal Palace Hotel, Victoria Island. After working for him for many months, I got another job in a manufacturing company based in Ikeja. Despite my exit from his company, Chief Akoni and I continued to meet at occasional pharmaceutical functions. He was always excited to introduce me to other colleagues as the only pharmacist who did not steal from his pharmacy.

The first time he introduced me as such, I was very surprised because I did not know that he had such a high opinion of me. That commendation encouraged me to maintain a high level of integrity everywhere I worked or called to serve.

Being faithful to your employer is a necessity for workers in all situations, whether private or public sector. 1 Corinthians 4:2 says, Moreover, it is required in stewards,  that a man be found faithful. There are many unfaithful workers today and they suffer the repercussions in later life. Many workers steal their employers’ money, materials, time and other resources. Some establish parallel businesses and divert their employers’ customers. Some spend most of their time running their private businesses.

Some years ago, the accountant of Pharmanews Ltd, with the collusion of other company staff, diverted our company cheques to one of the accomplices’ account in a Microfinance bank based in Ikorodu. The accomplice at the Microfinance bank got his own share of the ill-gotten money. The end of such deceitfulness is often shame and regret. Jeremiah  17:11 warns, As the partridge sits on eggs, and hatches them not; so is he that gets riches, and not by right, shall leave them in the middle of his days, and at his end shall be a fool.

In the attempt to get rich quick, many people have compromised and hardened their consciences. Incredibly and unfortunately, most of them are Christians who flock churches on Sundays and also participate in Bible study, fasting and prayer and vigils on week days. But their business life does not reflect the life of a believer. They are no longer the salt of the earth or light of the world.

It is a great opportunity to work for others, acquire experience, and develop yourself, using the talents, gifts and abilities God has given to you to serve Him. To many, it is both a training period and a trial period. As Luke 16:12 asks, And if you have not been faithful in that which is another man’s, who shall give you that which is your own?  This makes it clear that hardworking, loyal and faithful workers earn God’s blessing.

God is interested in your secular work because you are applying the resources He has given you into that work. Your life, time, talents, gifts, intellect, hands and the entire body belong to God. And He does not waste resources. Instead, He wants you to use the resources to serve and glorify Him. If you do otherwise, then you should expect the same judgement that befell the unprofitable servant in Matthew 25:14-30. For burying the single talent he was given, he was severely reprimanded and his talent recovered from him and given to the one who traded profitably with his five talents. Not only that, he was also cast into outer darkness, where there will be weeping and gnashing of the teeth.

I don’t know whether this parable terrifies you as it does me. That is why you should  make an inventory of God’s  resources available to you and endeavour to utilise them optimally and maximally.

One main reason why some people are not committed to their work or do it half-heartedly or deceitfully is their failure to know that they are serving God and not their employer. To their thinking, they serve God in church and during religious activities, while they serve man in so-called secular work. In other words, the same persons live two lives – one life on Sundays and the other life from Mondays to Saturdays.

This is a great error. In Colossians 3:23, Paul makes it clear that we are serving God, not only on Sundays but in our daily work. Appealing to servants who were bought to serve their masters, he said, Work willingly at whatever you do, as though you were working for the Lord rather than for people. Remember that the Lord will give you an inheritance as your reward, and that the Master you are serving is Christ (NLT).

How Pharmacy opened floodgate of success for me – Prof. Aguwa

0

Pharm Aguwa

In this exclusive interview with Adebayo Folorunsho-Francis, Dr Cletus Nzebunwa Aguwa, the first academic clinical pharmacist to be employed in Nigeria and the first professor of clinical pharmacy in the entire black Africa, opens up on his interesting journey to the world of Pharmacy and how the profession has brought him much success and recognition. Excerpts:

 Tell us about your educational background

I started my primary school a bit late at St. Joseph’s School, Eke Nguru (Now Central School, Eke Nguru) in Aboh Mbaise Local Government Area of Imo State. I left there in 1959 to study at Holy Ghost College, Owerri, through the Eastern Nigerian Regional Scholarship (1960-1964). Thereafter, I proceeded to Trinity High School, Oguta for two years higher programme (1965-1966). I was lucky to gain admission to study Pharmacy at Howard University College of Pharmacy, Washington D.C., USA. I proceeded without hesitation for my Bachelor of Science in Pharmacy. Today, I am a licensed pharmacist in the States of Maryland, Pennsylvania and Washington D.C.

What circumstances led you to study Pharmacy?

To be frank, I did not know anything about Pharmacy before I applied to study it. It was due to family influence. Majority of my older brothers favoured studying Pharmacy instead of Medicine and when I got the admission, I thought it was a divine call.

Looking back, was it a good decision?

It was a good decision. I have been successful and have had a most rewarding career in Pharmacy. Clinical pharmacy opened the floodgate for my success in life. I have never applied for a job but I am always sought after for my services, up till now.  I have recently fully retired from Faculty of Pharmacy, UNN and then drafted to be the dean of pharmacy faculty at Madonna University, Elele.

 Can you share some of your memorable experiences in the course of your career?

After finishing my programme at the Philadelphia College of Pharmacy and Sciences, Howard University College of Pharmacy invited me to give a seminar on what I was doing. At the end of that seminar, the dean – Professor Robinson – offered me a job as assistant professor of clinical pharmacy. I was so excited. I signed the contract and took the offer – the first Nigerian to be given such appointment at Howard University College of Pharmacy.

I was assistant professor of clinical pharmacy at Howard for four years when I received a phone call from the former Vice-Chancellor of UNN (Prof. Ezeilo) persuading me to join the Faculty of Pharmaceutical Sciences. The pressure was intensive from many quarters, especially the family front. I had to return to Nigeria (in 1978).

My academic career and challenge had just started as I was the first academic clinical pharmacist to be employed in Nigeria. I rose through the ranks and, by 1987, I had become the first professor of clinical pharmacy in the whole of Black Africa. In the course of my commitments to Pharmacy, I have been honoured with the fellowships of the Pharmaceutical Society of Nigeria (FPSN) and the West African Postgraduate College of Pharmacists (FPCPharm.). This is in addition to being a Award Winner (MAW) and pillar of the Pharmaceutical Association of Nigeria Students (PANS).

What was it like being the first academic clinical pharmacist?

As the first academic clinical pharmacist to be employed in Nigeria, and then the first professor of clinical pharmacy in Black Africa, I had no choice than to bear the burden of pioneering discussions, seminars and workshops, locally and nationally. I was invited across the country to speak on various aspects of clinical pharmacy. I think I influenced the curriculum of many schools of pharmacy in Nigeria, despite opposing views from some colleagues.

Is it true that you once led a delegation of pharmacy deans abroad?

Yes. In 1992, I led a delegation of some deans of many institutions to U.S.A. and with them I visited my alma maters – Howard University in Washington D.C. and the Philadelphia College of Pharmacy and Sciences. The main purpose of the trip was for these deans who were heads of pharmacy institutions in Nigeria to observe and get hands-on experience on how clinical pharmacy is taught and practised overseas.

The trip was a short one – 11 days. For me, it was homecoming and it was most rewarding as it convinced doubting Thomases among the deans. From there, it was forward march for the development of clinical pharmacy education and practice in Nigeria. I had earlier put clinical pharmacy into practice by personally taking final year students on clinical rotations in various wards in the hospital at Nsukka in 1991. The students were very excited about this development as they were the first group to venture into patient area.

In addition, I have written several books in the area of therapeutics and clinical pharmacy practice, demonstrating that trained clinical pharmacists are not those who can just talk, but those who can deliver pharmaceutical care.

What is your view about pharmacists in politics?

Pharmacists are very intelligent people and have excelled in various life struggles they have found themselves. Those who are interested should get into politics and play within the rules of the game. I remember that the then vice president of the United States, Hubert H. Humphrey, was a pharmacist. He was effective and highly respected.

What do you consider as your major contribution to the pharmacy profession?

My major contribution is that I have joined hands with other colleagues to train and graduate many pharmacists who are working in various areas nationally and internationally to improve the national economy. In addition, I have demonstrated leadership in the area of clinical pharmacy in Nigeria, thereby offering a new lease of hope and pride for the pharmacy profession. My books in print are a concrete testimony of monumental contribution to the profession of Pharmacy.

What do you think is the future of clinical pharmacy in Nigeria?

Clinical pharmacy in Nigeria is on forward-march as it is everywhere in the world. People may have different perspectives, but whether you call it patient-oriented pharmaceutical services, pharmaceutical care, they are all the same. What matters is the area of emphasis, who is practising and where the practice is taking place. The future is very bright in Nigeria as most pharmacists have entered the clinical practice. Schools of pharmacy have also started including it in their curriculum and are producing future clinical pharmacists who render better pharmaceutical care to the uninformed population.

What is your advice to pharmacy graduates seeking to follow your footstep?

Young pharmacists should try to find their area of calling. They have to be mature, disciplined and hardworking. You cannot reap where you did not sow. If you honestly burn your candles for just a few years, you will marvel at how success will follow you up.

 

 

PCN warns against unaccredited internship centres

0

Registrar of the Pharmacists Council of Nigeria (PCN), Pharm. Elijah Mohammed, has advised pharmacy students in the country to choose only institutions and centres accredited by the Council for their industrial attachment programme.

L-R: Pharm. (Chief) Yetunde Morohundiya, former national chairman of Association of Lady Pharmacists (ALPS); Pharm. N.A.E Mohammed, PCN registrar and Pharm. Ogheneochuko Omaruaye, chairman of the occasion.
L-R: Pharm. (Chief) Yetunde Morohundiya, former national chairman of Association of Lady Pharmacists (ALPS); Pharm. N.A.E Mohammed, PCN registrar and Pharm. Ogheneochuko Omaruaye, chairman of the occasion.

Addressing a gathering of 92 Bachelor of Pharmacy (B.Pharm) graduands of the Faculty of Pharmacy, University of Lagos, Akoka, during their recent induction and oathtaking ceremony which held at the institution’s main auditorium, Mohammed explained that the Council has made perennial search for prospective internship centres easier for students.

“Those of you who are in the habit of waiting for special call-ups from states and federal government parastatals are only wasting your time. You are not coming to sell motor spare parts or endanger the lives of Nigerians,” he cautioned. “Drugs are meant to saves lives. Therefore, as young professionals, ensure you do things right. When one doctor makes a mistake in diagnosis, only one patient dies. But when a pharmacist makes a mistake in compounding or mixing of drugs, a generation of people can pay dearly for it.”

The registrar further charged the graduands to always consider saving human lives ahead of monetary gain.

“If you are caught compromising your professional integrity in a desperate attempt to use your licence in unethical practice like ‘Register and Go,’ the PCN will not spare you. You will not only lose your licence, all your years of toil and hard work would have amounted to naught. Therefore, let he that has ears listen,” he warned.

The PCN boss congratulated parents of the graduands for encouraging them to complete the first phase of pharmacy training, saying that the second phase entails undergoing a mandatory one-year internship training programme under the supervision of a registered pharmacist in an accredited internship training facility.

Mohammed urged the graduands to get acquainted with the profession’s codes of ethics, adding that today’s Pharmacy has now been divided into two phases – products and practice components.

He explained that until now, Nigerians were used to only the product component which he described as a case of “bring-the-drug-and-collect-your-money”, noting that that Pharmacy had however been broadened to include counselling and patient care.

Urging the graduands to distinguish themselves from patent medicine dealers who are only out to make money, the PCN boss assured them that financial rewards would certainly come in the course of their commitment to professionalism.

The high point of the event saw one of the graduands, Pharm. Ayoola Babalola Smith, scooping up three awards – the PCN Prize to Best Graduating Student, the Faculty of Pharmacy Dean’s Prize to Best Graduating Student and the Pill Box Pharmacy Gift to Best Graduating Student; while Titilope Maryanne Ajayi picked up the prestigious Bowl of Hygeia Award (exclusively for lady pharmacists).

The colourful ceremony equally witnessed a massive turnout of participants, including the professors, faculty members, pharmacists in academia, students, parents as well as top PCN and PSN officials.

Prominent in attendance were Pharm. Ogheneochuko Omaruaye, chairman of the occasion; Prof. Duro Oni, UNILAG deputy vice chancellor (management sciences); Prof. Udoma Mendie, professor of microbiology; Pharm (Chief) Yetunde Morohundiya, former national chairman of Association of Lady Pharmacists (ALPS); Prof. Boladale Silva, dean, Faculty of Pharmacy; Prof. Olukemi Odukoya, former dean; and Pharm. Tosin Adeyemi, chairman, National Association of Pharmacists in Academia (NAPA).

Others were Pharm Ernest Okafor, managing director of Nemitt Pharma; Pharm. Bamisaye Oyawaluja, NAPA vice chairman; Pharm. (Mrs) Fatima Ikolaba, NAPA treasurer; Pharm (Mrs) Ogochukwu Amaeze, NAPA financial secretary; Pharm. Aminat Oyawaluja, lecturer, department of Pharmacognosy and Dr Rebecca Soremekun, a senior lecturer in the Department of Clinical Pharmacy.

Congratulating the graduating students, Prof Boladale Silva, faculty dean explained that aside from the induction marking the end of a five to six-year sojourn, it also marks the beginning of a career in pharmacy profession for the new inductees.

“As you go into another phase of life, you will undoubtedly be faced with so many obstacles but with these challenges come opportunities for leadership and innovation. It took Noah Webster 36 years to compile his Webster’s Dictionary. Where would we be today if he had not put in those countless hours of hard work behind his grand contribution to English Language?” he said.

The dean also charged the students to remain focused and remember that there are no shortcuts to success.

According to him, just like carbon, people also undergo a transformation under pressure and heat.

“The pressure of a challenge releases energy. When all is well, we don’t set tough goals. When we set high challenging goals, we see opportunities that were not visible before,” he remarked.

Silva expressed his appreciation to the PCN, PSN, UNILAG management, as well as academic and non-teaching staff of the faculty for their commitment and unflinching support over the years.

Ten first class graduands of the session (2014/2015) were presented at the event. They include: Ayoola Smith, Azeezat Ajenifuja, Oluwakemi Esan, Adenike Oyegbesan, Tope Elijah, Adeola Aminu, Titilope Adelekan, Innocent Akinnawo, Chukwudi Okwelogu and Uchechi Okpara.

NAIP charges pharma industry on workforce development

0

The Association of Industrial Pharmacists of Nigeria (NAIP), has charged the pharmaceutical industry to come up with strategies that will deliver inclusive growth, build vital competences, create wealth for all stakeholders and contribute substantially to the nation’s Gross Domestic Product (GDP).

NAIP charges pharma industry on workforce development
L-R: Mr Uche Attoh,the keynote speaker and Pharm. N.A.E. Mohammed, registrar, PCN, during NAIP’s 19th Annual National Conference, held in Lagos recently.

Pharm. (Prince) ‘Gbenga Falabi, the national chairman of NAIP, gave this charge during the recent opening ceremony of the 19th Annual National Conference of the association, held at Sheraton Hotel, Ikeja, Lagos, chaired by Dr Christopher Kolade, former Nigerian High Commissioner to the United Kingdom.

According to the NAIP boss, stakeholders in the pharmaceutical industry must begin to embrace Systems Thinking and Disruptive Thinking in developing human capital assets across board, while leveraging on technology to build capacities.

He further noted that the pharma industry will need to reinvent itself in order to effectively match, with required skills and competences, the emerging challenges confronting it at the moment, warning that the dearth of production pharmacists will pose a challenge for the current push to encourage the industry in favour of local production in line with the inclusive growth policy of the federal government.

The NAIP national chairman stated further that the pharma industry fully identifies with the commitment of the Buhari administration in restoring investors’ confidence in the nation’s economy, as well as its zero-tolerance for corruption across board.

He, however, urged the government to treat the health sector and the pharma industry as vital segments of the economy, which deserve special attention and preference as a result of their strategic roles in the nation’s well-being.

Pharm. Falabi bemoaned the paucity of foreign exchange to import finished pharmaceutical products and essential pharmaceutical raw materials for local production, adding that the situation portends a very dangerous development with serious negative consequences for the nation in terms of the availability of essential medicines for the citizenry.

He urged the federal government to urgently consider preferential allocation of vital foreign exchange to the pharma industry.

Speaking on the theme of the conference “Workforce Development: Imperative for Industrial Pharmacy Development,” Mr Uche Attoh, the keynote speaker, urged stakeholders in the pharmaceutical industry to take the issue of mentoring of the next generation of pharmacists seriously, noting that young pharmacists can learn a lot from notable professionals in the industry.

He also urged pharma industry stakeholders to market the industry – not only to attract the best brains but to retain such, despite the increasing cutthroat competition for the best personnel in the industrial sector.

Also speaking at the event, Dr Christopher Kolade congratulated NAIP for its 19th national conference and its choice of theme for the conference.

The distinguished elder statesman and seasoned industrialist also urged pharma industry stakeholders to take the issue of mentoring serious, adding that every generation must have a generation to follow.

 

While expressing confidence that the future of Nigeria would be great, he urged every Nigeria to contribute positively towards making this a reality soon enough.

Capacity to contract: Transactions of illiterate persons

20

A young pharmacist, Akinsola Bakare, plans to set up a community pharmacy in his neighbourhood.  He approaches Shomolu Microfinance Bank for a loan to facilitate his project.  His application is processed by the microfinance bank and a six-month loan facility is approved.  However, one of the conditions of the loan is the provision of a guarantor with a net worth exceeding the value of the loan and interest payable.

Consequently, Akinsola contacts his father in Abeokuta and appeals to him to stand as guarantor for the loan.  To support his son’s project, Pa Bakare travels to Lagos to meet with Shomolu Microfinance Bank, accompanied by his nephew, Olatunde.  Pa Bakare is not literate in the English language.  A simple Letter of Guarantee is therefore written on his behalf by Olatunde.  The letter does not contain the name and address of the writer but it is signed by Pa Bakare.

Six months after the loan facility was issued, Akinsola’s community pharmacy is yet to generate enough revenue to repay the loan.  To enforce the recovery of the outstanding sum, Shomolu Microfinance Bank contacts Pa Bakare to repay the loan on his son’s behalf.  Pa Bakare, however, contends that he was not aware that he would be required to pay the outstanding sum in the event of a default.  He explains that his understanding was that he was simply attesting to his son’s credibility and was in no way exposing himself to the risk of the transaction.

On the basis of this guarantee arrangement, what is the legal position of both parties?

A contract is defined as an agreement which is binding at law.  However, even when all the ingredients of a valid contract are present, it may not be enforceable against certain categories of people like infants, lunatics, drunkards and the illiterate.  Where the contract made by an illiterate person is an oral one, his position is no different from that of any other adult person.  He will be entitled to no privilege over the other party and will be fully liable for all his obligations.  Nevertheless, where the contract is in written form, special rules will apply.  These rules are to be found in various laws enacted in Nigeria for the protection of illiterate persons.

The issues to be considered in this case are:

  1. The legal position of contracts made by illiterate persons.
  2. The duties of the writer of such a contract.
  3. The meaning of illiteracy.

Section 2 of the Illiterates Protection Law provides as follows:

Any person who shall write any letter or document at the request, on behalf, or in the name of any illiterate person shall also write on such letter or other document his own name as the writer thereof and his address; and his so doing shall be equivalent to a statement

 

(a) that he was instructed to write such letter or document by the person for whom it purports to have been written and that the letter or document fully and correctly represents his instructions; and

(b) if the letter or document purports to be signed with the signature or mark of the illiterate person, that prior to its being so signed, it was read over and explained to that illiterate person, and that the signature or mark was made by such person.

 

In our case, involving Shomolu Microfinance Bank and Pa Bakare, the writer of the document was his nephew, Olatunde.  As earlier stated, the Letter of Guarantee does not contain the name and address of the writer.  In the case of U.A.C. v. Edems & Ajayi, the defendant was also a guarantor of a debt owed to the plaintiff company by one of their customers.  The defendant sought refuge under the Illiterate Persons Act, claiming that the guarantee was void because the contents of the document he thumb imprinted were not read over and explained to him.

From the decision in this case, it is now clear that the writer of such a document is not necessarily the person who negotiates the agreement.  It is the person who enters the name and address of the illiterate person in the document.  If such a writer fails to enter his name and address, or fails to prepare a statement to the effect that the agreement was read over and explained to the illiterate, before the latter put his mark on the document, as required by Section 3 of the Act, such a contract cannot be enforced against the illiterate person.

The most important issue to be determined in all such cases is whether the defendant is really an illiterate person, and so entitled to the protection of the law.  In PZ. & Co. Ltd. v. Gusau and Kantoma, the High Court took the view that “illiterate” meant not literate in the language used in the document under consideration.  It is irrelevant that the defendant might be literate in some other language.  Justice Oputa further propagated this view in the case of Osefor v. Uwania, when he defined an illiterate person as one “who is unable to read with understanding, the document made or prepared on his behalf… Illiteracy is thus purely comparative.  A graduate in English may well be an illiterate in German.”

Concluding this matter, it is evident that strict regulations are applied to protect illiterate persons who may be disadvantaged in contractual negotiations.  In doing so, however, the position of Justice Kayode Eso must be considered that, “while the law is aimed at preventing an illiterate from being cheated, it does not, in our view, provide him with a weapon to cheat others.”

Principles and cases are from Sagay: Nigerian Law of Contract

Moving up to extraordinary leadership

4

(By Lere baale)

“You can’t connect the dots looking forward; you can only connect them looking backwards. So you have to trust that the dots will somehow connect in your future. You have to trust in something – your gut, destiny, life, karma, whatever. This approach has never let me down, and it has made all the difference in my life.” – Steve Jobs

Many years ago, an 11-year-old boy applied through entrance examinations to Military School, Zaria, with the objective of joining the armed forces but was rejected. He tried it again at the age of 13 but got the same result. So, he decided to change to a technical school to help him gain vocational expertise quickly in order to raise money and see if he could help support his parents to pay the fees of his other siblings.

It was while seeking admission to the technical college that he met a Reverend Father who advised that it was better for him to go to a secondary school.  Eventually, he secured admission into a Catholic Missionary Secondary School. His five-year experience in the school changed him and impacted his life. He was able to enjoy special academic scholarship for indigent students and was significantly inspired while being provided with close guidance and counselling by two major individuals, Reverend Sister Margaret and Reverend Father McComboy. These two destiny-helpers supported him morally and financially, not just in his secondary school but also through A-Level and till the end of his undergraduate studies at the Ahmadu Bello University Zaria.

During his undergraduate years, the huge Kashim Ibrahim Library of the Ahmadu Bello University was of tremendous help to him as he was unable to buy any textbook throughout the course of his programme. Now, if he hadn’t been rejected by the military school, or failed in other attempts, he would not have learnt how to fail forward; his priceless encounters with inspirers like Reverend Sister Margaret and Reverend Father McComboy would not have taken place, and his knowledge of leadership would certainly have remained very ordinary.

 Your university is not good enough

While out of Ahmadu Bello University with his first degree, the young man pursued employment as management trainee in a number of multinational firms. During one of his encounters, he was told that he did not attend the “right university”. This fuelled his long-time ambition to pursue a postgraduate degree in a Cosmopolitan City. He eventually completed an MBA degree at age of 25 in the University of Lagos. The MBA significantly enriched his career growth and his continuous search for qualities of extraordinary leaders.

You are too young and too good for promotion

When he eventually got a job, this young man passionately applied himself to every assignment in his place of work and enjoyed rapid promotions to the board of a multinational at age 36. As he edged towards the peak of his career, many reasons were advanced why he had to be “slowed” down. The common ones he readily remembers are – “he is too lenient with workers to be a good leader”, “too young to be promoted” and “too good an asset to be allowed to leave the country for international roles”. In a nutshell, this young man experienced different kinds of humiliations and frustrations, but he pursued with vigour his desire to learn more, even from his negative experiences, about what it takes to be an extraordinary leader.

One sad day, after the loss of one of his younger brothers, he had an unpleasant encounter with a leader who was used to talking down to him and most times questioned the quality of his education, from his first degree to his MBA.  It was then realised that he had had enough. With a significantly bruised ego, he came to his senses and remembered that regardless of what anyone says, everyone is naturally endowed with what it takes to be a leader; everyone needs to start from his areas of strength, doing what he is passionate about and makes him happy.

Our young man had been an avid reader and teacher, so he prioritised daily activities and created more time for reading, teaching, writing and actively leading – because he knew that leaders always begin the journey to extraordinary leadership through the route of whatever they choose to read and act on.

You, too, can become extraordinary, if you learn how to passionately read and take action by applying the knowledge from whatever you have read. To sum it all, if this young man had not been rejected, if he had not learnt to fail forward, if the quality of his degrees were not questioned, if he had not been considered too young to be promoted, the article you’re reading right now would probably never have been written.

Lesson for leaders: Never give up

The story above is not alien to many who must have passed through career paths and become better leaders today. Don’t give up. People you come across in your career or life may create a cage of limitations for you and tell you many reasons why you cannot be a good leader. Don’t worry, start somewhere, from the very centre of your strengths – your passion, ability, personality, experience – and make a definitive choice to succeed in leadership no matter what you are going through.

Choose to succeed where others have failed. That is the beginning of the journey of extraordinary leadership. You must continuously beat the standard you have achieved yesterday. It is a journey of life.

The quote from Steve Jobs mentioned at the beginning of this piece is apt indeed. What seems like the end of the road may just be a cul de sac. It feels like rejection. It feels like failure. But it isn’t. You simply ran out of road on that route. So, it’s time to back up, turn around, and look for a new route to get where you want to go.

And as long as you keep smiling and moving forward, the road to extraordinary leadership is going to be far better than you can imagine – because, eventually, through all its twists and turns, it leads to happiness. So if you’re currently struggling, hang in there. Remember, sometimes the best thing that can possibly happen to you in the long run is not getting exactly what you want right now.

In the journey of life for extraordinary leadership, many lessons have emerged from studying many extraordinary leaders. We should all try to learn from them and leave leadership legacies wherever we find ourselves!